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Abstract 
Postural instability and gait difficulties are common symptoms in people with 
Parkinson’s disease (PD). These symptoms can lead to falls, fall-related injuries and 
reduced quality of life in this population. Concomitantly, the prevalence of cognitive 
impairment is greater in people with PD than in older adults. Recent studies have 
indicated a link between cognitive impairment, particularly executive function, and 
postural instability and gait difficulties in older adults. However, the effects of 
executive impairment on balance control and gait characteristics are not fully 
clarified in people with PD. The present study used extensive executive function 
measures and two different dual task paradigms both during gait and quiet balance to 
investigate the relationship between executive function and motor capacities. 
Furthermore, cerebral activation in the prefrontal cortex (PFC) may play a key role in 
mediation of the executive function and performances on balance and gait. However, 
few studies have used functional Near-Infrared Spectroscopy (fNIRS) methods to 
explore the functional relationship between cerebral activation in the PFC region and 
executive function in people with PD. 
The primary aims of this research were to determine: 1) which specific aspects 
of the executive function contribute to balance and gait performance in people with 
PD; 2) the impact of executive function on static postural stability under dual tasks in 
people with PD; 3) the impact of executive function on gait characteristics under dual 
task conditions in people with PD; and 4) whether brain activation in the PFC region 
is associated with decreased executive function in people with PD. To address these 
aims, this study consisted of the following two phases. 
Phase I: Clinical balance and gait tests and executive function and attention 
were investigated in 20 participants with PD and 20 age- and gender-matched 
healthy controls. Clinical gait and balance measures included the Tinetti, Timed Up 
& Go, Berg Balance Scale and the Functional Reach tests. General cognition was 
assessed using the Mini Mental State Examination (MMSE) and Addenbrooke’s 
Cognitive Examination (ACE). Executive function was evaluated using the Trail 
Making Tests (TMT-A and TMT-B) and a computerised cognitive battery of tests 
which included a series of choice reaction time (CRT) tests. The results showed that 
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the participants with PD performed significantly poorer than controls in the clinical 
tests of balance and gait, and took longer on the Trail Making Tests, CRT-Location 
and CRT-Colour (presence of inhibition response) tests. Participants with PD made 
more errors on the TMT-B than controls (p=0.003). Furthermore, deficits in 
executive function evidenced by longer CRT-Distracter times and greater errors on 
the TMT-B were associated with poorer balance and gait performance in the PD 
group, whereas measures of general cognition were not associated in either group. 
The finding indicates that the impaired components of executive function, 
particularly those involving inhibition response and distracters, are associated with 
poorer balance and gait performance. 
Phase II: This study further investigated the following four aspects using more 
specific and objective measures in a separate cohort (15 participants with PD and 17 
healthy controls) according to the results drawn from the Phase I study. 
1) Executive function: The inhibition component of executive function was
examined using the GoNoGo, the Stroop tests and the Trail Making Tests. For the 
Stroop test, the significant interaction between group and cognition indicated the 
reaction time was slower in the incongruent condition than in the congruent 
condition for the PD group (p<0.001) but not for the control group (p>0.05). Logistic 
regression showed that group (Controls, PD) had a significant relationship with 
whether someone made errors in the Go condition (Wald χ2= 4.718, p=0.030). Hence, 
the study has demonstrated that the inhibition response is impaired for people with 
PD and supported the outcome of the Phase I. 
2) Static balance: The impact of executive function on static balance was
investigated using a force platform during the performance of a concurrent cognitive 
task. Verbal fluency (VF) and serial subtraction of numbers (SN) tasks were 
implemented separately to increase cognitive load during the measurement of 
standing balance. Postural stability was evaluated using sway parameters including 
sway path length (PL), sway area, range of sway and variability in the medio-lateral 
(ML) and anterior-posterior (AP) directions. The cognitive performances were 
assessed by evaluating the number of generated words and the accuracy of the 
calculations during the static balance measurement. The results showed that all 
postural sway measures were greater in people with PD compared to the controls, 
and when the eyes were closed compared to eyes open. Cognitive performance was 
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not significantly different between the two groups under dual tasking. Importantly, 
the significant 3-way interaction between cognition, vision and group for the 
measure of PL indicated that increased cognitive load during the eyes closed 
condition induced greater PL in the participants with PD than in controls (F (2, 188) 
=4.418, p=0.013). Furthermore, an increased cognitive load was observed to increase 
sway area and postural sway in the ML direction for both groups. No correlations 
were found between baseline executive function and balance measures for the two 
groups. Therefore, PL could be a sensitive indicator for the detection of static 
postural instability in people with PD. 
3) Gait characteristics: The impact of executive function on gait 
characteristics was investigated using the GAITRite walkway and dual task 
paradigms. Participants were asked to walk in a straight line or to complete a 180° 
turn while performing a secondary cognitive task. The two tasks incorporated to 
increase cognitive loading were the same as those used for the measurement of static 
balance. The temporal and spatial parameters of gait were used as outcome measures. 
The cognitive performances were assessed through generated words and calculations 
during gait measurement. Firstly, the results showed that stride length variability 
(p<0.001), stride time variability (p<0.001) and stance time variability (p=0.009) 
were greater for participants with PD compared to the controls when averaged over 
all cognitive conditions. Secondly, all of the gait parameters were influenced by the 
performance of a secondary cognitive task, but the VF task, as an executive measure, 
had a greater impact on these gait parameters than the serial subtraction of numbers 
(SN) task. Furthermore, the significant interactions between the type of cognitive 
load (VF, SN or none) and group indicated that the participants with PD had poorer 
gait performance compared to the controls when performing the secondary cognitive 
tasks, including reduced stride length, cadence, velocity and swing time and 
increased stride time, step width, double support time and stance time. Thirdly, 
participants with PD took longer time than controls to complete the turning condition 
(F (1, 94) =5.688, p=0.019) and velocity and cadence were reduced significantly for 
both groups when performing either cognitive task compared to normal turning. 
Fourthly, there was no significant difference in the number of generated words or the 
accuracy of the calculations between the two groups. Lastly, poorer performance on 
executive function was associated with decreases in velocity, temporal (longer stride 
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time) and spatial parameters (shorter stride length) of gait for the participants with 
PD, while the healthy controls exhibited changes in some temporal measures of the 
gait cycle (shorter swing time and increased stance time and double support time). 
These distinct different changes of the two groups may indicate their different 
strategies applied during cognitive loading. An appropriate dual task paradigm, 
particularly the VF task, could provide a useful means to detect changes in gait 
characteristics in participants with PD. 
4) Cerebral activation in the prefrontal cortex: The functional correlation
between cerebral activation in the PFC and executive function was investigated using 
the fNIRS measurement for the two groups. The VF task was used as a measure of 
executive function, while the control task was reciting weekdays (WD). The results 
of this study have indicated a distinct pattern for the control group of increased 
oxygenated haemoglobin (O2Hb) and decreased deoxygenated haemoglobin (HHb) 
during the performance of a VF task. In contrast to controls, for the participants with 
PD, cerebral O2Hb remained at baseline levels, particularly in the right PFC region. 
However, decreases in HHb were similar to controls. These findings suggest that 
brain activation in the PFC is decreased in people with PD who have deficits in 
executive function. 
This study has made a significant contribution to better understand the impact 
of executive dysfunction on balance and gait, and the functional neural correlation 
with executive dysfunction in people with PD. The findings may lead to the 
development of effective strategies to improve cognitive function in individuals with 
PD, reduce their risk of falls, and ultimately enhance their quality of life. 
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Chapter 1: Introduction 
Parkinson’s disease (PD) is one of the most common neurodegenerative 
diseases. It is clinically characterised by impaired movement, rigidity, tremor, 
postural instability and gait difficulties, many of which can lead to falls or recurrent 
falls. The incidence of falls in PD patients is as high as 46% over a three-month 
period (Pickering et al., 2007). More importantly, fall-related injuries and 
hospitalisation reduce the quality of life (QOL) in people with PD. Not surprisingly, 
the results of falls experienced by PD patients often impose a significant burden on 
patients’ families, the healthcare system and society (Bloem & Bhatia, 2004; 
Parkinson's Australia, 2007). Therefore, identification and prevention of potential 
falls is an increasingly important concern in this population. 
The identification of potential indicators for falls in people with PD has 
indicated the risk factors, which include prior falls, longer disease duration, loss of 
arm swing, abnormal posture, freezing of gait (FOG), poor balance, leg weakness, 
disease severity, orthostatic hypotension, dementia and frontal brain impairment 
(Kerr et al., 2010; Latt et al., 2009a; Wood et al., 2002). However, previous studies 
have mostly focused on understanding the physiological and clinical factors leading 
to falls in people with PD. In recent years, there has been an emergence of evidence 
that indicates a relationship between cognitive function and balance and gait 
disturbance in elderly populations. Poorer executive function is associated with 
poorer performance on gait and balance (Woollacott & Shumway-Cook, 2002; 
Yogev-Seligmann et al., 2008) and falls risk (Herman et al., 2010; Holtzer et al., 
2007) in older adults. However, the relationship between cognitive function and 
balance and gait has not been extensively examined in people with PD. 
Cognitive impairment is also a common complication and a major factor 
leading to disability and decreased QOL in people with PD. Cognitive impairment 
has been reported in 24% of newly diagnosed people with PD, which is six times 
higher than evident in healthy controls (Aarsland et al., 2001; Muslimovic et al., 
2005). Longitudinal research has shown that there is a four-year prevalence of 
developing dementia in people with PD was nearly three times higher than for a non-
PD group and up to 80% of patients with PD develop dementia after eight years 
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(Aarsland et al., 2003). Importantly, executive function is one of the commonly 
affected cognitive domains, even in the early stages of PD (Bosboom et al., 2004; 
Uekermann et al., 2004). Specifically, response inhibition as one component of 
executive function is an important factor in adaptation to the changing environment 
that occurs in daily life (Yogev-Seligmann et al., 2008). There is evidence of an 
association between impairment of response inhibition and slower responses to 
distracter stimuli and poorer balance and gait performance and increased falls in 
older people (Anstey  et al., 2009). However, little is known about the specific 
aspects of executive function association with gait and balance performance in 
people with PD (Smulders et al., 2013). Given the higher risk of falling and cognitive 
impairments in the PD population, investigations focusing on the association 
between executive function, postural instability and gait disturbance are needed. 
A dual task paradigm is designed to explore the impact of changes in cognitive 
load on static balance (Chen et al., 1996; Maylor & Wing, 1996; Shumway-Cook et 
al., 1997) and walking (Bloem et al., 2001b). The more demanding cognitive tasks 
are more likely to have a greater effect on gait (Hausdorff et al., 2001; Herman et al., 
2010) and are known to be associated with a greater risk of falling in the elderly 
(Maylor & Wing, 1996; Springer et al., 2006). Verbal fluency (VF) is considered to 
be a good measure of executive function, as it evaluates response generation 
(Dirnberger & Jahanshahi, 2013). Serial subtraction of numbers (SN) task measures 
working memory and attention (Hittmair-Delazer et al., 1994). The use of VF and 
SN tasks has been separately described in gait studies in people with PD (Brauer & 
Morris, 2010; Plotnik et al., 2011). However, the evaluation of the impacts of the two 
cognitive tasks has not previously been implemented within the same study on static 
postural control and gait for people with PD. 
Measurement of postural sway is currently used to evaluate postural instability 
in people with PD. Much work has been done in the healthy older adults (Chen et al., 
1996; Maylor & Wing, 1996; Shumway-Cook et al., 1997), but the impact of 
increased cognitive load on balance control in people with PD remains unclear. This 
is interesting, given that cognitive impairments are more evident for people with PD 
than healthy controls (Muslimovic et al., 2009). It is also unclear which postural 
sway measure is best suited for detecting the subtle alterations in standing postural 
stability for people with PD. The very few studies in people with PD that have used 
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dual task paradigms have produced discrepant findings (Marchese et al., 2003; 
Yogev-Seligmann et al., 2013). Furthermore, previous studies have focused on 
investigating the contribution of motor ability to postural instability, however, 
cognitive changes assessed under dual tasking has been less studied in people with 
PD. Therefore, it is imperative to explore whether the executive impairment 
contributes to postural instability in people with PD. 
Postural stability during walking requires greater cognitive demand than static 
stability (Lajoie et al., 1996). A small number of studies have observed that walking 
stability deteriorated in people with PD when performing concomitant cognitive 
tasks (Plotnik et al., 2011; Yogev et al., 2005) and that this decline was worse than 
that of age-matched healthy controls (Yogev-Seligmann et al., 2013; Yogev et al., 
2005). The heterogeneous changes of gait parameters include decreased speed, 
shorter stride length, (Plotnik et al., 2011; Yogev-Seligmann et al., 2013), increased 
stride time variability and swing time variability (Hausdorff et al., 2003; Plotnik et 
al., 2011; Yogev et al., 2005). Nonetheless, the relationship between executive 
function and gait performance has not been fully clarified in PD patients. 
The mechanism of correlations between executive dysfunction and postural 
instability and gait disturbance is not clarified. Fronto-striatal circuits which connect 
cortex and basal ganglia could mediate both cognitive and motor aspects. In 
particular, the most important frontal-striatal circuits involve prefrontal cortex (PFC) 
in relation to executive function (Royall et al., 2002; Tekin & Cummings, 2002). 
Therefore, the rationale of study on the functional correlations of cerebral activation 
with executive function would help to better understand the association between 
cognition and motor factor in people with PD. Functional neuroimaging techniques 
provide useful means to investigate cerebral activation during performance of an 
executive task. Using functional magnetic resonance imaging (fMRI) in healthy 
populations, brain activation has been observed primarily in the PFC cortex while 
performing executive tasks (MacDonald III et al., 2000; Mitchell, 2010). In recent 
years, functional near-infrared spectroscopy (fNIRS) has provided a unique method 
for evaluating brain activation through measuring the changes in oxygenated 
haemoglobin (O2Hb) and deoxygenated haemoglobin (HHb). The fNIRS approach 
has flexible experimental time and less movement artefacts that could make it a 
suitable option for Participants with PD whose symptoms make it difficult for them 
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to remain completely motionless (Irani et al., 2007). In healthy populations, a few 
fNIRS studies have observed that higher levels of O2Hb in the PFC have been 
associated with the performance of underlying executive function tasks (Leon-
Carrion et al., 2008; Turner & Spreng, 2012). However, little is known about the 
cerebral activation associated with executive function in people with PD. 
The objective of the research was to investigate; 1) the relationship between 
executive function and balance and gait performance in people with PD; 2) 
functional neural correlations between brain activation in the PFC region and 
executive function for people with PD and healthy controls. The study was designed 
in two phases. 
In Phase I, the study used comprehensive clinical balance and gait tests, 
executive measures of the trail making test (TMT) and a series of computerised 
choice reaction time (CRT) tests to explore any differences in executive and attention 
aspects between people with PD and healthy controls, and to examine the 
relationship between their cognitive profiles and clinical measures of balance and 
gait performance. 
Based on the outcomes drawn from the Phase I, the Phase II study further 
investigated the relationships found in the Phase I using more specific and objective 
measures. Specifically, this involved assessing people with PD and healthy controls 
using tests that broadly came under four areas. Firstly, inhibition response as 
components of executive function was assessed using the Stroop test and the 
GoNoGo test. Secondly, standing postural stability was objectively measured using a 
force platform under dual task conditions (VF, SN). Thirdly, gait was evaluated on a 
straight-line and while turning using a GAITRite walkway with dual task conditions 
which were the same as those used in the static balance evaluation. Lastly, utilising 
advanced fNIRS methods, the association between executive performance and 
cerebral activation of the PFC was examined. 
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Chapter 2: Literature Review 
For simplicity, the literature review has been organised into five distinct 
sections. Section 2.1 reviews the prevalence of falls in people with PD and discusses 
studies that have sought to identify risk factors for falls in this population. Section 
2.2 reviews studies of balance and gait performance in healthy adults and people 
with PD. To better understand executive function in mediating balance and gait, 
Section 2.3 summarises the cognition deficits and executive dysfunction in people 
with PD compared to healthy adults. Section 2.4 reviews the association between 
executive function and cerebral activation in the PFC of these populations. Lastly, 
Section 2.5 reviews the studies of the relationship between executive function and 
balance and gait in healthy adults and people with PD. 
2.1 STUDIES OF FALLS IN PARKINSON’S DISEASE 
2.1.1 Prevalence of falls in Parkinson’s disease 
PD is the second most common progressive neurodegenerative disease and is 
clinically characterised by rigidity, bradykinesia, tremor and postural instability. The 
prevalence of PD has been reported to be 1-2% in the population over ages 65 (Alves 
et al., 2008). Importantly, the figure increases with aging (de Lau & Breteler, 2006) 
and increasing worldwide (Dorsey et al., 2006). With 23% of the Australian 
population estimated to be aged 65 years and over by the year 2050, the prevalence 
of PD as an age-related progressive neurodegenerative diseases is likely to increase 
(Australian Goverment, 2010). 
Falls resulting from postural instability and gait disturbance (PIGD) are a 
common complication in people with PD. In prospective studies, the incidence of 
falls ranged from 46% for patients with PD over a three-month period (Pickering et 
al., 2007) to nearly 70% over a 12 month period (Wood et al., 2002). The incidence 
of recurrent falls (greater than one fall per year) varies between 25% (Bloem et al., 
2001a) over a six-month period to 50% over a 12 month period (Wood et al., 2002). 
A recent study investigated falls in 101 patients with PD. among 59 of the 
participants without prior falls, 17 (29%) reported falls during a six-month follow-up 
(Kerr et al., 2010). Furthermore, the incidence of falls was 50.8% in people with PD, 
 6 Chapter 2: Literature Review 
whereas it was only 14.5% of healthy controls during six-month period (Bloem et al., 
2001a). Thus, people with PD have a higher incidence of falls than healthy older 
adults. 
2.1.2 Consequences of the falls in Parkinson’s disease 
Falls can cause many recognisable consequences such as injuries (e.g. fracture) 
(Gray & Hildebrand, 2000), fear of falling (Adkin et al., 2003; Bloem et al., 2001a), 
increased nursing home or hospital admission, and increased risk of mortality and 
morbidity (Hely et al., 1999; Wenning et al., 1999) in people with PD. 25% of 
patients with PD who have experienced a fall have incurred injuries (Balash et al., 
2005; Pickering et al., 2007). Specifically, minor fall-related injuries include bruises, 
cuts and abrasions, while major fall-related complications are limb or hip fractures 
and head traumas. Overall, the risk of fall-related fracture has been generally two 
times greater for people with PD compared with age- and gender-matched controls 
and three times greater for hip fracture (Melton et al., 2006). Another study reported 
that the incidence of fracture was 35% in people with PD who survive 20 years 
( Hely et al., 2008). Therefore, falling is a major cause of injury and hospitalisation 
in people with PD. 
In addition, previous falls can lead to fear of falling (Adkin et al., 2003), which 
has been reported to be as high as 45.8% in people with PD (Bloem et al., 2001a). 
Falls are associated with restriction of mobility, loss of independence, development 
of weakness and osteoporosis, eventually reducing the QOL in this population 
(Bloem et al., 2001a; Robinson et al., 2005). More importantly, recurrent falls impair 
the ability of people with PD patients to live independently, and not surprisingly, is a 
major factor affecting QOL in this population. 
Falls pose a significant socioeconomic burden on individuals with PD, their 
families, the healthcare system and society (Bloem & Bhatia, 2004; Parkinson's 
Australia, 2007). In a large study of 1,092 people with PD, around 55% had 
experienced at least one fall in the previous two years. Of these who fell, 75.5% 
sustained injuries that required health care services and 40.6% of those with fractures 
required surgery (Wielinski et al., 2005). Therefore, PD-related injuries can result in 
increasing medical services and costs. The direct medical costs associated with 
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patients with PD who fall are estimated to be twice as high compared to those who 
do not fall (Spottke et al., 2005). 
In Australia, the estimated cost of falls for the whole population to the health 
system was AUD498.2 million in 2001 and the projected costs related to fall-related 
injuries in older adults were predicted to increase to AUD788.7 million in 2021. In 
Queensland, the costs were AUD84.7 million (2001) and estimated to rise to 
AUD152.2 million (2021), respectively (Moller, 2003). With the average age of the 
population increasing, the cost of falls and falls-related injuries will continue to rise. 
Therefore, it is imperative that research efforts to be directed toward falls risk 
identification and prevention of falls in people with PD. 
2.1.3 Identification of fall risk in Parkinson’s disease 
The identification of risk factors for falls has long been a medical challenge in 
people with PD. Previous studies have mainly focused on understanding 
demographic, clinical characteristics, and physiological factors that may lead to falls. 
These studies have yielded heterogeneous findings. The possible risk factors include 
prior falls, longer disease duration, dementia, loss of arm swing (Wood et al., 2002), 
abnormal posture, FOG, frontal impairment, poor balance, leg weakness (Latt et al., 
2009a), urinary incontinence (Balash et al., 2005), disease severity (as measured by 
the Unified Parkinson’s Disease Rating Scale (UPDRS) score), occurrence of 
orthostatic hypotension, greater postural sway in the anterior-posterior direction and 
combined with lower Tinetti total score (Kerr et al., 2010). A meta-analysis of six 
prospective studies (Pickering et al., 2007) reported that prior falls were a predictor 
for falls risk in people with PD. The risk of recurrent falls increased to as high as 
five-fold for PD patients with prior falls (Bloem et al., 2001a). Disease severity and 
therefore longer disease duration was not viewed as good predictors of falls because 
PD patients may develop compensatory strategies or become immobilised. However, 
the limitation of using previous falls to predict risk is that ideally identification 
should occur before the first fall takes place. The ability to identify fall risk in people 
with PD who have not previously fallen could have substantial clinical implications 
for planning treatment or intervention (Pickering et al., 2007). 
Postural instability is one of the key features of PD and has the potential to 
contribute to falls in this population. Several performance-based balance and gait 
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tests have been developed for healthy populations, and have recently been employed 
in individuals with PD (Kegelmeyer et al., 2007; Landers et al., 2008; Smithson et al., 
1998; Stack et al., 2005). The commonly used tests include Physiological Profile 
Assessment (PPA) (Lord et al., 2003), the Tinetti Balance Score (TBS) and Tinetti 
Gait Score (TGS) tests (Tinetti, 1986), the Timed Up & Go (TUG) assessment 
(Podsiadlo & Richardson, 1991), the Berg Balance Scale (BBS) (Berg et al., 1989), 
and the Functional Reach (FR) test (Duncan et al., 1990). Some of these tests could 
provide useful information for identifying fall risk in people with PD (Kerr et al., 
2010; Latt et al., 2009a). However, it is important to note that these tests are 
influenced by inaccurate subjective factors (Marchese et al., 2003). For example, 
common clinical measures, such as the retropulsion test (sudden pulling backward on 
the participant’s shoulders to evaluate the recovery action for stability) relies on 
subjective factors from the examiners (Bloem et al., 1998). In general, all these tests 
have low or moderate sensitivity and specificity for predicting falls. The optimal 
approach was to use a combination of these tests rather than any single test to predict 
falls. The Tinetti Balance and Gait tests and TUG test were the best clinical tests in 
predicting falls in people with PD (Kerr et al., 2010). A combination of the Tinetti 
total score (TTS), the extent of postural sway in the anterior-posterior direction, the 
UPDRS total score, the FOG score and the occurrence of symptomatic postural 
orthostasis produced the best sensitivity (78%) and specificity (84%) (Kerr et al., 
2010). 
Declines in cognitive function have been considered a contributor to fall risk. 
The impaired cognitive function is associated with increasing instability during 
standing or walking (Plotnik et al., 2011; Yogev et al., 2005) and increasing falls risk 
in PD patients (Latt et al., 2009a). When postural instability and gait disturbance co-
exist with cognitive impairment in people with PD, there is a greater impact on QOL 
for this population. For example, in PD individuals with dementia there was a 1.6-
fold increase in overall fracture risk, and a doubling of hip fracture risk compared 
with PD patients who do not have dementia (Melton et al., 2006). Specifically, 
cognitive impairment related to the frontal lobe is a predictor of falling using the 
Mini-mental State Examination (MMSE) and the Frontal Assessment Battery (FAB) 
tests (Latt et al., 2009a). Conversely, a recent study found that the MMSE scores 
were not significantly different between fallers and non-fallers (Kerr et al., 2010). 
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Since these studies have employed cognitive assessments which are bed-side or 
simple, as well as nonspecific screening measures of cognitive function, the role of 
cognitive function, especially executive function in identification of falls risk need to 
be extensively examined in people with PD. 
With respect to the specific cognitive aspects that have the potential to 
contribute to fall risk, executive function deficits are one of the most widely 
recognised to be associated with single and multiple falls (Holtzer et al., 2007). 
Previous studies have shown that older adults who have deficits in executive function 
are likely to have a high incidence of falls (Beauchet et al., 2009; Hausdorff et al., 
2001; Springer et al., 2006), and the annual incidence of falls is as high as two-fold 
(Tinetti et al., 1988) compared to cognitively normal older adults. Likewise, older 
individuals who had not previously recorded falls, but who scored more poorly on 
tests of executive performance, were three times more likely to fall during a 2-year 
follow-up period (Herman et al., 2010). Specifically, reaction time measures that 
evaluated executive function and attention were found to be significant predictors for 
fall risk in older adults (Lord & Fitzpatrick, 2001; Woolley et al., 1997). In separate 
research, it was shown that occasional falls were associated with executive 
dysfunction, but recurrent falls were associated with global cognitive decline (Anstey  
et al., 2009). Interestingly, a meta-analysis has demonstrated that executive function 
was also associated with falls in cognitively intact older adults (Muir et al., 2012). It 
is inherently difficulty to discriminate older adult with “normal’ cognition from those 
who have subtle cognitive deficits, since the prevalence of mild cognitive 
impairment is as high as 19% in this population and 22% for people who are aged 
over 75 years (Lopez et al., 2003). On the other hand, this may suggest that cognitive 
function, to some extent, contributes to gait and balance prior to presentation of 
cognitive deficits (Burn et al., 2006). 
2.2 POSTURAL INSTABILITY AND GAIT DISTURBANCE IN 
PARKINSON’S DISEASE 
2.2.1 Assessment of balance and gait performances 
Postural instability and gait difficulties are common disabling symptoms 
leading to falls in people with PD. To better understanding the mechanism of balance 
and gait abnormalities in this population, appropriate measurements of balance and 
gait are required. 
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Clinical balance and gait tests 
The clinical balance and gait tests have been described in Table 2.1. Their 
scoring criteria are mostly based on qualitative observation of performance, therefore, 
their diagnostic value for postural stability may inevitably be influenced by 
subjective factors (Marchese et al., 2003). Additionally, these tests may be somewhat 
insensitive for detecting subtle changes in balance and gait (Behrman et al., 2002a; 
Behrman et al., 2002b), or require a combination of clinical tests (Dibble & Lange, 
2006). Hence, there is a need to quantitatively and objectively measure balance 
performance. 
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Table 2.1 Clinical tests of balance and gait 
Test Description Measures Indication 
Tinetti Balance and Gait Tests The test comprises the Tinetti balance 
score (TBS) and Tinetti gait score (TGS). 
The score is produced on 16 items, 9 
items for balance evaluation and 7 items 
for gait evaluation using a three point 
ordinal scale ranging from 0 to 2 or 0 to 1. 
“0” represents the most impairment. 
The maximum score is 16 for TBS score and is 12 points for 
TGS score, and the two sub-scores are combined to produce 
the Tinetti total score (TTS) (maximum score = 28). 
Higher balance and gait 
scores indicate better 
performance. 
Berg Balance Scale (BBS) Participants are required to perform 14 
tasks that are common activities of daily 
living, such as sit to stand and picking up 
an object from the floor. Each item is 
scored from 0 to 4, 4 representing 
completion of the task. 
The maximum score is 56. Higher score represents 
better balance 
performance. 
Functional Reach (FR) This test measures the maximum distance 
that the participants can reach in a 
standing position without losing their 
balance. 
The maximum distance. Evaluation of postural 
stability; higher value 
indicates better 
performance. 
Physiological Profile 
Assessment (PPA) 
The PPA includes a series of simple tests 
of vision, peripheral sensation, muscle 
strength, reaction time, and postural sway. 
Visual acuity (number of letters correctly identified), 
Maximum strength (knee, ankle, grip), Reaction time, 
Sensations (touch, temperature, vibration and proprioception). 
Assessment of falls risk. 
The Timed Up & Go test (TUG) The participant starts with their back 
against a chair and their arms resting on 
the chair arms. On the instruction “go”, 
the participant is asked to stand up and 
walk at a comfortable pace to a point 3m 
away, turn around, return to the chair and 
sit down. 
The time taken to complete the test. Shorter times for the TUG 
test indicate better 
performance. 
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Static balance 
Generally, static balance could be evaluated by measuring the amplitude and 
range of postural sway during quiet stance. A number of objectively quantitative 
measures have been employed in the studies of postural stability, including force 
platforms, inclinometric apparatuses (Matinolli et al., 2007) and swaymeters (Menant 
et al., 2011). Force platforms are widely used to assess static balance by measuring 
the displacement of the centre of pressure (COP) with integrated force transducers. 
When participants stand on the platform, changes in the position of the pressure 
under their feet is continuously recorded. The collected data can then be used to 
derive a number of postural sway parameters. Specifically, Sway path length is a 
measure of the distance covered between successive positions based on the moving 
COP. Sway area is defined as the smallest ellipse covering about 90% of the COP 
points (C90). Medio-lateral (ML) postural sway is the range of COP displacement in 
the medio-lateral (side-to-side) direction (x-axis), while the anterior-posterior (AP) 
sway measures the range of COP displacement in the anterior-posterior (front-to-
back) direction (y-axis) (Bortolami et al., 2006). 
Gait characteristics 
Temporal (e.g. stride time) and spatial (e.g. stride distance) gait characteristics 
are widely evaluated within the experimental and clinical environments to assess 
walking capacity and function. The common parameters of gait are summarised in 
Table 2.2 and Figure 2.1 (Huxham et al., 2006). Many of the temporal characteristics 
of gait are often expressed as a percentage of the gait cycle (e.g. double support time 
cycle), which facilitates inter-subject and inter-group comparisons. Additionally, the 
variability of gait characteristics (e.g. step length, step width or stride time) is also 
considered an important index and can be assessed by calculating the standard 
deviation of the above parameters (Brach et al., 2001; Hausdorff et al., 1997). 
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Table 2.2 Definition of temporal and spatial parameters of gait 
Gait Parameters Definition 
Velocity The distance covered between the first and last footfalls divided by the 
elapsed time 
Stride length The distance covered by the left or right heel between two consecutive heel 
contacts with the same foot 
Stride time The time taken for the left or right foot to complete two consecutive heel 
contacts with the same foot (gait cycle) 
Stride width Distance between the closest point of two consecutive footsteps 
Step length Distance between two consecutive contact of feet (heel-heel) 
Step time Time interval between two steps 
Cadence Number of steps taken in a minute 
Step width Distance between the outermost point of two consecutive steps 
Swing time Time between toe-off and the subsequent heel contact with the same foot 
Double support time Time spent with both feet in contact with  ground 
Stance time Time between heel contact and the subsequent toe-off for the same foot 
 
 
 
Figure 2.1 Definitions of the spatial characteristics associated with linear walking  
Source: Huxham et al.,(2006). Gait & Posture.23 (2) 159-163 
 
2.2.2 Postural instability and gait disturbance in Parkinson’s disease 
Static balance in Parkinson’s disease 
Postural control is a complex process requiring various sensory components 
(visual, vestibular, proprioceptive) that are integrated by the central nervous system 
to inform an appropriate motor response. Theoretically, these physical functions 
deteriorate with age and accordingly affect the postural control (Maylor & Wing, 
 14 Chapter 2: Literature Review 
1996). Previous studies have demonstrated that healthy older adults present greater 
postural sway than younger adults (Sullivan et al., 2009). In situations where sensory 
input was deprived (e.g. eyes closed), postural stability was shown to be age-
associated (Wolfson et al., 1992). Furthermore, older adults with a history of falls 
have been shown to have greater postural sway than younger adults (Condron et al., 
2002). Also, Maki et al. (1996) have reported that increased sway in the ML 
direction was associated with increased risk of falling in the elderly. However, 
separate observers have argued that postural stability for older adults is similar to 
younger adults on a stable platform (Condron et al., 2002; Shumway-Cook et al., 
1997), or that the correlation between age and body sway is weak (Anstey et al., 
1993). Nevertheless, standing postural stability gradually declines as aging 
progresses. 
Measurement of postural sway using a pressure-sensitive platform, such as a 
force platform, is one of the approaches currently used to objectively evaluate 
postural instability in people with PD. A few studies reported that various measures 
of postural sway, were greater in participants with PD compared to age-matched 
healthy controls including sway area, path length and sway range in the ML direction 
(Blaszczyk et al., 2007; Mitchell et al., 1995; Viitasalo et al., 2002) and sway range 
in the anterior-posterior (AP) direction (Blaszczyk et al., 2007; Kerr et al., 2010). 
Greater postural sway in the ML direction has been shown to be positively correlated 
with the severity and duration of the disease (Viitasalo et al., 2002) and lower 
clinical balance test (BBS scores) for participants with PD (Mitchell et al., 1995). 
Greater ML sway and sway area while standing with eyes closed could be helpful for 
discriminating individuals with an increased falls risk (Blaszczyk et al., 2007). One 
of the explanations is the amount of postural sway assists is helpful to maintain 
stability during quiet stance. The increased ML sway suggests Participants with PD 
tend to maintain their stabilisation of the impaired movement in the AP direction 
(Mitchell et al., 1995). In contrast, sway range in the AP direction along with other 
variables have been demonstrated to be predictors for potential falls in PD (Kerr et 
al., 2010). Furthermore, other studies have shown that postural sway was not 
different between PD individuals and controls (Chong et al., 1999; Frenklach et al., 
2009) or that data of the sway area was actually less for PD individuals compared 
with controls (Dietz et al., 1988; Horak et al., 1992). These conflicting findings 
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indicate that postural control in people with PD is complicated and that the specific 
mechanism underpinning balance problems in this population needs to be determined. 
Since many falls occur in situations where an individual is multitasking (Tideiksaar, 
1996), recent studies have sought to establish the effect of altering cognitive factors 
on postural stability using a dual task paradigm. These details are discussed in 
Section 2.5.2 (see page 35). 
Gait characteristics in Parkinson’s disease 
Previous studies have documented a variety of alterations in gait characteristics 
in people with PD including reduced gait speed, shorter stride length (Cole et al., 
2010; Hausdorff et al., 1998), stooped posture, reduced arm swing (Morris et al., 
1994; Morris et al., 1996b), increased stride time variability (Cole et al., 2010; 
Hausdorff et al., 1998), increased double support time (Cole et al., 2010) and poorer 
coordination (Plotnik et al., 2007; Plotnik & Hausdorff, 2008). According to most of 
the literature, cadence is relatively well preserved (Latt et al., 2009b; O'Sullivan et al., 
1998), however, one study has reported decreased cadence in people with PD 
(Morris et al., 1996a). Specifically, gait characteristics could be divided into general 
mobility and rhythmicity measures. General mobility is represented by temporal and 
spatial measures, such as gait speed and stride length, while rhythmicity can be 
assessed by gait variability measures, such as stride time variability. The findings 
from clinical gait assessments have demonstrated that PD patients have abnormalities 
in both general mobility and gait rhythmicity (Yogev et al., 2005). Furthermore, 
increased variability of gait parameters has been considered as an important indicator 
of the gait abnormalities in people with PD. Increased stride time variability may 
reflect instability and arrhythmicity of gait, and therefore may be useful in the 
prediction of future falls in people with PD (Cole et al., 2011; Hausdorff et al., 1998; 
Morris et al., 1996b; Schaafsma et al., 2003). To some extent, stride time variability 
may be affected by many factors including strength, balance, gait speed, functional 
status, and mental health (Hausdorff et al., 2001). By contrast, Latt et al. (2009a) 
reported that step timing variability, step length, and velocity were not significantly 
different between PD fallers and PD non-fallers. Therefore, the implications of gait 
variability in the prediction of the falls risk in PD are not fully understood. 
To understand gait performance under real-world walking situations, several 
concurrent complex motor tasks and dual tasking have been applied in PD studies. 
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The complex locomotion includes walking and turning or holding a glass of water or 
tray (Bond & Morris, 2000). The studies of the cognitive impact on gait in patients 
with PD are reviewed in Section 2.5 (see page 38). 
2.3 COGNITIVE AND EXECUTIVE FUNCTION IMPAIRMENT IN 
PARKINSON’S DISEASE 
2.3.1 Cognitive function correlates with aging 
Considerable cross-sectional studies between older and younger adults have 
been conducted to investigate age-associated cognitive deficits. Cognitive function is 
extensively evaluated in various domains including attention, executive function, 
language, memory, visuospatial, and psychomotor performance. Consistent 
observations have indicated that declines in cognitive functions are associated, but 
the rate of cognitive decline is not parallel with aging. In fact, certain cognitive 
abilities decline with aging, and yet some cognitive functions may be relatively 
preserved (Verhaeghen & Salthouse, 1997). However, the age-associated cognitive 
functions are not well clarified. It is commonly recognised that age-related changes 
in cognition include declines in processing speed, memory (Buckner, 2004; Deary et 
al., 2009; Hedden & Gabrieli, 2004), reasoning, executive function (Buckner, 2004; 
Daigneault & Braun, 1993; Malloy & Richardson, 1994), working memory (Myerson 
et al., 2003; Salthouse, 1994) and visuospatial function (Libon et al., 1994), while the 
relatively preserved cognitive abilities include verbal ability, some numerical 
abilities, general knowledge (Deary et al., 2009), autobiographical memory and 
semantic knowledge (Hedden & Gabrieli, 2004). The inherent difficulty is 
distinguishing non-pathological aging from pathological cognitive decline, 
particularly amongst healthy older adults who may have some unnoticeable 
pathological condition. Other factors such as education, culture, socioeconomic 
status, and differences in recruitment could also affect the results of aging studies of 
cognitive function (Hedden & Gabrieli, 2004). 
Nevertheless, executive function is one of the first cognitive functions to 
decline with aging (Bryan & Luszcz, 2000; Buckner, 2004) and two of these 
important components are inhibition and switching ability, decline while aging 
(Hedden & Gabrieli, 2004; Wecker et al., 2005). A study reported slower reaction 
times when performing an executive task in older adults compared with younger 
adults (Zysset et al., 2007). It should be noted that some cognitive capacities have 
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been closely associated. For instance, decline in visuospatial performance may be 
affected by age-related decline in executive function, despite the fact that 
visuospatial ability depends on right-side hemisphere functioning (Libon et al., 1994). 
2.3.2 Executive function 
Executive function is defined as “a set of cognitive skills that are responsible 
for the planning, initiation, sequencing, and monitoring of complex goal-directed 
behaviour” (Royall et al., 2002). Alternatively, it is considered the ability to regulate 
and mediate other cognitive functions to achieve a goal (Bryan & Luszcz, 2000). In 
brief, executive function can be summarised as comprising three distinct and relevant 
factors that include set shifting, inhibition and updating (Miyake et al., 2000). As the 
important aspect of executive function, mental flexibility or shifting refers to an 
ability to switch between different tasks (Wecker et al., 2005), while inhibition is 
described as the capacity to resist an irrelevant response. 
Attention is a specific example of executive function (Stuss & Brian, 2002). 
For a better understanding of this concept, attention can be divided into separate 
functions (Lezak, 1995; Rogers, 2006): 1) Selective attention is the ability to filter 
distractive information to allow concentration on a specific task; 2) Sustained 
attention refers to the ability to maintain attention constantly over a certain period of 
time whilst performing a task; 3) Divided attention refers to the ability to participate 
in more than one task simultaneously; and 4) Alternating attention refers to the 
shifting of attention between different tasks. These aspects of attention interact 
simultaneously while performing a cognitive task. 
For the purposes of this research, a battery of executive function assessments 
has been developed to evaluate the different aspects of executive function. 
Specifically, the tests include the Stroop test (Stroop, 1935), the Trail Making Test 
(TMT) (Golden, 1976a), the Wisconsin Card Sorting Test (WCST) (Milner, 1963) 
and the verbal fluency test (Benton et al., 1978). Several executive function tests are 
described in Table 2.3. 
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Table 2.3 Tests of executive function and attention 
Test Description Measures Abilities assessed 
Trail Making Test (TMT) The TMT test has two parts. TMT-A requires a 
participant to draw a line connecting consecutive 
numbers from 1 to 25. TMT-B requires a participant to 
draw lines connecting number and letters in an 
alternating sequence 
Time and errors to complete TMT-A, 
TMT-B. Difference between the two 
completed times 
Executive function, set shifting/mental 
flexibility (TMT-B). Processing speed 
and visual search skill 
Stroop Test The Stroop test has congruent and incongruent 
conditions. The congruent condition requires a 
participant to identify colour or naming as presented. 
The incongruent condition or interference condition 
requires a participant to ignore irrelevant stimuli 
(tendency to read word) and identify the colour hues 
(e.g. respond “RED” to the word GREEN written in red 
ink) 
Reaction time. 
Number of items correctly named. 
Number of errors 
Response inhibition and monitoring 
Wisconsin Card Sorting 
Test (WCST) 
Participants are required to sort the cards based on 
specified rules such as colour or number, and the rule is 
changed after a fixed numbers of successive correct 
responses 
Total number of categories achieved. 
Number of perseverative errors. 
Number of non-perseverative errors 
Attention, conceptualisation, planning, 
set shifting, working memory (spatial) 
Verbal Fluency (VF) Participants generate as many words as possible 
beginning with a specific letter(phonemic) (Benton et 
al., 1978) or a certain category (semantic) (Goodglass et 
al., 1983) or between two different categories (Delis et 
al.,2001) 
Numbers of words generated Response generation, set activation, 
switching, response inhibition 
GoNoGo Test Participants respond to a Go signal and inhibit the 
response to the NoGo signal 
Reaction time; errors Response inhibition, attention, executive 
function 
Digit Symbol Match 
(DSM) Test 
Participants examine a series of nine meaningless 
geometric designs and then for each symbol in the 
sequence, they search a key for that symbol and 
substitute a digit for the symbol 
The score is the number of correct 
substitutions in each time interval 
(Spreen & Strauss, 1998) 
Attention and processing speed 
 Chapter 2: Literature Review 19 
2.3.3 Cognitive impairment in Parkinson’s disease 
PD with dementia 
The prevalence of PD with dementia (PDD) has been reported to be between 
25 and 30%, which is four to six times higher than in age-matched healthy controls 
(Aarsland & Kurz, 2010; Aarsland et al., 2005). Longitudinal research has shown 
that the four-year prevalence of developing dementia in people with PD was nearly 
three times higher than that in a non-PD group and up to 80% of PD patients 
developed dementia after eight years of follow-up (Aarsland et al., 2003). Similarly, 
about 50% of newly diagnosed people with PD showed cognitive decline and 9% had 
dementia after three years of follow-up (Muslimovic et al., 2009). Therefore, the 
accumulate prevalence of dementia increases as the disease progresses. 
Generally, the criterion for the diagnosis of PDD is based on the Diagnostic 
and Statistical Manual of Mental Disorders Revised Fourth Edition (DSM-IV). The 
criteria for PDD is defined as impaired cognitive function in more than one domain 
and a decline in cognitive function from the cognitive level of prior-onset of the 
disease that is severe enough to affect daily life (social, functional activities) (Emre 
et al., 2007). A crucial issue for PDD is to identify the impact on daily life caused by 
cognitive impairment rather than motor factors. Theoretically, cognitive impairment 
is detected using standardised global neuropsychological instruments such as the 
Mattis Dementia Rating Scale (Matteau et al., 2012), which is sensitive to 
subcortical-frontal dementia that is common in people with PD. Additionally, brief 
global cognitive assessments, such as the MMSE, have been widely used in PD 
studies and several other instruments have been developed on the features of 
cognitive deficits in PD (e.g. Parkinson’s Disease Cognitive Rating Scale; PD-CRS; 
(Pagonabarraga et al., 2008)). 
1) The Mini-Mental State Examination (Folstein et al., 1975) is widely used in 
both the general and PD population (Dubois et al., 2007). The major advantage of the 
MMSE is that it is easy to administer and only takes a short amount of time to 
complete. The MMSE is used as a screening instrument for dementia and the 
acceptable cut-off score is either <24 (Tangalos et al., 1996) or <25 (Dubois et al., 
2007). However, MMSE is not sensitive to executive dysfunction (Dubois et al., 
2007). 
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2) The Addenbrooke’s Cognitive Examination (ACE) was developed by 
Mathuranath (2000) and revised by Mioshi et al. (2006). The ACE comprises items 
of the MMSE and accordingly produces both the ACE and MMSE scores. The ACE 
evaluates five cognitive domains including attention/orientation, memory, fluency, 
language and visuospatial skills. The test has higher reliability, construct validity and 
sensitivity than the MMSE for screening dementia and it is a reliable instrument for 
the early detection of dementia (Mathuranath et al., 2000), including evaluation of 
general cognitive function in PD studies (McColgan et al., 2012). The ACE takes 
between 15 and 20 minutes to administer and has a maximum score of 100. A total 
score of < 82 has been shown to provide 84% sensitivity and 100% specificity for the 
identification of dementia (Mioshi et al., 2006). 
3) The Parkinson’s Disease Cognitive Rating Scale (PD-CRS) consists of 
seven cognitive tasks assessing frontal-subcortical functions, namely sustained 
attention, working memory, alternating and action verbal fluencies, clock drawing, 
immediate and delayed free-recall verbal memory; and two tasks assessing 
instrumental-cortical functions, namely confrontation naming and copying a clock. 
The PD-CRS is a reliable and validated PD-specific cognitive battery for PDD and 
fronto-subcortical deficits (Pagonabarraga et al., 2008). Total score on the PD-CRS 
ranges from 0 to 204 (higher scores indicate better functioning), with the subcortical 
score assessed out of a maximum of 174 points and cortical score assessed out of a 
maximum of 30 points, with higher scores indicating better functioning. Notably, a 
recent study reported that the PD-CRS score was closely correlated with the ACE 
scores in people with PD, but the PD-CRS took longer to complete than the ACE 
(McColgan et al., 2012). 
PD with mild cognitive impairment 
Previous studies have found that those people with PD whose cognitive deficits 
do not reach a sufficient level to be classified as PDD can be classified as PD with 
mild cognitive impairment (PD-MCI). The prevalence of PD-MCI has been reported 
to be between 19% and 38% (mean 27%) (Litvan et al., 2011), which is two times 
higher than that in the general population (Aarsland et al., 2009). Understandably, 
the rate of PD-MCI may be lower in an early stage PD cohort, but may be higher for 
patients who are in the more advanced or late stages of the condition. The diagnosis 
of PD-MCI is influenced by a general lack of consensus around the cognitive deficits 
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that typify mild cognitive impairment (MCI) and the difficulties with identifying 
cognitive deficits that are not significant enough to affect daily activities (Petersen et 
al., 1999). The criterion has recently been defined (Litvan et al., 2012). Furthermore, 
different criteria result in variation of the prevalence. A recent study assessed four 
cognitive domains including executive function, attention, memory and visuospatial 
ability in people with PD and healthy controls. This study suggested using two 
cognitive test scores at 1.5 SD lower than the scores of the controls for any single 
domain across the four cognitive domains. This resulted in a 30% prevalence of PD-
MCI. Alternatively, using one cognitive test score at 1.5 SD lower than that of the 
controls in any two cognitive domains showed a 37% prevalence of PD-MCI 
(Dalrymple-Alford et al., 2011). Therefore, it is not surprising that the prevalence of 
PD-MCI has been reported to be as high as 55% (Janvin et al., 2003). 
PD-MCI has been recognised as a predictor for the development of dementia in 
people with PD. A study prospectively investigated community-based non-demented 
PD individuals and reported that 62% of the PD-MCI patients developed dementia 
after a 4-year follow-up, whereas only 20% of the cognitively intact Participants with 
PD developed dementia (Janvin et al., 2006). Overall, the PD-MCI subjects are more 
likely to develop dementia compared to healthy controls. 
Profiles of cognitive impairment in Parkinson’s disease 
Studies have demonstrated cognitive impairments in PD across a wide range of 
cognitive domains including executive function (Aarsland et al., 2009; Levy et al., 
2002; Mahieux et al., 1998), attention (Dujardin et al., 1999), visuospatial 
dysfunction (Aarsland et al., 2009; Levin et al., 1991; Mahieux et al., 1998; Stern et 
al., 1993), verbal fluency, memory and language dysfunction (Levy et al., 2002). 
However, the areas of cognition that have been shown to deteriorate the most in 
people with PD are global cognitive functions (Janvin et al., 2003), processing ability 
(Reid et al., 2011), and attention and executive function (Aarsland et al., 2009; Emre, 
2003; Muslimovic et al., 2005). Particularly, deficits in these functions have also 
been reported for patients who are in the early stages of the disease (Muslimovic et 
al., 2005; Uekermann et al., 2004). However, it should be noted that some 
neuropsychological assessments are unable to independently assess different areas of 
cognitive domains, as many of them overlap. For example, the Stroop test, the TMT-
A and TMT-B tests could be viewed as assessing either attention or executive 
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function. Nonetheless, non-memory impairments predominantly reported in people 
with PD (Aarsland et al., 2009; Janvin et al., 2006) and visuospatial deficits are 
likely to combine with deficits in other cognitive domains (Dalrymple-Alford et al., 
2011). Therefore, it is clear that deficits in attention, executive function, memory, 
and visuospatial abilities are common cognitive problems for people with PD 
(Dalrymple-Alford et al., 2011; Janvin et al., 2003; Reid et al., 2011). 
Cognitive decline has been previously viewed as a subcortical type of cognitive 
impairment in PD (Beatty et al., 2003). Presumably, subcortical items are derived 
from assessments of attention, executive function, visuospatial and construction 
abilities, whereas cortical scores are derived from language and memory evaluations. 
As a result, subcortical scores are greater than cortical scores in PDD when 
compared with healthy controls (Beatty et al., 2003). Another study assessed frontal 
impairment using the Tower of London (TOL) test while verbal fluency and 
temporal lobe impairment used pattern recognition memory. The results showed that 
34% of a population of participants with PD had deficits in frontostriatal functioning, 
while 24% had reduced temporal functioning, and 42% had impaired functioning in 
both domains (Foltynie et al., 2004). In addition, posterior impairment has also been 
reported in another study using the pentagon copying test, which defines visuospatial 
and construction ability for parietal functioning (Williams-Gray et al., 2007). The 
discrepancies that exist between separate studies provide evidence to suggest that 
there might be multiple patterns of cognitive decline in people with PD, exhibiting 
executive-visuospatial impairment and memory-dominant impairment (Aarsland & 
Kurz, 2010), which could be explained by the combination of subcortical and cortical 
dysfunction (Bosboom et al., 2004). 
This knowledge of the impaired cognitive domains has been used in prediction 
of dementia in people with PD. A study reported the most frequent cognitive deficits 
were evident on measures of the digit symbol match (DSM) test, the TOL test, the 
TMT-B, the clock drawing task and the memory score in non-demented individuals 
with PD (Muslimovic et al., 2005). After a three-year follow-up, these measures 
remained sensitive, and the Stroop interference test and controlled oral word 
association test also became sensitive measures. Overall, attention and psychomotor 
speed were shown to deteriorate more rapidly over time than other cognitive 
functions in people with PD. Executive function, visuospatial ability and memory 
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become declined domains (Muslimovic et al., 2009). Interestingly, another study 
classified PD-MCI into a single non-memory cognitive domain, deficit in memory 
and multiple cognitive domains. The results revealed that deficit in a single non-
memory cognitive domain and multiple cognitive domains may show a higher risk of 
developing dementia in the future. In contrast, amnestic PD-MCI was not associated 
with developing dementia in people with PD (Janvin et al., 2006). Nevertheless, 
impairment of attention and executive function are some of the most commonly 
reported cognitive changes to affect people with PD. 
Attention and executive function impairment in Parkinson’s disease 
Since impairments in executive functioning were first described in people with 
PD (Dubois & Pillon, 1997), relatively few studies have emphasised the importance 
of studying executive function in these individuals. Specific deficits in executive 
function that have been reported for people with PD include, a poorer ability to 
develop plans or strategies (Sammer et al., 2006), an impaired capacity to maintain 
or inhibit attention (Mahieux et al., 1998), reduced flexibility in thinking or set 
shifting (Dubois & Pillon, 1997; Dujardin et al., 1999; Monchi et al., 2004), and a 
decreased working memory (Jacobs et al., 1995; Levy et al., 2002; Woods & Tröster, 
2003) or difficulties with the whole goal-directed executive process (Williams-Gray 
et al., 2007). The WCST and verbal fluency tests are used as executive measures and 
have been demonstrated declines in executive function for people with PD (Green et 
al., 2002; Lees & Smith, 1983). Conversely, another study used the Stroop test and 
WCST tests and the verbal fluency (VF) task to evaluate executive impairment. 
Interestingly, the Stroop test and the VF task provided evidence of deficits in 
executive functioning, whereas the WCST task did not show any deficits for the PD 
population (Mahieux et al., 1998). Thus, the appropriate executive measures for 
identification of executive dysfunction in PD are yet to be determined. 
It is important to note that some components of executive function require 
motor skills. Due to impairments of motor function such as tremor and bradykinesia 
in people with PD, the selection of appropriate executive function assessments 
should have a minimal motor requirement. The TMT and Stroop tests are 
assessments that both place a relatively small emphasis on motor function and, 
importantly, they are easy to administer. These tests examine executive ability and 
reflect mental flexibility and response inhibition, which are important abilities in 
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adapting to changing environments (Yogev-Seligmann et al., 2008). The difference 
between the time taken to complete the TMT-A and the TMT-B has also been used 
when movement speed is compromised such as often occurs in PD (Plotnik et al., 
2011). 
Previous studies have revealed that phonemic rather than semantic fluency 
declined in people with PD (Levy et al., 2002). However, these findings cannot rule 
out that some overlap exists between frontally- and temporally- based executive 
strategies because verbal fluency involves short-term memory to retrieve specific 
information. Furthermore, working memory is known to store this type of 
information (e.g. verbal) and is also involved in other executive function components 
(selection, manipulation, and coordination of information) during the adaptive 
process. Working memory is therefore considered to be associated with executive 
function (Buckner, 2004) or to be viewed as a component of executive function 
(Dubois et al., 2007). Working memory impairment (Owen et al., 1992) could be 
explained by executive dysfunction that leads to the defective usage of stored 
information in people with PD (Bosboom et al., 2004). In addition, visuospatial 
ability is influenced by executive function such as planning (Bosboom et al., 2004). 
As previously stated, executive dysfunction is viewed as a subcortical-
cognitive syndrome (Bohnen et al., 2006; Pagonabarraga et al., 2008). The pattern of 
executive impairment exhibited in cognitive flexibility and working memory are 
similar to symptoms in people with frontal lobe lesions. Therefore, the emerging 
concepts of ‘fronto-executive dysfunction’, ‘frontostriatal syndrome’ (Kehagia et al., 
2010), or frontostriatal executive dysfunction (Owen et al., 1992) have been 
postulated to describe the cognitive impairment in people with PD, even in early 
stages of the disease. Previous research suggests that cognitive deficits in non-
demented PD are also associated with changes within the frontostriatal connections  
(Williams-Gray et al., 2007). Thus, the pattern of executive deficits in PD may not 
only arise from frontal pathology, but may also result from interruptions within 
frontostriatal circuitry or degeneration in the frontal-subcortical tracts (Dubois & 
Pillon, 1997; Leh et al., 2009; Owen, 2004). 
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2.4 EXECUTIVE FUNCTION AND HEMODYNAMIC CHANGES IN THE 
PREFRONTAL REGION 
2.4.1 Functional neuroimaging techniques 
Executive function has been considered to be related to the frontal cortex, 
particularly, the PFC. Figure 2.2 depicts the dorsolateral prefrontal cortex (DLPFC), 
the largest part of which is region 9, followed by regions 10 and 46. Over the past 
few decades, the neuroanatomical correlation of executive function have been 
evaluated in brain-damaged people (e.g. frontal damaged) and these studies have 
demonstrated that deficits in executive function are associated with frontal lobe 
lesions (Demakis, 2004; Golden, 1976a). With the development of functional 
neuroimaging techniques, particularly fMRI and fNIRS, the functional neural 
correlation of the prefrontal region could be investigated within the intact nervous 
system. 
 
Figure 2.2 Map of Brodmann areas (sagittal view) 
Source: http://www.umich.edu/~cogneuro/jpg/Brodmann.html 
 
Functional magnetic resonance imaging 
fMRI technique measures regional cerebral oxygenation and regional cerebral 
blood flow (rCBF). Theoretically, the MRI signal is dependent on the uniformity of 
the magnetic properties of water. The property of HHb (deoxygenated haemoglobin) 
is highly paramagnetic in contrast to surrounding tissues, whereas O2Hb (oxygenated 
haemoglobin) has lower paramagnetic qualities and causes a more uniform magnetic 
field. The BOLD (blood oxygen level-dependent) signal is an important indicator 
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which reflects relative changes in blood oxygen concentration (HHb level) in the 
defined area. Generally, brain activation is reflected by increased metabolic and 
hemodynamic changes in response to cognitive stimuli. Increased consumption of 
oxygen in an activated area leads to an enhanced HHb concentration, and 
subsequently, the decreased oxygen and glucose result in vasodilatation of the 
brain’s arteries. As a result, cerebral blood volume (CBV) and rCBF increase and 
more oxygen and glucose are supplied to the activated region. The increased CBF 
leads to enhanced O2Hb and decreased HHb. The mechanism is defined as 
neurovascular coupling (Gratton et al., 2001). Therefore, brain activation is 
considered as a response to functional stimulation. Although fMRI has good spatial 
resolution, it is unavoidably restricted by the closet testing environment in which it is 
difficult to assess executive function concurrently in the presence of highly 
influential movement artefacts (Chance et al., 1993). 
Functional near-infrared spectroscopy 
The fNIRS technique provides a non-invasive and unique method to assess 
brain activation by measuring the change in O2Hb and HHb in vivo. The spectrum of 
infrared light is between 700nm-1400nm and the light sources are emitted from 
either light emitting diodes (LEDs) or a fibre optical bundle (optode). Afterwards, a 
light detector receives the transmitted light after its absorbance through tissue. 
Typically, the O2Hb is loaded with oxygen and is red in colour, while the HHb is 
depleted of oxygen and is coloured purple-blue (Lague-Beauvais et al., 2013). The 
different colour represents different wavelengths; as a result, the different 
haemoglobins absorb the near-infrared light in the characteristics spectra range. 
Therefore, the level of O2Hb can be distinguished from the change to HHb by 
measuring the change of absorption reflectance at different spectrums for O2Hb and 
HHb, respectively. Several studies have validated the method (Chance et al., 1993; 
Hoshi & Tamura, 1993), and the approach has recently been applied to brain 
functional research. In summary, fNIRS is a unique technique reflecting neuronal 
activation by variation in O2Hb and HHb concentration comparisons of baseline 
measurements. 
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Figure 2.3 O2Hb, HHb, and tHb changes in fNIRS measurement 
Source: (Hoshi, 2003). 
 
Notes: Relative concentration changes in O2Hb, HHb, and total haemoglobin (tHb) during the 
performance of the n-back task. Baselines were selected from the resting state, and these values are 
taken as zero for each signal. Changes from baseline are represented as a relative amount with an 
arbitrary unit. Upward (plus) and downward (minus) trends show increases and decreases in values, 
respectively. 
 
Importantly, optical measures in fNIRS have been cross-validated in line with 
BOLD-based fMRI in several studies (Huppert et al., 2006; Strangman et al., 2002; 
Toronov et al., 2001). Considering HHb is the common basis for these two functional 
neuroimaging techniques, the level of HHb has understandably been considered to be 
associated with the BOLD signal for fMRI (Huppert et al., 2006; Toronov et al., 
2001). A study was performed using both fMRI and fNIRS methodologies on an 
event-related motor task (finger tapping) in 11 healthy subjects. (Huppert et al., 
2006). The study reported the hemodynamic changes in the primary motor and 
sensory regions in the BOLD-based fMRI temporally corresponded with the fNIRS 
approach. A strong correlation was found between the HHb measured with fNIRS 
and the BOLD signal from the fMRI. Interestingly, another study found all optical 
measures, O2Hb, HHb and total haemoglobin (tHb: the sum of O2Hb and HHb) were 
correlated with the BOLD-based fMRI, but the highest correlation was for the O2Hb 
measure (Strangman et al., 2002). This has been supported by the concentration of 
O2Hb elevation which may be a sensitive and reliable indicator to reflect cerebral 
activation (Obrig & Villringer, 2003) and alteration in rCBF (Heinzel et al., 2013). 
Overall, brain activation is accompanied with hemodynamic and metabolic changes 
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(increased rCMR and rCBF), exhibiting increased O2Hb and decreased HHb 
(Herrmann et al., 2005; Huppert et al., 2006; Strangman et al., 2003) in fNIRS 
measurements (see Figure 2.3). The advantage of the fNIRS technique is the flexibity 
of the experimental time to simultaneously measure brain activation when 
performing executive tasks. In particular, the fNIRS technique has less movement 
artefacts (Irani et al., 2007), and is feasible for Participants with PD who often have 
difficulties with maintaining a motionless state. Therefore, fNIRS is a promising 
quantitative approach to explore the correlation between neural activation and 
hemodynamic changes induced by a cognitive task. 
2.4.2 Cerebral activation correlation with executive function in healthy people 
Theoretically, cognitive task results in neuronal activation characterised by an 
increased O2Hb and a decreased in HHb, and increased rCBF in the related region of 
the cerebral cortex. A number of fMRI studies have revealed cerebral activation 
primarily in the DLPFC and anterior cingulated cortex during the performance of 
different executive function tasks for healthy subjects, including the interference 
(incongruent) condition of the Stroop test (Leung et al., 2000; MacDonald III et al., 
2000; Mitchell, 2010), in virtual stylus TMT task (Zakzanis et al., 2005) and the VF 
task (Fu et al., 2002). As the complexity of executive tasks increased, activation in 
the DLPFC region was relative constant (Mitchell, 2010), while more cortical 
regions besides the PFC could be recruited including parietal cortex and the 
supplementary premotor area (Yeung et al., 2006) even sub-cortical regions (Fu et al., 
2002). Specifically, a study has indicated greater brain activation in the left DLPFC 
(Zakzanis et al., 2005) or selectively in the right inferior frontal cortex for inhibition 
task, while in left inferior parietal cortex for attentional shift task (Dodds et al., 2010). 
Thus, it is assumed that the DLPFC and inferior frontal cortex are differentially 
involved in specific aspects of executive function. The DLPFC is thought to account 
for working memory, set shifting, generation, and fluency, whereas the inferior 
frontal cortex is thought to be associated with stimulus-driven behaviour, impulse 
control or inhibitory processes (Lezak, 1995; Royall et al., 2002; Royall et al., 2001; 
Stuss & Brian, 2002; Turner & Spreng, 2012). The mechanism of these multiple 
increase in brain activation may be due to the frontoparietal network modulating the 
interaction between brain regions in the PFC and parietal cortex (Dodds et al., 2010; 
Yeung et al., 2006) to enable the go-directed executive process. Nevertheless, the 
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activation of specific cerebral regions is dependent on the nature of cognitive tasks 
and the PFC region is the primary activated area. 
A number of fNIRS studies have demonstrated similar oxygenation pattern for 
healthy subjects. The PFC region is the primary region of brain activation using 
fNIRS while performing the interference task of Stroop test (Turner & Spreng, 2012). 
Additionally, a greater bilaterally increase in O2Hb in the PFC during the 
performance of the TMT-B task, which indicated the PFC region was associated with 
set shifting ability of executive function (Shibuya-Tayoshi et al., 2007). Furthermore, 
a higher level of O2Hb in the PFC was associated with shorter reaction time in the 
conflict Stroop test (Leon-Carrion et al., 2008). The PFC region is divided into 
superior and inferior prefrontal regions, the inferior frontal region was reported 
playing a key role in the Stroop interference condition (Derrfuss et al., 2005), 
particularly the left inferior frontal region (Ehlis et al., 2005). A similar activation 
pattern was reported in the inferior PFC while performing the GoNoGo task 
(inhibition response) (Herrmann et al., 2005). Importantly, increased O2Hb and 
decreased HHb change in the frontal region were found during a word fluency task, 
predominantly in the left cortex greater activation (Chaudhary et al., 2011) and the 
temporal lobe (Chaudhary et al., 2011; Kameyama et al., 2004). Executive abilities 
consist of distinct components including interference, switching, inhibition, and 
working memory, correspondingly, these components can result in different 
activation in specific regions. Therefore, fNIRS studies enable clinicians and 
scientists to identify the activation depending on involvement of cognitive 
components. 
Furthermore, a number of studies have explored the functional correlation for 
older adults. Decreased rCBF and metabolism at rest have been observed using 
positron emission tomography (PET) in older adults (Meltzer et al., 2003). 
Understandably, neuroanatomical study has observed age-associated brain structural 
changes including brain atrophy and white matter hyperintensities which particularly 
affect the frontal cortex (Raz et al., 2000). Accordingly, these structural changes may 
account for the impairment of executive function in older people. Consistently, rCBF 
markedly decreased in the anterior region compared with posterior region during 
performance of a cognitive task, which suggested the frontal region of the anterior 
area was associated with cognitive task (Gur et al., 1987). The elderly mainly recruit 
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similar brain regions to young adults during performance of executive tasks in 
bilateral DLPFC and ventrolateral prefrontal cortex (VLPFC) (Langenecker et al., 
2004). Specifically, older adults recruit the DLPFC, supplementary motor cortex and 
left inferior parietal cortex for working memory, and right inferior frontal gyrus and 
pre-supplementary motor cortex for inhibition (Turner & Spreng, 2012). However, 
older adults activated more diffused cerebral regions (DiGirolamo et al., 2001; 
Langenecker et al., 2004; Zysset et al., 2007) which were not elicited in the younger 
adults (Milham et al., 2002), even less difficult cognitive task. Compensation 
strategies have been proposed for this phenomenon. Older adults may activate more 
task-related regions to maintain the executive ability. On the other hand, the level 
neural response was less increased in the older adults when attention demands 
increased (e.g. interference condition) compared with the younger adults. The finding 
suggests older adults have inability to allocate neural resource to match increased 
cognitive demand (Milham et al., 2002; Prakash et al., 2009), although the same 
activation in the PFC using the fNIRS in older adults as younger adults (Schroeter et 
al., 2003). Nevertheless, the functional relationship between cerebral activation and 
executive function has not been well clarified. 
Switch ability is an important component of the executive process. A recent 
study using the fNIRS investigated the activation patterns in the PFC while 
performing inhibition and switch tasks in the same cohort. Older adults recruited 
more extent the bilateral anterior DLPFC for switch task besides involvement of the 
posterior left DLPFC and bilateral VLPFC during inhibition tasks (Lague-Beauvais 
et al., 2013). Switch ability mainly recruited the VLPFC, whereas inhibition mainly 
involved the DLPFC (Derrfuss et al., 2005; Milham et al., 2002; Zysset et al., 2007). 
Older adults showed activation in the frontal region even in non-switch condition 
whereas younger adults did not (DiGirolamo et al., 2001). Furthermore, a study using 
both fMRI and Diffusion Tensor Imaging techniques observed that white matter 
integrity in frontoparietal region was correlated to switch cost due to disrupt 
frontostriatal network, and the correlation was age-related (Gold et al., 2010). A 
recent study further has supported that the activation in the middle frontal and 
inferior parietal cortex are associated with age during performance of a VF task, 
suggesting to recruit more neural sources to meet increasing cognitive demand as 
compensation strategies (Heinzel et al., 2013). 
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2.4.3 Cerebral activation correlates with executive function in PD 
Brain activation is associated with increased rCBF in related regions. Many 
studies using single photon emission computed tomography (SPECT) or Positron 
Emission Tomography (PET) have mainly investigated perfusion patterns in people 
with PD. The SPECT and PET techniques can measure rCBF and metabolic change 
via radiotracer. These studies have reported executive-related decreased perfusion 
patterns in the frontal cortex (Firbank et al., 2003; Van Laere et al., 2004), posterior 
cingulate and parietal region (Nobili et al., 2011; Van Laere et al., 2004), and in the 
frontal lobe in the early stages extending to the posterior cortex in the late stages for 
patients with PD (Paschali et al., 2010). A PET study using 18F-fluorodopa revealed a 
reduced uptake in the frontal region which was associated with a poor VF task and 
decreased working memory in people with PD (Rinne et al., 2000). It is noteworthy 
that the disconnection of frontostriatal circuits may be attributed to the hypoperfusion 
in the frontal lobe and deficit in executive function in people with PD (Owen et al., 
1998; Paschali et al., 2010). In line with the assumption, stimulation of the thalamus 
and globus pallidus induced decreased rCBF in frontal lobe in people with PD 
(Sakatani et al., 1999). Specifically, the stimulation in the left caudate nucleus 
resulted in decreased rCBF in the DLPFC based on the dopamine transporter (DAT) 
of SPECT imaging during performance of a VF task in people with PD (Paschali et 
al., 2010). Overall, these findings suggest dopamine depletion in the nigrostriatal 
region may cause hypoperfusion in the cortex that correlates with executive 
performance (Nobili et al., 2011), and frontoparietal connectivity plays a key role in 
executive function for  people with PD (Paschali et al., 2010). Notably, an influx of 
CBF may not reflect brain activation because rCBF can exceed the demand of 
cerebral oxygenation (Fox & Raichle, 1986); measuring rCBF may therefore not 
reflect cerebral activation accurately. 
Patients with PD present a distinct cerebral metabolic pattern compared with 
other neurodegenerative disease (Griffith et al., 2008; Hosokai et al., 2009). An 
investigation using the PET technique reported that hypometabolism regions are 
located in the frontal and occipital cortex for cognitively intact individuals with PD, 
and extend to the posterior cortex for PD with MCI (Hosokai et al., 2009). 
Accordingly, the networks analysis derived from functional imaging has been used to 
study metabolic networks in PD (Eidelberg, 2009). A separate study reported that the 
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cognitive related activation pattern showed reduction of metabolic activity in the 
prefrontal and parietal areas (Huang et al., 2007). Furthermore, PET studies 
suggested dopamine in the extra-striatal region may account for the cognitive 
impairment in PD (Brück et al., 2006; Rinne et al., 2000). Consistently, dopamine 
levels are dependent on gene type (Williams-Gray et al., 2008) or dopaminergic 
receptor (Ko et al., 2013). Particularly, a significant correlation was observed 
between reduced dopamine input of the caudate and abnormality in metabolic 
networks relevant to cognition (Niethammer et al., 2013). Conversely, the dopamine 
level was not associated with executive performance (Ko et al., 2013). Nonetheless, 
SPECT and PET techniques provide discrepancy perfusion patterns (Owen et al., 
1998; Van Laere et al., 2004) and inevitable radioactive exposure and require a 
cognitive task is undertaken prior to imaging acquirement (Pavese & Brooks, 2009). 
fMRI and fNIRS methods are well suited to elucidate functional correlation via 
the principle of haemoglobin oxygenation in PD. An fMRI study reported that under-
activation in the frontal-parietal connection was associated with attentional set 
shifting ability, an aspect of executive impairment (Williams-Gray et al., 2008). 
Interestingly, a study using fMRI reported that cerebral activation is dependent on 
the involvement of caudate, increased activation is associated with a cognitive task 
without involvement of caudate, while decreased activation occurs in a cognitive task 
requiring caudate involvement (Monchi et al., 2007). However, the use of fMRI is 
restricted to people with PD who have difficulty maintaining a stationary position 
and a closed space is difficult to implement an executive task. As an emerging 
neuroimaging technology, fNIRS provides a unique approach with the advantage of a 
flexible experimental setting and resemble to living experiment for the participant 
and less movement artefacts. However, limited research has used fNIRS technique to 
investigate the functional correlates between brain activation and executive tasks in 
people with PD. Given the high risk of executive impairment in people with PD, 
identifying the relationship between executive function and cerebral activation using 
fNIRS in the frontal region has significant implications. 
2.5 THE RELATIONSHIP BETWEEN EXECUTIVE FUNCTION, 
BALANCE AND GAIT DISTURBANCE IN PD 
In recent years, cognitive factors have been noticed as potential contributors to 
balance and gait performance for people with PD. This has resulted in a number of 
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studies to examine the relationship between executive function and balance and gait 
mainly for older adults, but few for people with PD. There have been correlations 
shown that are indicative of relationships between executive function and balance 
and gait performance. However, the underling pathophysiology and interaction 
between motor and cognitive aspects remains poorly understood. The meaningful 
alterations balance and gait characteristics and specific cognitive involvement are yet 
to be determined. The following sections review the correlation studies of these 
aspects in older adults and in PD. 
2.5.1 Static balance and executive function in older adults 
Postural control has long been viewed as relying on sensory input with little 
attentional requirements. However, relative studies have indicated that deficits in 
sensory and motor factors alone are not sufficient to explain postural instability in 
older people (Lord et al., 1991). It has been suggested that postural stability also 
relies on high-level cognitive functioning (Lajoie et al., 1996; Teasdale et al., 1993), 
hence declines in cognition may also influence maintenance of postural stability 
(Rankin et al., 2000; Weeks et al., 2003). A dual task paradigm has been used to 
explore the cognitive impact on balance control. For example, the dual task paradigm 
has been used to compare the change in static balance when performing a secondary 
cognitive task compared with just quiet standing (Chen et al., 1996; Maylor & Wing, 
1996; Shumway-Cook et al., 1997). Furthermore, research has revealed that 
attentional requirement increases when sensory input is reduced for example, in 
situations where vision is deprived (e.g. when eyes are closed) or when 
somatosensory information is reduced (e.g. when standing on a foam surface) 
(Teasdale et al., 1993). For older adults with balance impairment (as evidenced by a 
lower BBS total score), more time was required to recover when performing a 
secondary cognitive task (Brauer et al., 2001). Furthermore, reduced cognitive 
performance was associated with increased sway path (Sullivan et al., 2009), 
providing additional evidence to support that attentional resources play a key role in 
balance control. The dual task approach could be a useful methodological approach 
to detect the subtle changes in postural sway to identify older adults who have an 
increased falls risk (Bergland & Wyller, 2004). 
Since cognitive capacity usually declines with normal aging, older adults often 
present with an inability to allocate attentional resources between balance control and 
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other cognitive demands. Compared to young adults, older individuals have been 
shown to have poorer balance performances when performing a concurrent cognitive 
task (Maylor & Wing, 1996; Teasdale et al., 1993; Woollacott & Shumway-Cook, 
2002). During dual tasking, it has been proposed that there is a typical hierarchy of 
control, such that balance control is prioritised over the performance of the secondary 
cognitive task (“Posture first” strategy). Older adults show an inability to allocate 
their attentional resource between balance control and added cognitive tasks (Lajoie 
et al., 1993). Also, older adults seem to be less capable of effectively using this 
strategy than younger adults (Bloem et al., 2001b). Support for this hierarchy of 
priorities has been provided in separate research, which speculated that during a 
concurrent completion of a balance and cognitive task, attentional resources are 
preferentially allocated to balance control to maintain stability, which may affect the 
performance of cognitive task (Shumway-Cook et al., 1997). However, despite this 
rationale, these studies showed that the decrement in the postural sway measures was 
less evident than decreases in the performance of the secondary cognitive task during 
the concurrent performance of balancing and cognitive tasks. As such, changes in 
postural stability with the performance of a secondary task may be due to changes in 
the connectivity between brain structures, which could influence the integration of 
vestibular, visual and proprioception information to stabilise posture (Coppin et al., 
2006; Shumway-Cook et al., 1997). 
To date, there have been no standardised cognitive paradigms. The different 
type and complexity of cognitive tasks utilised in dual task paradigms has indicated a 
variety demands of attention for balance control (Woollacott & Shumway-Cook, 
2002). Since executive dysfunction in PD has been demonstrated in previous 
research (Aarsland et al., 2009; Muslimovic et al., 2005), most dual task paradigms 
have been designed to evaluate the interference of different elements of executive 
function. Admittedly, a variety of cognitive tasks have been applied in dual task 
designs, including verbal fluency, arithmetic tasks, talking, counting, memorisation, 
and responses to auditory and visual stimuli. It has been found that postural stability 
of older adults was significantly worse than younger adults while performing Brooks’ 
spatial memory task and a backward digit recall (Maylor & Wing, 1996). Another 
study revealed that a working memory task deteriorated postural stability in younger 
adults (Dault et al., 2001). However, other studies have argued that mental tasks do 
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not affect postural stability in healthy subjects, showing that under different 
conditions involving different sensory inputs (eyes open or closed, firm or foam 
surface), reaction times were decreased both in younger and older adults during the 
more complex of postural tasks. Postural sway was not affected by auditory reaction 
time as a secondary task (Andersson et al., 2002). Overall, the provided evidence 
suggests that balance control involves many areas of the nervous system and further 
research aimed at better understanding its complexity would be beneficial. 
2.5.2 Static balance and executive function in Parkinson’s disease 
To date, very few studies have investigated how cognitive function influences 
postural sway in people with PD and many of these have yielded conflicting results. 
Research has shown that sway area was greater in participants with PD than in 
healthy controls while simultaneously performing a counting backward task or a 
motor sequence task, particularly in PD patients who had experienced falls 
(Marchese et al., 2003). Similar results were reported in other studies (Ashburn et al., 
2001; Morris et al., 2000). However, the study was based on retrospective falls data 
(Ashburn et al., 2001). Paradoxically, the changes in postural stability were also 
meaningfully observed not only on performance of a cognitive task but also when 
performing a motor task (motor sequence of thumb contact with the other fingers) 
(Marchese et al., 2003). By contrast, another study which used a visual-spatial 
cognitive task did not demonstrate any affects of this task on standing balance in 
people with PD (Schmit et al., 2006). More recently, Yogev-Seligmann et al. (2013) 
reported that a VF task caused a similar increase in COP velocity for people with PD 
and older adults. These conflicting findings indicate that further investigation is 
required with regards to the relationship between changes in postural sway and 
increased cognitive loadings, particularly given the potential risk of falling in 
individuals with PD. 
2.5.3 Gait characteristics and executive function in older adults 
Despite the tendency for gait to be considered an automatic and simple 
movement pattern, it is a complex motor task that is heavily reliant on cognitive 
function, especially executive function (Lajoie et al., 1993). Impairment of one or 
more of the components of executive function and attention may affect gait 
performance. For example, response inhibition allows people to focus on gait while 
 36 Chapter 2: Literature Review 
ignoring distractions that exist within our daily environment. Divided attention plays 
an important role in multi-tasking situations associated with walking (Yogev-
Seligmann et al., 2008). This has resulted in a number of studies that have examined 
the association between gait disturbances and cognitive impairment in the elderly 
population. 
Indeed, walking requires greater cognitive demands than static instability 
(Lajoie et al., 1996). The dual task paradigm has been accepted as an approach to 
assess the effect of executive function on gait. The methodology is designed such 
that participants are asked to perform a concomitant attention-demanding task while 
walking (Bloem et al., 2001b). As previously mentioned, many tasks have been 
applied in dual task research. The type and complexity of a secondary cognitive task 
can have different effects on gait performance and, hence, careful consideration must 
be given to the nature of the task when designing a research study. Not surprisingly, 
more demanding cognitive tasks are more likely to have a greater effect on gait 
(Hausdorff et al., 2001; Herman et al., 2010) and increase the risk of falling in the 
elderly (Maylor & Wing, 1996; Springer et al., 2006). There are five different 
methodologies used to assess dual tasking, including: 1) reaction time tasks; 2) 
discrimination and decision-making tasks; 3) mental tracking tasks; 4) working 
memory task; and 5) VF task. Interestingly, it has been shown that declines in verbal 
fluency performance are associated with increased age. Furthermore, VF task have 
been shown to have the greatest effect on gait speed and stride time; while working 
memory tasks have the greatest effect on gait cadence and stride length and mental 
tracking has a greater impact on stride time variability (Al-Yahya et al., 2011).  
The cumulating evidence has shown that deficits in executive function are 
associated with a variety of gait characteristics including decreased gait speed 
(Coppin et al., 2006; Hausdorff et al., 2008; Holtzer et al., 2006; Montero-Odasso et 
al., 2009), decreased step length, and increased double support time (Rosano et al., 
2005; Verghese et al., 2007), and increased variability in the spatial (e.g. stride 
length) and as well as measures of balance instability (mediolateral trunk sway) (van 
Iersel et al., 2008). Poorer performance on the TMT measures was associated with 
decreased gait speed in older adults (Ble et al., 2005; Hausdorff et al., 2005). 
Conversely, in one study it has been reported that gait parameters (gait speed, step 
 Chapter 2: Literature Review 37 
length and step length variability) were not affected by the dual task paradigm, 
despite the decline in cognitive performance with aging (Schrodt et al., 2004). 
Gait variability can be considered as an important marker for gait performance, 
because it reflects one’s capacity to adapt to changing walking environments. 
Specifically, the poorer performances on the Stroop and GoNoGo tests was shown to 
be associated with increased stride time variability in older adults (Hausdorff et al., 
2005). Similarly, swing time variability was shown to increase under dual tasking 
conditions for fallers but not for non-fallers, based on retrospective falls data 
(Springer et al., 2006). Gait alterations are controlled by the frontal region of the 
cerebral cortex, hence profound gait changes under cognitive loading may provide 
early insight into gait disturbance and falls risk in older adults (Sheridan et al., 2003). 
This notion is supported by separate research that has shown that gait variability 
predicted future falls in older people, while changes in gait velocity did not (Herman 
et al., 2010). Collectively, these findings could be interpreted to suggest that 
impairments of executive function and attention in older adults lead to a reduced 
ability to allocate cognitive resources to gait under dual task conditions (Chen et al., 
1996; Lajoie et al., 1996; Woollacott & Shumway-Cook, 2002). Accordingly, this 
inability leads to inappropriate adaption to changing situations and consequently 
increases fall risk (Herman et al., 2010; Springer et al., 2006). Possibly, cortico-
striatal loops (Alexander et al., 1986) account for the relationship between cognition 
and motor performance (see Figure 2.4). These neural networks originate in the PFC 
and connect the frontal lobe to the striatal structures. Specifically, there are three 
cortico-striatal loops that are recognised to be associated with executive functioning 
(Royall et al., 2002; Tekin & Cummings, 2002), and eventually involvement of 
modulation of gait process. 
Functional neuroimaging seems ideal for investigating correlation between 
cognition and motor profiles. Particularly, the feasibility of the fNIRS method can be 
used in actual gait investigations. A recent study using the fNIRS technique showed 
greater brain activation in the PFC when walking under dual task conditions, 
compared with a single task of walking. Importantly, the PFC activation was 
significantly decreased in older adults compared to younger adults, suggesting older 
adults may be unable to effectively use their PFC due to deficits in attention, 
executive function and gait disturbance (Holtzer et al., 2011), and increased 
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activation of the PFC in preparation for walking (Suzuki et al., 2008). Overall, the 
underlying pathophysiological mechanism is required to be extensively studied. 
 
 
Source: Dagher & Nagano-Saito, 2007 
Figure 2.4 Schematic diagram of the cortico-striatal loops 
Notes: SMA Supplementary motor area, M1 primary motor cortex, PMC premotor cortex, PFC 
prefrontal cortex, OFC orbitofrontal cortex, GPi globus pallidus internal segment, SNr substantia 
nigra pars reticulata, VL ventrolateral, MD mediodorsal, VA ventral anterior, SNc substantia nigra 
pars compacta, VTA ventral tegmental area. 
 
2.5.4 Gait characteristics and executive function in Parkinson’s disease 
As described in Section 2.1.3 (see page 7), cognitive impairment could be a 
potential predictor for fall risk in subjects with PD. Also, PD patients with postural 
stability and gait disturbance are likely to develop dementia (Burn et al., 2006; 
Muslimovic et al., 2009). Similarly, a recent study reported that executive function, 
particularly working memory and VF task, was associated with functional mobility 
measured with the TUG test and the PIGD scores (derived from the UPDRS) 
(Smulders et al., 2013). However, the evaluation of mobility only employed clinical 
measures. Investigation of this association using objective gait parameters could 
provide useful information for people with PD. Given the higher risk of falls and 
executive function impairment in people with PD, identifying the association 
between executive function and gait disturbance in PD has significant implications. 
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Relatively few studies using dual task paradigms have been done to examine 
the impact of cognitive function on gait characteristics in people with PD. Dynamic 
stability has been shown to deteriorate with increased cognitive load in people with 
PD (Plotnik et al., 2011; Yogev et al., 2005) and this decrease is greater than that 
observed for age-matched healthy people (Yogev-Seligmann et al., 2013; Yogev et 
al., 2005). These studies using different dual task paradigms have observed 
heterogeneous alterations in gait parameters. Specifically, under cognitive loading, 
PD patients tend to decrease speed, shorter stride length, (Plotnik et al., 2011; 
Yogev-Seligmann et al., 2013), increased stride time variability and swing time 
variability (Hausdorff et al., 2003; Plotnik et al., 2011; Yogev et al., 2005) and 
impaired bilateral coordination of gait (Plotnik et al., 2011; Yogev et al., 2007). A 
study using verbal fluency as a secondary cognitive task, found slower walking speed 
and greater stride variability in subjects with PD compared with healthy controls 
(Camicioli et al., 1998; Yogev-Seligmann et al., 2013). The changes in gait 
parameters (reduced speed, stride length and cadence) may be a compensation 
strategy in people with PD in response to the dual task situation in order to reduce 
the risk of falls (O'Shea et al., 2002). In contrast, one study has shown that reduction 
in walking speed that was evident when performing a secondary task was similar in 
people with PD and healthy controls (Yogev et al., 2005). Particularly, dual tasking 
paradigms that involved a motor task (e.g. coin transfer) or a cognitive task (serial 
subtraction of 3) had a similar effect on gait. Decreased speed and decreased stride 
length were observed for both PD individuals and healthy controls. Therefore, in 
order to design effective future interventions, there is a need to comprehensively 
investigate the association between cognitive function and gait difficulties in people 
with PD. 
Furthermore, dual task cost could be regarded as an indicator for risk of falls in 
people with PD (Yogev et al., 2005). A promising study has shown that practising 
performing concurrent cognitive tasks while walking may be effective in improving 
characteristics of gait (e.g. increased step length) (Brauer & Morris, 2010). However, 
there is contradiction regarding whether the “stop walking when talking” 
phenomenon does not predict falls risk in PD individuals ( Bloem et al., 2000; 
Smulders et al., 2012). The underlying mechanism of gait abnormalities under dual 
tasking in PD is not well understood. Bloem et al. (2001b) suggested that the 
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unconscious, healthy “posture first” strategy might be one of the keys to avoiding 
hazards and preventing falls during walking. Healthy older adults give priority to 
maintaining the stability of their gait patterns when walking and performing a 
cognitive task. PD individuals may inappropriately use a “posture second” strategy 
and accordingly, increase their falls risk in dual tasking situations (Bloem et al., 2006; 
Bloem et al., 2001b; Galletly & Brauer, 2005). 
The structural imaging study indicated that the PFC and subcortical areas may 
affect gait speed in older adults (Rosano et al., 2007), and these regions may be 
associated with executive function (Royall et al., 2001). Importantly, the association 
between deficits in executive function and balance and gait difficulties may be due to 
white matter abnormalities, which affect connectivity of networks between the basal 
ganglia and the frontal cortex (fronto-striatal circuits). These circuits are known to 
regulate both motor and cognitive function (Alexander et al., 1986) (see Figure 2.4). 
The disruption of subcortical white matter has been reported to be associated with 
declines in cognitive function (Beyer et al., 2006; Lee et al., 2010; Owen et al., 1992), 
and mobility (Rowe et al., 2002; Wakefield et al., 2010) in people with PD. Given 
the impaired balance caused by defective basal ganglia circuits in PD patients, they 
may require to increase allocation of attentional resources to maintain postural 
stability (Morris et al., 2000). In the future, underlying mechanisms of cognitive 
factors that contribute to postural instability and gait disturbance could be elucidated 
by combining functional and structural neuroimaging techniques in people with PD. 
2.6 SUMMARY AND IMPLICATIONS 
As outlined above, postural instability and gait disturbance and cognitive 
impairment are common disabling symptoms in people with PD compared to healthy 
adults. They are major factors causing a reduced QOL, and thereby pose a greater 
impact on quality of life if they co-exist in people with PD. Furthermore, although 
evidence has clearly shown a relationship between cognitive function deficits and 
postural instability and gait disturbance, the underlying pathophysiological 
mechanism, precise involvements, and alterations of the motor and cognition aspect 
are not fully understood in this population. 
Deficits in executive function and attention are one of the important aspects 
across a range of cognition impairments in people with PD (Aarsland et al., 2009; 
 Chapter 2: Literature Review 41 
Emre, 2003; Muslimovic et al., 2005). Importantly, it has been shown that executive 
function plays an essential role in maintenance of balance and gait. The inhibition 
response, as a key component of executive function, may affect locomotion activity 
during times of distraction in older adults (Anstey  et al., 2009). However, less is 
known about the specific aspects of executive function association with gait and 
balance performance in people with PD. Therefore, extensive investigations of the 
inhibition process associated with balance and gait are required in people with PD. 
Furthermore, executive function is functionally correlated with brain activation in a 
specific cortex. Functional neuroimaging methods provide a useful means to explore 
the cerebral activation during performance of an executive function task. Recently, 
fNIRS has provided a unique approach for evaluating brain activation by measuring 
the changes in O2Hb and HHb. One of the advantages of fNIRS is less movement 
artefacts, so it can be applied more easily to PD participant groups who may have 
difficulties maintaining motionless positions (Irani et al., 2007). The fNIRS studies 
have revealed brain activation primarily in the PFC while performing executive tasks 
in a healthy population (Heinzel et al., 2013; Herrmann et al., 2006). However, the 
functional correlation between executive function and cerebral activation remains 
unclear in people with PD. 
Executive function and attention have been shown to have an impact on 
standing balance (Lajoie et al., 1993; Shumway-Cook et al., 1997) for healthy people. 
Dual task paradigms have been used to detect cognitive impact on gait characteristics. 
Firstly, measurement of postural sway derived from displacement of the COP could 
objectively evaluate postural stability in a quiet stance. Previous studies have mainly 
assessed postural sway using dual task paradigms for older adults (Chen et al., 1996; 
Maylor & Wing, 1996; Shumway-Cook et al., 1997). Very few dual tasking studies 
have explored the cognitive impact on standing stability in people with PD 
(Marchese et al., 2003; Yogev-Seligmann et al., 2013). To date, it remains unclear 
which measure of postural sway is best suited for detecting the subtle alterations 
during performance of executive tasks for people with PD. Secondly, a number of 
studies in older adults have indicated a relationship between cognitive function and 
gait (Hausdorff et al., 2008; van Iersel et al., 2008). Few studies have reported 
executive function associated with clinical measure of mobility (Smulders et al., 
2013) or gait parameters (Yogev-Seligmann et al., 2013; Yogev et al., 2005). Due to 
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the complexity of cognitive tasks and gait measurement, it remains unclear which 
gait parameters are sensitive to identify changes under dual task situations in people 
with PD. Thirdly, FOG occurs frequently in a turning condition and is viewed as a 
contributor to falls in people with PD. However, there has been limited research 
investigating the cognitive impact on gait during a turning situation. Lastly, a variety 
of cognitive tasks have been employed in these dual task studies. The verbal fluency 
task and subtraction of numbers assess executive function and working memory, and 
hence the two cognitive loads implemented can provide comparison information to 
better understand the cognitive effect on both balance and gait in people with PD. 
Furthermore, previous studies have focused on the investigation of the motor aspects 
of the disease, whereas the performance on a secondary cognitive task has been less 
studied in people with PD. Taken together, in order to design effective future 
interventions, it is imperative to comprehensively investigate the association between 
cognitive function and gait difficulties in people with PD. 
Importantly, neuroanatomical substrate and frontostriatal circuits may account 
for the correlation between executive function, balance and gait performance. These 
networks are known to regulate both motor and cognitive function (Alexander et al., 
1986). The disruption of the networks may be responsible for declines in cognitive 
function (Beyer et al., 2006; Owen et al., 1992), and mobility (Wakefield et al., 2010) 
in people with PD. In addition, the PFC region is associated with executive function. 
Similarly, the PFC cortex has been shown to be associated with gait alteration, and 
profound gait change under cognitive loading may provide useful or earlier 
information for gait disturbance and falls risk in older adults (Sheridan et al., 2003). 
Given the higher rates of executive impairment and falls in people with PD, it is 
imperative to investigate functional correlation between cerebral activation and 
executive function in these people. 
2.7 RESEARCH QUESTIONS AND DESIGN 
2.7.1 Research questions 
1. Which specific aspects of executive function are responsible for balance 
and gait performance in people with PD? (Phase I) 
2. How does executive function influence static postural stability in people 
with PD and healthy controls? (Phase II) 
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a) Which objective balance measure accounts for cognitive effect 
under different dual task conditions? 
b) Are static balance and cognition both declined under dual task 
conditions? 
3. Does executive function influence gait characteristics in people with PD 
and healthy controls? (Phase II) 
a) Which objective gait parameters account for cognitive effect under 
dual task conditions? 
b) Are gait characteristics and cognition both declined under dual 
task conditions? 
4. Are hemodynamic changes in the PFC region associated with a decrease in 
executive function in people with PD? (Phase II) 
2.7.2 Research design 
To address the aims of this study, the research was designed in two phases as 
follows. 
Phase I of the study used comprehensive clinical balance and gait tests, the 
TMT and a series of computerised CRTs tests to explore any differences in executive 
function and attention aspects between people with PD and healthy controls, 
Furthermore, this phase of the project aimed to examine the relationship between 
people’s cognitive profiles and clinical measures of balance and gait performance. 
The combination of clinical gait and balance measures comprised the TBS, TGS, 
TTS, TUG, BBS and FR tests. Cognition assessments consisted of the MMSE and 
ACE and executive function and attention was assessed using the TMT-A, TMT-B 
and a computerised cognitive battery which included a series of CRT tests. 
Phase II was based on the results drawn from Phase I. Those results were used 
to objectively investigate the following four aspects using more specific measures in 
people with PD and healthy controls (same cohort). 
1) The study examined the components of executive function using the 
computerised Stroop test, the GoNoGo test, and the TMT between people with PD 
and healthy controls. These executive function tests measure inhibition more 
precisely as they are focused on response and flexibility abilities. 
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2) The study objectively examined the impact of executive function on 
standing postural stability using a dual task paradigm. Postural stability was 
measured using a force platform and cognitive loadings were performed concurrently. 
The testing protocol included two visual conditions (eyes open and eyes closed) for 
the three cognitive states (no additional cognitive loading, VF and SN). The testing 
orders were randomly allocated across all the participants. The outcome measures for 
postural stability were path length (PL), sway area, postural sway range in the ML 
direction and variability, and postural sway range in the AP direction and variability. 
The cognitive performances were measured by scoring the correct numbers of 
subtraction or numbers of words generated. 
3) The study examined the impact of executive function on gait characteristics 
using the dual task paradigms as in static balance. The gait characteristics were 
measured using the GAITRite walkway and the cognitive loadings were performed 
concurrently. Participants performed six conditions consisting of two walking 
conditions (walking straight and turning) and three cognitive states (no cognitive task, 
VF, SN). The testing orders were randomly allocated across all participants. 
Outcome gait parameters included gait velocity, cadence, stride time and stride time 
variability, swing time (% gait cycle) and variability, stance time (% gait cycle) and 
variability, double support time (% gait cycle), stride length and variability, step 
width and variability. For the turn condition, the outcome measures were cadence, 
steps taken and duration of turning. The cognitive performances were measured by 
scoring correct numbers of subtraction or numbers of words generated. 
4) The study utilised advanced fNIRS methods to examine the association 
between executive performance and cerebral oxygenation in the PFC. The cerebral 
activation in the PFC regions was bilaterally examined using the fNIRS approach 
when performing the VF task in people with PD and age and gender-matched 
controls. To exclude the motor factors, tasks, for example, lip movement, reciting 
weekdays (WD) task were used as a control. Outcome measures were O2Hb and 
HHb. It was hypothesised that hemodynamic change in the PFC region measured 
through O2Hb correlates to executive function in people with PD. 
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Chapter 3: Cognition and postural instability in 
people with PD 
3.1 INTRODUCTION 
Postural instability and gait disturbance are a major concern for people with PD 
particularly given their relationship to an increased risk of falls in this population 
(Cole et al., 2010; Kerr et al., 2010; Latt et al., 2009a). Although clinical tests of 
balance and gait have been widely used to assess functional capacity and fall risk in 
older adults (Tinetti, 1986) and people with PD (Kerr et al., 2010), less attention has 
been given to the possible contribution of cognitive function to postural instability in 
the PD population (Smulders et al., 2013; Thevathasan et al., 2010). 
Cognitive impairment is as common as gait and balance disturbances in people 
with PD, with a prevalence six times greater than healthy controls (Aarsland et al., 
2001). Across the range of cognitive domains, several studies have reported 
impairments in executive function and attention for people with PD (Aarsland et al., 
2009; Muslimovic et al., 2005). Specifically, impaired components of executive 
function include deficits in set shifting ability (Owen et al., 1992) and poorer 
response inhibition (Obeso et al., 2011). 
Previous evidence has suggested that decreased executive function was 
associated with poorer gait and balance performance (Holtzer et al., 2006; Persad et 
al., 2008; Watson et al., 2010) and increased falls risk (Herman et al., 2010; Holtzer 
et al., 2007) in older adults. Similarly, impairment of response inhibition and slower 
responses to distracter stimuli are also associated with poorer balance and gait 
performance and increased falls in older people (Anstey  et al., 2009). However, the 
ways in which these specific aspects of cognition affect balance and gait in people 
with PD is yet to be determined. 
Few studies have examined the impact of cognitive function on gait and 
balance performance in people with PD (Hausdorff et al., 2006; Plotnik et al., 2011). 
Yogev et al. (2005) observed that declines in executive function in people with PD 
were associated with increased gait variability while performing a concurrent 
cognitive task. Furthermore, a separate study showed that practising performing a 
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concurrent cognitive task while walking may be effective in improving 
characteristics of gait (e.g. increased step length) in people with PD (Brauer & 
Morris, 2010). Nevertheless, the existing research presents contradictory arguments 
regarding the role of cognition in predicting falls risk in individuals with PD (Bloem 
et al., 2000; Smulders et al., 2012). Therefore, in order to design effective future 
interventions, there is a need to comprehensively investigate whether executive 
function is related to postural instability and gait disturbance in this population. 
The current study evaluated balance and gait performance utilising a 
combination of commonly used clinical assessments validated in PD (Kegelmeyer et 
al., 2007; Landers et al., 2008; Smithson et al., 1998; Stack et al., 2005). These 
included the Tinetti balance and gait tests (Tinetti, 1986), the TUG (Podsiadlo & 
Richardson, 1991), the BBS (Berg et al., 1989), and the FR tests (Duncan et al., 
1990). The objective of this study was to explore any differences in executive 
function and attention aspects between people with PD and healthy controls and 
examine the relationship between their cognitive profiles and clinical measures of 
balance and gait. It was hypothesised that people with PD would perform worse on 
measures of executive function and the assessments of balance and gait than their 
healthy counterparts. Furthermore, poorer performance on measures of executive 
function would be correlated with poorer performance on clinical tests of balance 
and gait. 
3.2 METHODS 
3.2.1 Participants 
The study comprised of Participants with PD (n=20) recruited from community 
support groups and neurology clinics in Southeast Queensland from June 2010 to 
December 2010. During this time, 20 age- and gender-matched healthy controls were 
enrolled from a pre-existing database of individuals who expressed an interest in 
participating in this type of research as well as patients’ spouses. Participants were 
required to be aged 40 years or over, living independently in the community, and to 
be able to walk independently without the use of aids. Participants with PD fulfilled 
the UK Brain Bank criteria (Gelb et al., 1999) and were assessed as having mild to 
moderate disease severity (Hoehn and Yahr score: Stage 1-3). Participants were 
excluded if they had undergone deep brain stimulation surgery, were unable to walk 
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independently or had: i) recent history of cardio-vascular problems; ii) injuries or 
surgery; iii) any uncorrected visual disturbances; iv) other known neurological or 
psychiatric disorders; or v) significant cognitive impairment (MMSE total scores <25 
(Folstein et al., 1975)). 
Recruitment process Flyers relating to the research were distributed in 
neurologic clinics and PD support groups. Alternatively, participants were recruited 
from a pre-existing database of patients who had expressed interest in being involved 
in research. Prospective participants were sent a letter of invitation and an 
information package, which outlined the study description and the potential risks and 
benefits of the research. A short period after the mail-out, these potential participants 
were encouraged to telephone the researcher to ascertain their interest and eligibility 
in participating. Some prospective participants contacted the researcher following 
receipt of the invitation letter to express their interest. During an initial telephone 
conversation, prospective participants were screened for eligibility via a series of 
screening questions (e.g. “do they need a walking aid?”). Once the eligible 
participants were identified and their testing assessments had been scheduled, they 
were sent a confirmation letter which outlined the time and date of the testing 
sessions and a map to assist with getting to the location of the testing sessions 
(Institute of Health and Biomedical Innovation). 
The study was approved by the UnitingCare (#1022) and Queensland 
University of Technology (# 0900000118) Human Research Ethics Committees in 
Brisbane, Australia. After a full explanation of the procedures involved in the study, 
all participants completed and signed a written informed consent form prior to 
commencing any data collection. 
3.2.2 Procedures 
Demographic characteristics and baseline assessments 
All participants completed a series of questionnaires in relation to demographic 
data, overall health status, medications. To evaluate disease state and symptom 
severity, Participants with PD were clinically evaluated using the UPDRS, the Hoehn 
and Yahr scale and the Schwab and England activity of daily living (S&E ADL) 
scale (Schwab et al., 1959). Additionally, the extent of any gait difficulties was 
evaluated using the FOG questionnaire (Giladi et al., 2000) and the PIGD derived 
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from the UPDRS (sum of items 13 to 15, 27 to 30). Participants with PD were 
classified into tremor dominant, akinetic-rigid or mixed subtypes based on UPDRS 
items according to the method described by Kang et al (2005). Tremor scores were 
derived from the sum of UPDRS items 20 and 21 divided by 4. Rigidity scores were 
derived from the sum of items 22 to 27 and 31 divided by 15. Based on the ratio of 
tremor scores to rigidity scores, Ten Participants with PD were classified as being of 
the akinetic rigid type, seven were tremor dominant and three were considered to be 
of the mixed subtype. 
The ACE (Mathuranath et al., 2000), which incorporates the MMSE score, was 
administered to all participants prior to other testing to identify any participants with 
dementia. This general cognitive screening test evaluates five cognitive domains 
including attention/orientation (date and place orientation, number subtraction, 
spelling word backwards), memory (anterograde and retrograde memory and recall), 
fluency (VF and category fluency, e.g. types of animals), language (comprehension, 
naming, reading, writing and repetition) and visuospatial skill (clock drawing, 
copying a diagram, e.g. pentagons and perceptual ability). 
During the first session, baseline assessments that included the TMT and 
clinical balance and gait assessments were completed. During the second visit, 
seventeen participants (ten participants with PD and seven controls) derived from the 
above cohort also completed a series of computerised cognitive assessments 
described previously (Anstey  et al., 2009; Derrfuss et al., 2005). Participants with 
PD performed all assessments under their optimally-medicated state. 
Clinical balance and gait assessments 
To clinically evaluate balance and gait, the participants were assessed using the 
Tinetti balance and gait tests (Tinetti, 1986), the TUG (Podsiadlo & Richardson, 
1991), the BBS (Berg et al., 1989), and the FR (Duncan et al., 1990). 
(1) Tinetti balance and gait tests (Tinetti, 1986) is a qualitatively clinical 
balance and gait assessment, which comprises a TBS (maximum score=16) and the 
TGS (maximum score=12). The two sub-scores are combined to provide the TTS 
(maximum score=28). (2) The BBS was used to assess balance while performing 14 
tasks that are common for daily living, such as sitting to standing and picking up an 
object from the floor (maximum score=56). (3) FR was used to measure the 
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maximum distance that a participant could reach without losing his/her balance in a 
standing position. (4) The TUG test is a timed test to assess mobility. It measures the 
time taken for a participant to stand from a seated position, to walk at a comfortable 
pace to a distance 3m away, to turn around and to return to the chair to sit down 
(Podsiadlo & Richardson, 1991). Two trials were completed and the best of two was 
used for the analysis. Higher scores for the measures of TBS, TGS, TTS, BBS and 
FR indicate better performance, while shorter times for the TUG indicate better 
performance. 
Executive function and attention assessments 
(1) The TMT. The TMT comprises part A and part B. Participants were 
required to connect consecutive circled numbers (1 to 25) for the TMT-A and to 
connect numbers and letters in an alternating sequence (1-A-2-B-3-C) for the TMT-B. 
In both tasks, the time taken to complete the test and the number of errors were 
recorded. The difference between time taken to complete TMT-A and TMT-B (TMT 
B-A) was calculated to represent executive function controlling for processing speed 
(Lezak, 1995; Plotnik et al., 2011). Greater time and errors on the TMT indicated 
poorer executive function (Golden, 1976a; Spreen  & Strauss 1991). 
2) Computerised cognitive battery. The computerised cognitive battery 
included a series of reaction time tests, the DSM test and the Self-Ordered Pointing 
Test (SOPT). The battery has been used to assess executive function, visual attention, 
reaction time, processing speed, and working memory in older adults (Anstey  et al., 
2009; Wood et al., 2008). To familiarise participants, a series of practice trials were 
performed for all tests before commencing. 
Reaction time tests. Participants were instructed to perform a set of tasks using 
a response box of three buttons for the hands and two response pedals for the feet. 
Two buttons on the response box and the two pedals were used in all choice reaction 
time (CRT) tasks, and the additional middle button on the response box (Stop) was 
used in the CRT task that included distracters (Figure 3.1). 
For the Simple Reaction Time (SRT) test, a stimulus (picture of a red car) was 
presented at random intervals on the screen. Participants were required to respond by 
pressing the button as quickly and accurately as possible with their dominant hand. 
There were 30 trials in this test. 
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The CRT test used the same visual stimulus (picture of a red car) that was 
randomly presented in one of the four corners of the screen. Participants were asked 
to respond by pressing the button or pedal corresponding to the quadrants that the car 
displayed in. For example, if a car appeared in the top left corner of the screen, 
participants were required to press the left button with the left hand; when a car was 
presented in the bottom right corner of the screen, participant were required to press 
the right pedal with the right foot. There were 40 trials for the CRT test, with 10 
trials randomly presented in each quadrant of the screen. 
 
 
Figure 3.1 Illustration of Choice Reaction Time tests 
 
The Choice Reaction Time Location (CRT-L) task was similar to the CRT task, 
but for this test, participants were asked not to respond if the stimulus appeared in the 
top right corner. There were 40 trials in total, which included 10 trials in the “no 
response” quadrant (inhibition responses). 
The Choice Reaction Time Colour (CRT-C) task was similar to the CRT task 
but participants were instructed not to respond to the occurrence of a blue car on the 
screen. There were 64 trials including 16 trials with inhibition responses (image of a 
blue car), and the blue car was presented randomly four times in each corner of the 
screen. 
The Choice Reaction Time Distracter (CRT-D) test was similar to other CRT 
tasks, but a “stop” sign (distracter target) randomly appeared in the centre of the 
screen following a presented car. If the “stop” sign appeared on the screen, 
participants were required to press the additional middle button on the response box 
after pressing the corresponding button or pedal. Average reaction times for correct 
response (CRT-DT) and for the time taken to respond to the stop sign (CRT-DS) 
 Chapter 3: Cognition and postural instability in people with PD 51 
were recorded. The CRT-D test included 60 trials, 16 of which involved 
presentations of the stop sign (distracter). 
For all of the reaction time tasks, only correct trials were included for 
calculation of average reaction times and any values that lay further than +/-3 SD 
from the mean were replaced with a value equal to the mean ±3 SD (Wood et al., 
2008). The numbers of response inhibition errors were also recorded for the CRT-L 
and CRT-C tasks. 
Digit Symbol Match (DSM): A list of matching pairs of symbols and numbers 
was presented at the top of the screen. Participants were required to press “yes” if the 
pairs matched or “no” if the pairs unmatched. There were 72 pairs of symbols 
presented in the task and the mean reaction time for correct response was measured. 
This test has been used previously to evaluate processing speed in older adults 
(Anstey  et al., 2009). 
Self-Ordered Pointing Test (SOPT): Participants were presented with 12 
different patterns that were arranged in different orders. Participants were instructed 
to select a pattern on the first presented display, after which the display was shuffled 
and the participants were asked to select a different pattern on the next display. This 
process was repeated until all 12 original patterns had been selected without selecting 
the same pattern twice. The errors (select patterns more than once) were measured. 
Scores ranged from 0 to 11. The test was designed to evaluate executive function and 
working memory (Daigneault & Braun, 1993). 
3.2.3 Statistical analyses 
Descriptive statistics were calculated for each of the continuous variables 
derived from the assessments of cognition, executive function, balance and gait. The 
normality of the data was determined by examining frequency statistics, histograms, 
and the values of skew and kurtosis. Independent two-tailed t-test was used to 
examine mean differences between the two groups for the assessments of cognition 
and balance and gait measures. The Mann-Whitney U test was used to examine the 
difference between the two groups for the tests of cognition and balance and gait 
measures when normality assumptions were violated. The Chi-square test was used 
to compare the two groups on categorical variables (gender, errors). Correlations 
between cognition, balance and gait measures and UPDRS derived scores were 
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tested with Spearman’s correlation coefficient. All statistical analyses were 
performed using the Statistical Package for Social Sciences (SPSS v17.0 for 
Windows, SPSS Inc., Chicago, IL). The significance level was p <0.05. 
3.3 RESULTS 
Age and years of education were similar for the two groups. The participants 
with PD were predominantly in the early-stage of the disease (Table 3.1). 
 
Table 3.1 Demographic characteristics of PD and control groups  
 PD (n=20) Controls (n=20) p value 
Demographics   
Age (yrs) 65.9 (9.4) 68.9 (4.8) 0.209 
Male number (%) 13 (65) 13 (65)  
Education (yrs) 12.4 (2.5) 12.7 (3.4) 0.752 
Participants with PD characteristics   
Disease duration (yrs) 6.0 (3.8)   
UPDRS I scores 2.8 (2.2)   
UPDRS II scores 11.4 (7.4)   
UPDRS III scores 26.6 (10.8)   
UPDRS total scores 40.8 (17.8)   
H-Y stage 1.4 (0.9)   
FOG scores 2.0 (0-14.0)^   
PIGD score 4.5 (3.6)   
Tremor score 1.0 (0.7)   
Akinetic/rigidity scores 1.2 (0.5)   
S&E ADL (%) 86 (8.4)   
PD medications    
Levodopa (numbers taken) 14   
Dopaminergic agonists (numbers taken) 8   
COMT inhibitor (numbers taken) 4   
Monoamine oxidase inhibitor (numbers taken) 1   
Benzodiazepine (numbers taken) 2   
Serotonin reuptake inhibitors (numbers taken) 1   
No medication (numbers) 4   
LED (mg) 622.25 (477.17)   
 
Notes: UPDRS=Unified Parkinson’s Disease Rating Score, H-Y=Hoehn and Yahr scale, 
FOG=Freezing of Gait, PIGD=Postural Instability and Gait Disturbance, S&E ADL=the Schwab and 
England Activity of Daily Living scale, LED=Levodopa equivalents dosage (Tomlinson et al., 2010), 
COMT=catechol-O-methyltransferase. 
^ Data are not normally distributed values reported are median (range). 
All other data are normally distributed and values reported are mean (SD) and t-test. 
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3.3.1 Balance and gait performances 
Compared with the healthy controls, participants with PD performed 
significantly worse on all measures of balance and gait performance (Table 3.2). 
With the exception of FR, all of the balance and gait tests were significantly 
correlated with the UPDRS motor score and the PIGD score (p<0.01) (Table 3.3). 
 
Table 3.2 Balance and gait performance for the Parkinson’s disease and control groups 
 PD (n=20) Controls (n=20) p value 
TBS score 15 (8-16) 16 (15-16) <0.001^ 
TGS score 9.9 (2.1) 11.2 (1.0) 0.016 
TTS score 23.7 (4.4) 27.2 (1.0) 0.002 
BBS score 53 (34-56) 56 (48-56) 0.003^ 
TUG (s) 10.8 (2.5) 9.3 (1.1) 0.027 
FR (cm) 24.5 (5.9) 35.7 (6.0) <0.001 
 
Notes: TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total Score; 
TUG=Timed Up & Go, BBS =Berg Balance Scale; FR= Functional Reach. 
^ Data are not normally distributed; values reported are median (range) comparisons with Mann-
Whitney test. 
All other data are normally distributed and values reported are mean (SD) and t-test. 
Significant p values are marked in bold. 
 
Table 3.3 Correlations between UPDRS motor score and PIGD balance and gait tests 
 TBS TGS TTS TUG BBS FR 
UPDRS 
(III) 
-0.804 (<0.001) -0.635 (0.003) -0.731 (<0.001) 0.701 (0.001) -0.657 (0.002) -0.229 (0.332) 
PIGD -0.771 (<0.001) -0.809 (<0.001) -0.841 (<0.001) 0.725 (<0.001) -0.848 (<0.001) -0.309 (0.185) 
 
Notes: TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total Score; 
TUG=Timed Up & Go, BBS =Berg Balance Scale; FR=Functional Reach; UPDRS=Unified 
Parkinson’s Disease Rating Score; PIGD=Postural Instability and Gait Disturbance. 
The values in parentheses are p values. Significant p values are marked in bold. 
 
3.3.2 Cognitive function measures 
General cognitive measures 
Compared with the controls, participants with PD had significantly lower mean 
MMSE and ACE total scores and lower ACE attention and orientation subscores 
(Table 3.4). 
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Table 3.4 General cognitive function for the Parkinson’s disease and control groups 
 PD (n=20) Controls (n=20) p value 
General Cognitive Scores   
MMSE 27.6 (1.6) 28.7 (1.1) 0.016 
ACE 90.2 (6.4) 93.8 (3.8) 0.039 
Sub-Scores   
Attention/Orientation 17.1 (0.9) 17.7 (0.5) 0.013 
Memory 22.4 (3.5) 23.8 (1.7) 0.107 
Fluency 11.0 (2.2) 11.6 (2.1) 0.428 
Language 24.6 (1.0) 25.2 (1.1) 0.112 
Visuospatial 15.5 (11.0-16.0) 16.0 (14.0-16.0) 0.340^ 
Executive Function Assessments 
TMT-A (s) 48.7 (34.0-144.4) 35.4 (25.7-62.0) 0.004^ 
TMT-B (s) 118.3 (66.4-449.2) 85.2 (43.6-250.9) 0.002^ 
TMT-B (participants with errors) 13 (65%) 3 (15%) 0.003# 
TMT B-A (s) 78.0 (16.3-304.8) 49.8 (7.0-195.7) 0.015^ 
 
Notes: MMSE=Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination; TMT-
A=Trail making test A; TMT-B=Trail making test B; TMT B-A=TMT-A (time)-TMT-B (time)). One 
participant with PD made a single error and no control participants made an error on TMT-A. 
^ Data reported are median (range) and compared with Mann-Whitney test. 
All other data are normally distributed and values reported are mean (SD) and t-test. 
# Chi-square test. 
Significant p values are marked in bold. 
 
Trail making tests 
Participants with PD took significantly longer on the TMT-A (p=0.004), TMT-
B (p=0.002) and TMT B-A (p=0.015) than controls. On the TMT-A, only one 
participant with PD made a single error, while control participants recorded no errors. 
For the TMT-B thirteen participants with PD made at least one error and six made 
greater than two errors, whereas only three control participants made a single error 
(p=0.003) (Table 3.4). 
Computerised cognitive measures 
Compared to the control group, participants with PD had longer reaction times 
for the response inhibition tasks during the CRT-L (p=0.028) and CRT-C (p=0.023) 
(Table 3.5). Neither group made errors for the CRT-C task, but one participant with 
PD made an error during the CRT-L and three participants with PD made errors 
during the CRT-D task. 
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Table 3.5 Computerised cognitive measures for the Parkinson’s disease and control groups 
 
PD (n=10) Control (n=7) p value 
SRT (s) 0.287 (0.033) 0.283 (0.031) 0.816 
CRT (s) 0.743 (0.150) 0.674 (0.083) 0.293 
CRT-C (s) 0.882 (0.167) 0.731 (0.063) 0.023 
CRT-L (s) 0.850 (0.178) 0.697 (0.062) 0.028 
CRT-DT (s) 0.877 (0.198) 0.774 (0.128) 0.254 
CRT-DS (s) 2.109 (0.403) 1.912 (0.127) 0.232 
DSM (s) 2.362 (0.450) 2.213 (0.229) 0.435 
SOPT (scores) 2.400 (0.843) 2.000 (0.577) 0.295 
 
Notes: SRT=Simple Reaction Time; CRT=Choice Reaction Time; CRT-L=Choice Reaction Time 
Location; CRT-C=Choice Reaction Time Colour; CRT-DT=Choice Reaction Time Distracter; CRT-
DS=Choice Reaction Time Distracter with stop signs, DSM=Digit-Symbol Match; SOPT=Self-
Ordered Pointing Test. 
All data are normally distributed and values reported are mean (SD) and t-test. 
Significant p values are marked in bold. 
 
3.3.3 Correlations between balance and gait and cognitive and executive 
function 
For all correlations, PD and control groups were examined separately due to 
the observed differences. For the participants with PD, longer times for the TMT-A, 
TMT-B and TMT B-A and a greater number of errors on the TMT-B were all 
associated with poorer performance on the TBS. TMT-B errors were correlated with 
poorer performance on the TGS (r=-0.513, p=0.021), while the longer times on the 
TMT-B and TMT B-A were associated with poorer performance on the BBS (r=-
0.464, p=0.039 and r=-0.523, p=0.018). Furthermore, the time to complete the TMT-
A was positively associated with performance on the TUG in the PD group (r=0.509, 
p=0.026) (Table 3.6). 
For the participants with PD, slower reaction times for CRT-DT and CRT-DS 
tests were significantly correlated with lower scores on the BBS (r=-0.717, p=0.020 
and r=-0.779, p=0.008) and TGS tests (r=-0.747, p=0.013 and r=-0.735, p=0.016) 
and slower performance on the TUG test (r=0.806, p=0.005 and r=0.661, p=0.038). 
Additionally, the CRT-L times were negatively associated with the TBS scores (r=-
0.750, p=0.012) and the DSM measure was positively correlated with the TUG test 
(r=0.733, p=0.016) (Table 3.8). 
There was no correlation between any of the executive function measures and 
tremor scores. However, there were significant correlations between executive 
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function measures and the rigidity scores, PIGD scores and UPDRS motor scores 
(Table 3.6). Similarly, longer time on CRTs, particularly CRT-L and CRT-DT, were 
associated with higher PIGD scores, UPDRS motor scores and the rigidity scores 
whereas there was no correlation between CRTs and tremor scores (Table 3.8). 
There were no significant correlations between any of the cognitive measures 
and balance and gait performance in the control group (Table 3.7 and Table 3.9). 
Similarly, there were no significant correlations between the measures of global 
cognition (ACE, MMSE) and balance and gait performance for either group. 
 
Table 3.6 Correlations between cognitive function and the gait and balance measures and UPDRS 
derived scores for the PD group 
 TBS 
score 
TGS 
score 
TTS 
score 
BBS 
score 
TUG (s) FR 
(cm) 
UPDRS 
(III) 
Tremor 
score 
Rigidity 
score 
PIGD 
ACE score .371 
(.107) 
.241 
(.306) 
.283 
(.227) 
.337 
(.146) 
-.370 
(.119) 
-.073 
(.760) 
-.364 
(.115) 
-.509 
(.022) 
-.187 
(.429) 
-.290 
(.215) 
MMSE 
score 
.310 
(.184) 
.290 
(.215) 
.288 
(.217) 
.143 
(.546) 
-.366 
(.123) 
-.078 
(.744) 
-.453 
(.045) 
-.571 
(.009) 
-.336 
(.147) 
-.149 
(.531) 
TMT-A (s) -.609 
(.004) 
-.370 
(.109) 
-.491 
(.028) 
-.437 
(.054) 
.509 
(.026) 
-.286 
(.221) 
.637 
(.003) 
.266 
(.257) 
.619 
(.004) 
.466 
(.038) 
TMT-B (s) -.530 
(.016) 
-.390 
(.089) 
-.461 
(.041) 
-.464 
(.039) 
.440 
(.059) 
-.281 
(.230) 
.513 
(.021) 
.112 
(.639) 
.445 
(.049) 
.491 
(.028) 
TMT-B 
(error) 
-.533 
(.015) 
-.513 
(.021) 
-.587 
(.007) 
-.431 
(.058) 
.161 
(.511) 
-.186 
(.433) 
.467 
(.038) 
-.232 
(.325) 
.488 
(.029) 
.478 
(.033) 
TMT-B-A 
(s) 
-.460 
(.041) 
-.412 
(.071) 
-.435 
(.055) 
-.523 
(.018) 
.451 
(.053) 
-.217 
(.358) 
.418 
(.067) 
.084 
(.724) 
.343 
(.138) 
.486 
(.030) 
 
Notes: One participant with PD made an error on TMT-A. 
MMSE =Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination; TMT-
A=Trail making test A; TMT-B=Trail making test B; TMT B-A=TMT- A (time)-TMT-B (time). 
TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total Score; TUG=Timed Up 
& Go, BBS=Berg Balance Scale; FR=Functional Reach. UPDRS=Unified Parkinson’s Disease Rating 
Score; PIGD=Postural Instability and Gait Disturbance. 
The values in parentheses are p values. Significant p values are marked in bold. 
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Table 3.7 Correlations between cognition and the gait and balance measures for the control group 
 TBS score TGS score TTS score BBS score TUG (s) FR (cm) 
ACE score .217 (0.373) -.024 (0.924) .063 (0.797) .169 (0.489) .143 (0.559) -.071 (0.772) 
MMSE score .202 (0.407) -.305 (0.204) -.231 (0.341) -.101 (0.681) .152 (0.535) -.302 (0.209) 
TMT-A (s) .129 (0.598) .337 (0.158) .398 (0.091) -.018 (0.941) .449 (0.054) -.383 (0.106) 
TMT-B (s) .172 (0.481) -.021 (0.931) .046 (0.853) .053 (0.829) .356 (0.135) -.134 (0.585) 
TMT-B error .102 (0.678) .201 (0.410) .243 (0.317) .077 (0.755) .395 (0.094) -.119 (0.628) 
TMT B-A (s) .172 (0.481) -.214 (0.379) -.153 (0.532) .177 (0.468) .328 (0.170) -.159 (0.515) 
 
Notes: No control participants made an error on TMT-A. 
MMSE=Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination; TMT-
A=Trail making test A; TMT-B=Trail making test B; TMT B-A=TMT- A (time)-TMT-B (time). 
TBS= inetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total Score; TUG=Timed Up 
& Go, BBS=Berg Balance Scale; FR =Functional Reach. 
The values in parentheses are p values. 
 
Table 3.8 Correlations between computerised cognitive measures and balance and gait measures 
and UPDRS derived scores for the PD group 
 TBS 
score 
TGS 
score 
TTS 
score 
BBS 
score 
TUG (s) FR (cm) UPDRS 
(III) 
Tremor 
score 
Rigidity 
score 
PIGD 
SRT (s) -.543 
(.105) 
-.333 
(.347) 
-.421 
(.226) 
-.312 
(.381) 
.418 
(.229) 
.030 
(.933) 
.717 
(.020) 
.068 
(.853) 
.729 
(.017) 
.457 
(.184) 
CRT (s) -.517 
(.126) 
-.562 
(.091) 
-.591 
(.072) 
-.480 
(.160) 
.394 
(.260) 
.018 
(.960) 
.620 
(.056) 
-.080 
(.826) 
.723 
(.018) 
.622 
(.055) 
CRT-C 
(s) 
-.569 
(.086) 
-.432 
(.212) 
-.555 
(.096) 
-.287 
(.422) 
.455 
(.187) 
.396 
(.257) 
.547 
(.102) 
.025 
(.946) 
.693 
(.026) 
.463 
(.177) 
CRT-L 
(s) 
-.750 
(.012) 
.562 
(.091) 
-.689 
(.028) 
-.474 
(.167) 
.539 
(.108) 
.220 
(.542) 
.827 
(.003) 
.049 
(.893) 
.930 
(<.001) 
.634 
(.049) 
CRT-
DT (s) 
-.763 
(.010) 
-.747 
(.013) 
-.762 
(.010) 
-.717 
(.020) 
.806 
(.005) 
.189 
(.601) 
.875 
(.001) 
.289 
(.418) 
.809 
(.005) 
.781 
(.008) 
CRT-DS 
(s) 
-.530 
(.115) 
-.735 
(.016) 
-.671 
(.034) 
-.779 
(.008) 
.661 
(.038) 
.073 
(.841) 
.729 
(.017) 
.062 
(.866) 
.742 
(.014) 
.774 
(.009) 
DSM (s) -.550 
(.100) 
-.438 
(.205) 
-.463 
(.177) 
-.355 
(.314) 
.733 
(.016) 
.506 
(.136) 
.644 
(.044) 
.228 
(.527) 
.517 
(.126) 
.470 
(.171) 
SOPT 
score 
-.238 
(.508) 
-.447 
(.195) 
-.402 
(.249) 
-.162 
(.655) 
-.085 
(.815) 
-.475 
(.165) 
.164 
(.650) 
-.260 
(.469) 
.138 
(.704) 
.442 
(.201) 
 
Notes: SRT=Simple Reaction Time; CRT=Choice Reaction Time; CRT-L=Choice Reaction Time 
Location; CRT-C=Choice Reaction Time Colour; CRT-DT=Choice Reaction Time Distracter; CRT-
DS=Choice Reaction Time Distracter with stop sign, DSM=Digit-Symbol Match; SOPT=Self-
Ordered Pointing Test. TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total 
Score; TUG=Timed Up & Go, BBS=Berg Balance Scale; FR=Functional Reach; UPDRS=Unified 
Parkinson’s disease Rating Score; PIGD=Postural Instability and Gait Disturbance. 
The values in parentheses are p values. Significant p values are marked in bold. 
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Table 3.9 Correlations between executive functions and balance and gait measures for the control 
group 
 TGS score TTS score BBS score TUG (s) FR (cm) 
SRT (s) -.028 (0.952) -.028 (0.952) .348 (0.444) -.234 (0.613) -.054 (0.908) 
CRT (s) -.580 (0.172) -.580 (0.172) .394 (0.382) -.750 (0.052) .143 (0.760) 
CRT-C (s) -.661 (0.106) -.661 (0.106) .179 (0.701) -.523 (0.229) .432 (0.333) 
CRT-L (s) -.580 (0.172) -.580 (0.172) .158 (0.736) -.286 (0.535) .429 (0.337) 
CRT-DT (s) -.265 (0.612) -.265 (0.612) .273 (0.600) .371 (0.468) .486 (0.329) 
CRT-DS (s) -.206 (0.658) -.206 (0.658) -.020 (0.967) .000 (1.0) .143 (0.760) 
DSM (s) -.617 (0.140) -.617 (0.140) -.059 (0.900) -.607 (0.148) .071 (0.879) 
SOPT score -.420 (0.348) -.420 (0.348) -.516 (0.236) -.401 (0.373) -.134 (0.775) 
 
Note: Controls’ TBS scores are constant. 
SRT=Simple Reaction Time; CRT=Choice Reaction Time; CRT-L=Choice Reaction Time Location; 
CRT-C =Choice Reaction Time Colour; CRT-DT=Choice Reaction Time Distracter; CRT-
DS=Choice Reaction Time Distracter with stop sign, DSM=Digit-Symbol Match; SOPT=Self-
Ordered Pointing Test. TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total 
Score; TUG=Timed Up & Go, BBS=Berg Balance Scale; FR=Functional Reach. 
The values in parentheses are p values. 
 
3.4 DISCUSSION 
This study investigated the association between cognition, particularly 
executive function and attention and clinical measures of balance and gait for people 
with PD and healthy older adults. The results showed that cognition, executive 
function, and balance and gait were impaired in people with PD. Furthermore, the 
observed impairments in executive function and attention were associated with 
poorer performance on the balance and gait assessments for this population. 
These results have revealed that global cognition (MMSE and ACE total scores) 
was significantly reduced for participants with PD compared to controls. The mean 
MMSE score for the PD group was 27.6, which was comparable with the results 
(27.5) presented in a previous study (Dalrymple-Alford et al., 2011), but different 
from another study in which similar MMSE scores (28.5) were reported for 
participants with PD and controls (Plotnik et al., 2011). Although a few studies have 
identified cognitive impairment as an independent predictor of falls risk in people 
with PD (Latt et al., 2009a; Wood et al., 2002), global cognitive function (MMSE 
scores) has not previously been reported to be significantly different between PD 
fallers and non-fallers (Kerr et al., 2010). In accordance with this, the present study 
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found that the measures of global cognitive deficit (MMSE and ACE total scores) 
were not associated with poorer balance and gait performance in this population. 
With respect to the different cognitive domains, participants with PD took 
significantly longer to complete the TMT-A, which indicates deficits in attention and 
processing speed. This finding was supported by the attention/orientation sub-score 
of the ACE, which was also significantly reduced for the participants with PD. These 
findings agree with previous research that has shown that the TMT-A and attention 
index are both decreased in people with PD (Plotnik et al., 2011) and that attention 
and psychomotor speed both declined more rapidly than other aspects of cognitive 
function in this population (Muslimovic et al., 2009). 
Executive function could be summarised into three distinct factors that include 
set shifting, inhibition and updating (Miyake et al., 2000), and the TMT-B primarily 
evaluates set shifting. It was observed that participants with PD took significantly 
longer on the TMT-B and TMT B-A compared to controls. These results were 
partially consistent with a previous study (Plotnik et al., 2011), which reported that 
the TMT-B times were significantly longer for participants with PD. In contrast, this 
study reported that TMT B-A times were not significantly different to normative data; 
this disparity may be a result of constraining the sample to people with PD who 
presented with motor response fluctuations. Importantly, results from the current 
study showed that participants with PD recorded more errors on the TMT-B, 
suggesting this also could be a sensitive indicator for identifying deficits of executive 
function in people with PD. These data, however, were not reported by Plotnik and 
colleagues (Plotnik et al., 2011). 
Inhibition response may be an important component of executive function, as it 
would allow people to focus on maintaining balance during walking by ignoring 
concurrent distractions from the environment (Yogev-Seligmann et al., 2008). In two 
of the CRT tests (CRT-C and CRT-L) that involved inhibiting responses, participants 
with PD recorded longer times than controls, suggesting impaired response inhibition 
in this group. This finding is consistent with a study that used the same battery to 
assess older adults and observed that fallers performed worse than non-fallers on 
CRT-C and CRT-L tests (Anstey  et al., 2009). 
This study demonstrated that executive function rather than general cognitive 
function was correlated with poorer balance and gait performance in people with PD. 
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Similarly, Plotnik et al. (2011) reported that executive abilities (e.g. set shifting 
assessed using the TMT) were correlated with gait performance in participants with 
PD. It was also observed in the current study that the TMT B-A measure was 
significantly associated with balance scores and that participants with PD who made 
more errors on the TMT-B were likely to perform poorer on the TGS. This finding 
indicates that errors on the TMT-B may provide insight into executive function 
deficits as it excludes the influence of processing speed. Furthermore, the findings 
suggest that executive function may play a more important role in the balance and 
gait of people with PD than general cognition. 
Importantly, participants with PD with longer reaction times on the CRT-L test 
were likely to have poorer balance according to the TBS. Furthermore, slower 
reaction times on the CRT-DT and CRT-DS (presence of distracter) were correlated 
with poorer performance on the TGS, TTS, BBS and longer times on the TUG. 
These findings indicate that the impaired response inhibition for participants with PD 
may impact their capacity to walk effectively, particularly in environments with 
many distracters. 
There were distinct differences in which PD sub-types were associated with 
decreased executive function. Increased tremor severity was associated with an 
increase in overall cognitive decline (high tremor score was associated with low 
MMSE/ACE scores) but not with a decrease in executive function. It should be noted 
that the findings are in line with the latest studies (Lord et al., 2014; Pfeiffer et al., 
2014).  However, increases in both akinetic-rigidity and PIGD were both associated 
with decreased executive function. Interestingly, the PIGD score was correlated with 
the TMT (B-A) scores which is the best indicator of an executive function deficit 
(Plotnik et al., 2011). The correlations of the UPDRS (Part III) motor and rigidity 
scores were mainly related to the TMT time for the A and B tests, which is indicative 
of overall movement slowing rather than an executive function deficit. In fact, the 
pattern of rigidity correlations was very similar to those of the PIGD correlations but 
this was most likely because they share several UPDRS variables in common and, 
hence, they are not entirely independent. Increased rigidity was also more related to 
slower reaction time measures associated with executive tasks. However, general 
movement slowing, as would be indicated by increased rigidity, may also partly 
explain the correlation (as per significant SRT and CRT correlations). As the PIGD 
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measure also utilises items from the UPDRS motor scores (Part III) that are reflective 
of posture and gait then similar correlations to the clinical balance measures would 
be expected. 
One of the strengths of this study was that it assessed participants using a 
combination of commonly used clinical balance and gait tests, while previous studies 
have typically only employed one of these tests (e.g. TUG (Plotnik et al., 2011)). It is 
noteworthy that participants with PD performed worse than controls on all clinical 
balance and gait assessments in the current study. The results of the current study 
found the time of the TUG test (10.8 ± 2.5s) was consistent with one study (Kerr et 
al., 2010), but longer than in another study (9.3±7.9 s) (Plotnik et al., 2011). 
Interestingly, performance on the TUG test was more affected by deficits in 
processing speed (longer TMT-A and DSM times) and less by executive capacities 
(e.g. TMT-B errors or TMT B-A) for the PD group. This suggests that hand mobility 
(TMT-A) and body movements (TUG) are correlated, which is supported by recent 
research showing that inhibition evaluated using the Stroop test was not related to 
mobility (TUG) in this population (Smulders et al., 2013). The lack of any significant 
correlations between cognition and the FR test may be due to the fact that FR is not 
known to be a sensitive predictor of falls risk in people with PD (Behrman et al., 
2002a), while the Tinetti and BBS tests are known predictors of falls in this 
population (Kerr et al., 2010). 
It is acknowledged that this study has a number of limitations and these should 
be considered in light of the results. Firstly, the relatively small sample size may 
have affected our capacity to detect some of the relationships between cognitive 
function and balance and gait. Secondly, although the clinical balance and gait 
evaluations are validated, reliable and widely used, these scales involve somewhat 
subjective factors. Nevertheless, this preliminary study provides a promising 
direction for the future by improving our understanding of the relationship between 
balance and gait disturbances and executive dysfunction in PD, which may have 
significant implications for the improved QOL of these people. 
In summary, attention and executive function were found to be impaired in 
people with PD, particularly the components of executive function involving set 
shifting and inhibition response when compared with healthy controls. The TMT-B 
could be a sensitive indicator for identifying deficits of executive function in people 
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with PD. Furthermore, the impairments in executive function and attention were 
associated with poorer balance and gait performance for the PD group. The results 
suggested that executive function may play a more important role in the balance and 
gait of people with PD than general cognition. 
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Chapter 4: Assessment of executive function in people 
with PD 
4.1 INTRODUCTION 
Recently, cognitive impairment as a non-motor symptom has received growing 
attention since its symptoms are major factors for disability and reduced QOL in 
people with PD. People with PD have a higher rate of cognitive impairment 
compared to older adults. The prevalence of dementia has been reported to be 25-30% 
in people with PD (Aarsland et al., 2005). In addition, among the people with PD 
who do not meet the criteria of dementia, the prevalence of MCI is known to range 
between 19 and 38% (mean 27%), which is higher than that of older adults (Litvan et 
al., 2011). Importantly, the evolution of dementia increases in people with PD as the 
disease progresses (Aarsland et al., 2009; Janvin et al., 2006). PD-MCI has been 
reported to be as high as 19% in newly-diagnosed and untreated patients with PD 
(Aarsland et al., 2009) and up to 80% of these patients develop dementia after eight 
years (Aarsland et al., 2003). 
Executive function is considered as regulation and mediation of other cognitive 
functions to fulfil a goal (Bryan & Luszcz, 2000). One of the important abilities 
during the adaptive execution process is inhibition response (Yogev-Seligmann et al., 
2008). The Phase I study has revealed that impaired executive function and attention 
was evident in people with PD. In particular, the reaction time was greater in CRT 
tests of location and colour (CRT-C and CRT-L) which involved participants with 
PD inhibiting their responses compared with healthy controls. The findings are in 
agreement with previous investigations (Aarsland et al., 2009; Muslimovic et al., 
2005) as well as the types of impairment to non-memory functions predominantly 
reported in people with PD (Aarsland et al., 2009; Janvin et al., 2006). Furthermore, 
the impairment of executive function and attention, especially aspects of inhibition 
response and distracter presence, were significantly associated with poorer balance 
and gait performance in people with PD. In order to better understand these 
executive elements contributing to balance and gait performance, further 
investigation using the well-established executive measures in people with PD is 
required. 
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The Stroop and GoNoGo tests are regarded as assessments of inhibition 
response. To some extent, assessment of executive function is dependent on 
processing speed, which requires motor components. Due to motor symptoms, such 
as tremor and bradykinesia, which may affect executive ability for people with PD, 
the ideal executive measure should be minimally influenced by motor factors. The 
Stroop test involves relatively less motor input and is easy to administer. It is 
important to note that the Stroop test, the DSM test and the TMT-B could be 
sensitive measures for predicting longitudinal alterations of cognitive impairment in 
PD individuals (Muslimovic et al., 2009). Likewise, the GoNoGo task assesses 
response inhibition with involvement of fewer motor factors; it requires the 
participants to make a response to a go signal and resist responding to the no-go 
signal, thereby measuring response inhibition and attention (Malloy & Richardson, 
1994). Therefore, the GoNoGo and the Stroop tests could represent precise measures 
of inhibition response for executive function. However, evidence regarding the 
effectiveness of the combination of these tests to measure inhibition response in 
people with PD is limited. The present study sought to extend the understanding of 
the inhibition response in people with PD using more precise and objective measures 
of executive function (the Stroop test, the GoNoGo test and the TMT test). 
Specifically, the study aimed to investigate the effect of inhibition factors in people 
with PD compared to healthy controls. It was hypothesized that inhibition response is 
impaired for people with PD compared with healthy controls. 
4.2 METHODS 
4.2.1 Participants 
Sample size 
The sample size for this study was calculated using a sample size calculator 
available online (http://www.stat.ubc.ca/~rollin/stats/ssize/n2.html) prior to 
participant recruitment (Appendix C). The level of statistical power sought was 80% 
and the p value was defined at 0.05. The mean and standard deviation used in the 
calculations were based on a published paper relevant to cognitive deficits in people 
with PD (Dalrymple-Alford et al., 2011). The sample size calculation resulted in 14 
cases required for the appropriate power level (n=14 people with PD and n=14 age 
and gender-matched controls). 
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Participants 
The final enrolment comprised 15 participants with PD and 17 age- and 
gender- matched healthy controls. The recruitment process and inclusion criteria 
were described in Section 3.2.1 (see page 46). In addition to recruiting control 
participants from the pre-existing database, some of the patients’ spouses were 
recruited as healthy controls using the same methods outlined in Section 3.2.1. 
Of the 56 people with PD who received an invitation letters for participation, 
18 participants declined because they were afraid of the burden of the tests or for 
personal reasons and 21 subjects did not meet the inclusion criteria (7 had cognitive 
impairment, 6 used walking aids, 5 were undergoing deep brain stimulation treatment, 
2 had recent fractures, and 1 had a separate severe chronic disease (e.g. chronic 
kidney disease)). Of the remaining 17 participants with PD, 1 did not complete all of 
the balance trials because of fatigue and 1 failed to complete the gait measurement. 
The remaining 15 participants with PD were included in this study. 
Of the 28 healthy controls who received invitation letters, 5 people declined 
and 4 did not meet the inclusion criteria (1 had heart disease, 1 had a hearing 
difficulty, 2 had chronic disease (e.g. cancer)). To maintain the same cohort for the 
subsequent balance, gait and fNIRS measurements, 2 controls were excluded because 
1 did not perform the objective gait assessment and 1 did not complete the executive 
function assessment. The remaining 17 controls were included in the analysis. 
Ethical approval was provided by the Uniting Care Health Human Research 
Ethics Committee and the St Andrew’s Medical Institute Research Committee 
(#1022) in addition to the QUT Human Research Ethics Committee (#1000000781). 
The variation was approved on 18th July, 2011. All participants provided informed, 
written consent after a full explanation of the study procedures had been provided at 
the beginning of the first testing session. Participants with PD performed all 
assessments in their optimally-medicated state. To prevent potential fatigue 
participants may experience, the tests were divided to two sessions which run for 
approximately two hours respectively. Breaks were offered on regular intervals or as 
participants requested and/or discontinue the session. All of the testing sessions were 
conducted at the Institute of Health and Biomedical Innovation at Queensland 
University of Technology between October 2011 and June 2012. 
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4.2.2 Testing procedures 
Demographics characteristics 
All participants completed a series of questionnaires to collect basic 
demographic data and information about overall health status, medications and 
handedness. Based on the Edinburgh handedness inventory (Oldfield, 1971), the 
majority of participants were classified as being right-handed, while one participant 
with PD was left-handed. 
Baseline assessments 
To evaluate PD severity, the UPDRS and Hoehn &Yahr scale were 
administered for the participants with PD, while the S&E ADL scale was used to 
assess the ability of the participants to carry out activities of daily living. General 
cognitive screening was performed using the ACE and MMSE score, and balance 
and gait were clinically assessed using the Tinetti balance and gait tests. Mobility 
was assessed using the TUG for both groups (see Section 3.2.2. page 47). 
The two groups completed the Activities-specific Balance Confidence (ABC) 
scale (Powell & Myers, 1995). Participants with PD were also asked to complete the 
FOG questionnaire and the Gait and Falls questionnaire (GFQ) (Giladi et al., 2000) 
(see Section 3.2.2, page 47). 
The ABC scale is used to assess self-reported mobility confidence according to 
self-reported scales while performing 16 daily indoor and outdoor activities. Each 
item is measured on a scale from 0% to 100%, with 100% indicating complete 
confidence and 0% indicating no confidence (Powell & Myers, 1995). The 
questionnaire has been previously validated in the population with PD (Adkin et al., 
2003). 
Executive function assessments 
Both groups undertook a series of executive function assessments: the 
computerised Stroop test and the GoNoGo test using E-prime software (Psychology 
Software Tools, Sharpsburg, PA, USA) and the TMTs A and B, which have been 
described in Section 3.2.2 (see page 49). The test order was randomly-assigned to 
each participant. 
All of the testing was conducted in a quiet laboratory-based environment. The 
testing requirements and instructions were explained to participants and also 
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presented on a computer screen before commencement of testing. Prior to the 
computerised assessment, there was a 60-s rest period for participants to concentrate 
on testing while looking at a blank computer screen. Subsequently, a number of 
practice trials were performed at the beginning for familiarisation with the test 
environment. 
1) The GoNoGo Test provides a simple measure of executive function and 
response inhibition. The tasks require the participants to respond to a Go signal and 
resist responding to the NoGo signal (Malloy & Richardson, 1994). The GoNoGo 
test was measured using the E-prime software, which was attached to an external 
response pad to record the reaction time of the response. The seated participants 
placed their index finger of the dominant hand on the button of the response pad. For 
the “Go” condition, the participants were instructed to press the button as quickly 
and accurately as possible with their dominant hand in response to any letter 
presented on the screen. Each letter was visible for 500 ms with a time lapse of 1000 
ms before the following letter. For the “NoGo” condition, the participants were 
instructed to respond as quickly and accurately as possible when any letter except the 
letter “X” was presented on the computer screen. There were 20 trials of 30-s for 
each “Go” or “NoGo” condition. The testing sequence was “Go condition”-rest-
“NoGo condition”-rest. The reaction time was recorded for a correct response, and 
accuracy (correct number) was measured for each condition. 
2) The Stroop Test (Stroop, 1935) is a well-established measure of executive 
function that is used to assess response inhibition and response monitoring. Before 
commencing the test, specific instructions were given to participants, and a legend 
was also presented on the screen. The seated participants placed their index finger of 
their both hands on the buttons of the response pad. The Stroop paradigm included 
two conditions. For the congruent condition, the appearance of colours and words 
were matched. Participants were required to identify the colour. For example, if the 
word “red” was presented in a red colour, the participant was to press the button 
using left hand as quick and accurately as possible, while word “green” using right 
hand. Each word was visible for 500 ms with a time lapse of 1000 ms before the next 
word. For the incongruent condition, the semantic meaning word was not matched to 
the colour. For example, the word “red” may have presented on the screen in green 
(Figure 4.1). The participants were required to identify the colour and ignore the 
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meaning of word. They were instructed to press the button as quickly and accurately 
as possible with the left hand. There were 15 trials for each condition. 
The reaction times and accuracy were recorded for the correct responses. As 
there were errors with specifically designated keys and fingers, responses using the 
right hand were not recorded. The responses using the left hand were successfully 
recorded. Higher scores on the Stroop test indicate increased reaction time and 
poorer performance. Poor scores on the colour-word page have been associated with 
frontal lobe lesions (Golden, 1976b; Perret, 1974). 
According to previous studies, there is a slightly greater prevalence of people 
with PD that are left-side affected rather than right-side affected (Haaxma et al., 
2010). Furthermore, there were no differences in the various cognitive domains 
between right- and left-side affected people with PD (Cooper et al., 2009). Therefore, 
the left-hand response likely represents cognitive function, especially since the same 
procedures were conducted for both the PD and control groups. 
 
 
 
Figure 4.1 Illustration of the Stroop test 
 
4.2.3 Statistical analyses 
Descriptive statistics were calculated for each of the continuous variables 
derived from demographic and clinical variables in addition to baseline assessments. 
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The normality of the data was determined by examining frequency statistics, 
histograms, and the values of skew and kurtosis. Group comparisons (PD vs control) 
were performed using t-tests for continuous variables and Chi-square tests for 
categorical variables. The Mann-Whitney U Tests were conducted if the data were 
not normally distribution. 
For the GoNoGo and Stroop tests, descriptive analyses were conducted for the 
measures of reaction time, reaction time variability and accuracy. Repeated measures 
of Analysis of Variance (ANOVA) were conducted with group (PD, control) as the 
between-subjects factor and testing conditions (Go, NoGo or congruent, incongruent) 
as the within-subject factors to examine the executive function and inhibition effects. 
If a significant main effect was identified, pairwise comparisons were conducted 
using the Fisher’s Least Significant Difference (LSD) test. For the variability of 
reaction time for the Go condition and reaction time for the NoGo condition, log 
transformations were applied to normalise the skewed variables, and then the 
repeated measures ANOVA procedure was performed. The Chi-square test was used 
to compare the participants who made errors in the PD and control groups. In order 
to explore the errors based on groups or reaction time, separate logistic regressions 
analyses were conducted for the different testing conditions (Go, NoGo congruent or 
incongruent). 
All statistical analyses were performed using SPSS v19.0 for Windows. The 
significance level was set at p<0.05 and a marginally significant difference was 
defined as 0.1<p<0.05. 
4.3 RESULTS 
4.3.1 Baseline assessments 
The PD and control groups were of a similar age, gender, height and mass, and 
had received a similar number of years of education. Participants with PD were 
predominantly in the early-stages of the disease, with a mean UPDRS total score of 
31.9 ± 15.1 and a mean Hoehn &Yahr score of 1.6 ± 0.7 (Table 4.1). 
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Table 4.1 Demographic characteristics of the Parkinson’s disease and control groups 
 PD (n=15) Control (n=17) p value 
Age (yrs) 68.5 (7.5) 70.1 (1.8) 0.436 
Male (%) 13 (86.7) 14 (82.4) 1.000# 
Education (yrs) 13.5 (2.9) 13.4 (3.6) 0.961 
Height (cm)  172.9 (8.9) 173.0 (6.5) 0.835 
Mass (kg)  78.7 (15.6) 76.9 (9.3) 0.960 
Participants with PD characteristics    
Disease duration (yrs) 8.8 (5.6)   
UPDRS I scores 1.5 (1.5)   
UPDRS II scores 11.2 (6.3)   
UPDRS III scores 17.5 (10.2)   
UPDRS total scores 31.9 (15.1)   
H-Y scale 1.6 (0.7)   
FOG scores 3.7 (3.3)   
PIGD scores 2.9 (2.6)   
PD subtype,%    
TDT 46.7   
ART 40.0   
MT 13.3   
S&E ADL (%) 84.7 (9.5)   
ABC scale (%) 89.4 (68.1-98.8) 96.9 (75.6-100.0) 0.006^ 
PD medications    
Levodopa (numbers taken) 10   
Dopaminergic agonists (numbers taken) 5   
COMT inhibitor (numbers taken) 5   
Monoamine oxidase inhibitor (numbers taken) 0   
Benzodiazepine (numbers taken) 2   
Serotonin reuptake inhibitors (numbers taken) 2   
No medication (numbers) 2   
LED (mg) 471.20 (370.81)     
 
Notes: PD=Parkinson’s disease, UPDRS=Unified Parkinson’s disease Rating Score, FOG=Freezing 
of Gait, PIGD=Postural Instability and Gait Disturbance, ART=akinetic-rigid subtype, TDT=tremor-
dominant subtype, MT=mixed subtype, S&E ADL= the Schwab and England activity of daily living 
scale, LED=levodopa equivalent dosage, ABC scale=Activities-specific Balance Confidence. 
^ Data reported are median (range) and comparison with Mann-Whitney test. All other data are 
reported mean (SD) and compared using t-test. 
# Chi-square test. 
 
The participants with PD performed poorly on the TBS, TGS and TTS tests 
compared to the controls, but not on the TUG test (Table 4.2). They had significantly 
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lower ACE total scores (p=0.038), but there were no significant differences in the 
subscores compared with the controls (Table 4.3). 
 
Table 4.2 Balance and gait scores in Parkinson’s disease and control groups 
 PD (n=15) Control (n=17) p value 
TBS (score) 15 (12-16) 16 (0) <0.001 
TGS (score) 12 (8-12) 12 (0) 0.002 
TTS (score) 27 (21-28) 28 (0) <0.001 
TUG (sec) 9.6 (7.3-18.8) 9.4 (8.3-11.9) 0.850 
 
Notes: TBS=Tinetti’s Balance Score, TGS=Tinetti’s Gait Score, TTS=Tinetti’s Total Score; 
TUG=Timed Up & Go. 
All data reported are median (range) and compared with a Mann-Whitney test. 
Significant p values are marked in bold. 
 
Table 4.3 General cognitive function in the Parkinson’s disease and control groups 
 PD (n=15) Control (n=17) p value 
MMSE scores 29.1 (1.2) 29.5 (0.5) 0.171 
ACE scores 91.1 (7.4) 95.6 (2.3) 0.038 
ACE Subscores    
Attention/Orientation 18 (17-18) 18 (17-18) 0.289^ 
Memory 22 (17-26) 25 (18-26) 0.103^ 
Fluency 12 (4-14) 13 (8-14) 0.464^ 
Language 24.9 (1.5) 25.6 (0.5) 0.103 
Visuospatial 15.1 (1.2) 15.7 (0.5) 0.062 
 
Notes: MMSE=Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination;  
^ data reported are median (range) and comparison with Mann-Whitney test. 
All other data are normally distributed and values reported are mean (SD) and t-test. 
Significant p values are marked in bold. 
 
4.3.2 Executive function 
GoNoGo test 
The main effect of condition on reaction time was significant [F (1, 30) 
=344.94, p<0.001]. There was no interaction between group and condition [F (1, 30) 
=0.064, p=0.802]. Therefore, the reaction time was significantly slower in the “NoGo” 
condition than in the “Go” condition for both groups. Similarly, the main effect of 
condition on reaction time variability was significant [F (1, 30) =5.120, p=0.031]. 
There was no interaction between group and condition [F (1, 30) =0.113, p=0.739]. 
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Therefore, the reaction time variability was significantly higher in the “NoGo” 
condition than in the “Go” condition for both groups. There were no differences in 
either reaction time [F (1, 30) =0.632, p=0.433] or reaction time variability [F (1, 30) 
=0.050, p=0.825] between the PD and control groups (Figure 4.2). 
 
Table 4.4 GoNoGo test results, compared between the Parkinson’s disease and control groups 
Test PD (n=15) Controls (n=17) p value 
RT on Go (ms) 280.48 (95.63) 265.04 (46.20) 0.558 
RT on NoGo (ms) 434.27 (73.98) 414.68 (39.62) 0.350 
    RT variability on Go (ms) 88.08 (47.76) 80.99 (27.16) 0.943 
RT variability on NoGo (ms) 106.61 (52.63) 96.46 (48.10) 0.756 
    Participants made errors on Go, numbers (%) 8 (53.3) 3 (17.6) 0.062# 
Participants made errors on NoGo numbers (%) 14 (93.3) 12 (70.6) 0.178# 
 
Note: RT=reaction time. 
All values are reported as mean (SD) or number (%). 
# Chi-square test. 
 
 
Figure 4.2 Comparison of reaction time (RT) and variability between the PD and control groups in 
the GoNoGo test 
 
The number of people making errors was not significantly different between 
the PD and control groups either on the Go condition (p=0.062) or NoGo condition 
(p=0.178) (Table 4.4). There was only one PD participant that did not make any 
errors in the NoGo condition. However, Logistic regression showed that group 
(controls, PD) had a significant relationship with whether someone made errors in 
the Go condition (Wald χ2= 4.718, p=0.030, OR = 0.148), but the reaction time did 
not significantly change the odds of making a mistake in the Go condition (Wald 
χ2=2.814, p=0.093, OR=0.989). In the NoGo condition, group (controls vs PD) had 
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no significant relationship with whether someone made errors (Wald χ2=3.032, 
p=0.082, OR =0.044), nor did reaction time (Wald χ2=2.999, p=0.083, OR =0.953). 
Stroop test 
There was a significant main effect of conditions for the measure of reaction 
time [F (1, 30) =17.983, p<0.001] and a significant interaction between group and 
condition [F (1, 30) =4.650, p=0.039] as depicted in Figure 4.3. Post-hoc 
comparisons indicated that the reaction time was slower in the incongruent condition 
than in the congruent condition for the PD group (p<0.001) but not for the control 
group (p=0.138). The main effect of condition was significant [F (1, 30) =4.704, 
p=0.038] and there was no interaction between group and condition [F (1, 30) =0.004, 
p=0.948] for reaction time variability. The results indicated that reaction time 
variability was significantly lower in the congruent condition than the incongruent 
condition for both groups. There were no differences in either reaction time [F (1, 30) 
=1.706, p=0.201] or reaction time variability [F (1, 30) =1.538, p=0.225] between the 
two groups (Table 4.5). 
There were no significant differences in the correct responses between the 
congruent and incongruent conditions [F (1, 30) =3.010, p=0.093], or between the 
two groups [F (1, 30) =2.364, p=0.135]. 
 
Table 4.5 Stroop test results, compared between the Parkinson’s disease and control groups 
Test PD (n=15) Control (n=17) p value 
RT congruent (ms) 496.53 (143.78) 477.94 (71.04) 0.794 
RT Incongruent (ms) 634.35 (213.17) 520.18 (106.43) 0.069 
    RT Variability on congruent (ms) 116.83 (46.49) 93.06 (47.44) 0.164 
RT Variability on incongruent (ms) 147.41 (77.93) 121.83 (89.25) 0.398 
    Correct response on congruent 7.00 (1.85) 7.76 (2.02) 0.260 
Correct response on incongruent 5.93 (2.60) 7.00 (2.48) 0.252 
 
Note: RT=reaction time. All values are reported as mean (SD) 
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Figure 4.3 Comparison of reaction time (RT) and RT variability between the PD and control 
groups in the Stroop test 
 
Trail making test 
The participants with PD spent a significantly longer time and made 
significantly more errors on the TMT-B than the controls (Table 4.6). 
 
Table 4.6 Trail making test results, comparison between the Parkinson’s disease and control 
groups 
 PD (n=14) controls (n=17) P value 
TMT-A(s) 44.0 (30.1-81.8) 39.2 (28.2-62.8) 0.219^ 
TMT-B (s) 113.5 (25.8) 92.8 (17.4) 0.013 
TMT-B (participants with error) % 6  (42.9) 1 (5.9) 0.028# 
TMT B-A (s) 67.8 (26.0) 51.6 (15.9) 0.041 
 
Note: TMT-A=Trail making test A; TMT-B=Trail making test B; TMT B-A=the difference between 
TMT-B and TMT-A. 
#Chi-square test. 
^ Data are not normally distributed values reported are median (range) comparisons with Mann-
Whitney test. All other data reported are mean (SD) and compared using t-tests. 
Significant p values are marked in bold. 
1 PD participant did not complete the test. 1 PD participant made three errors and no control 
participants made errors on TMT-A. 
 
4.4 DISCUSSION 
The study has investigated the inhibition response, component of executive 
function, using the GoNoGo and the Stroop tests in people with PD compared with 
healthy controls. PD participants have shown deficit in executive function, 
particularly inhibition response. In the Stroop test, the significant interaction between 
group and task complexity suggested that participants with PD had slower reaction 
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times during the tasks that incorporate inhibition responses, but this was not evident 
for the control group. Longer time on the TMT-B and TMTB-A and more errors on 
TMT-B for the PD participants compared with the healthy controls, supporting the 
outcomes of the Phase I. 
The participants with PD had a lower total ACE score compared with the 
controls, but not for the total MMSE score. The mean MMSE score for the PD group 
was consistent with a recent study (29.1) (Fuller et al., 2013). Across different 
cognitive domains in the present study, the subscores of ACE were not significantly 
different between the participants with PD and the healthy controls, but the 
visuospatial scores was marginally lower, which supports previous findings that 
visuospatial ability is decreased in people with PD (Aarsland et al., 2009; Levin et al., 
1991; Mahieux et al., 1998). Visuospatial deficits were likely not to be present on 
their own, but combined with impairment in other cognitive domains (Dalrymple-
Alford et al., 2011). Similarly, the use of the pentagon copying task as an assessment 
of visuospatial ability, in conjunction with VF task at baseline assessment, could be a 
useful indicator for dementia in PD (Williams-Gray et al., 2007). The commonly 
affected domains are attention, executive function, memory, and visuospatial ability 
in people with PD (Dalrymple-Alford et al., 2011). It should be noted that executive 
function has been reported as one of the commonly affected cognitive domains 
(Aarsland et al., 2009; Levy et al., 2002; Muslimovic et al., 2005). However, while 
the ACE is often employed for general cognitive screening, it is typically not used to 
assess the specific aspect of cognitive domains and, hence it is not able to measure 
executive function. Therefore, specific domains may need to be assessed using a 
combination of a couple of cognitive measures to avoid any bias. 
Inhibition response is an important factor during a whole goal-directed 
executive process, such as walking or maintenance of balance. The results of the 
present study indicate that both groups had greater time variability during the tests 
involved in inhibition response, for example, NoGo or incongruent conditions. 
Importantly, the present study has demonstrated that the participants with PD were 
slower in the incongruent condition compared to the congruent condition. The 
findings are consistent with a study suggesting that people with PD had difficulty in 
suppressing habitual responses on the Stroop test due to deficits in inhibition, and 
longer reaction times on the more demanding conditional stop signal compared to 
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controls (Obeso et al., 2011). This is also consistent with previous studies that have 
shown an impaired capacity to maintain and inhibit attention (Mahieux et al., 1998), 
in addition, to a reduced flexibility in thinking or attentional set shifting (Dubois & 
Pillon, 1997; Dujardin et al., 1999; Monchi et al., 2004; Owen et al., 1992) in people 
with PD. The Stroop test has been reported as one of the sensitive measures of 
longitudinal cognitive change (Muslimovic et al., 2009) in PD individuals. However, 
the executive assessment was not significant different between PD and controls. The 
result was inconsistent with other studies for the early stage of the disease (Foltynie 
et al., 2004; Muslimovic et al., 2005). Nevertheless, the current study revealed a 
trend of greater reaction time for incongruent (p=0.069) and lower accuracy on Go 
condition (p=0.062) for the participants with PD. 
Interestingly, the group (PD, controls) that an individual was part of 
significantly influenced the number of errors in the “Go” condition (p=0.030) but not 
for the reaction time measure. The PD participants tended to make error on “Go” 
condition compared with the controls. This finding further supports the Phase I study, 
which suggested that the TMT-B could act as a sensitive indicator for identifying 
deficit in executive function deficits in people with PD. However, these findings are 
in contrast with those of a previous study, which reported a significant difference in 
the performance index rather than accuracy between people with PD and controls 
using the GoNoGo measure. In the non-interference condition of the Stroop test, a 
significant difference was found in the performance index and standard deviation of 
reaction times rather than accuracy. In the Stroop interference condition, significant 
difference was found in the performance index and reaction time (Hausdorff et al., 
2006). It should be noted that the performance index (accuracy/reaction time × 100) 
consists of both accuracy and reaction time factors. However, the accuracy was not 
affected as much as in the previous study. 
For the TMT tests, test, measures of the TMT-B and TMT B-A were 
significantly longer for the participants with PD, which was somewhat consistent 
with the Phase I in a different sample. The times on the TMT-A was not different 
between participants with PD and controls. Likewise, the time on the TMT tests, 
particularly for the TMT-A, varied between different studies (Muslimovic et al., 
2009; Plotnik et al., 2011), however, these studies compared different stages in 
people with PD or normative data and lacked comparisons with healthy controls. 
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Nevertheless, the results further support that deficits in set shifting ability and 
flexibility exist in people with PD. 
In addition, participants with PD showed lower mobility confidence compared 
with the controls, which may be related to fear of falls. Recently, there has been 
growing interest in linking these components of executive function with balance and 
gait performances and falls risk in the elderly, and the results indicate that reaction 
time during executive and attention assessments could be a significant predictor of 
falls risk (Lord & Fitzpatrick, 2001; Woolley et al., 1997). Occasional falls were 
associated with executive dysfunction, but recurrent falls were associated with global 
cognitive decline (Anstey  et al., 2009). Executive measures have been associated 
with gait variability in PD, which accordingly lead to increased falls in people with 
PD (Yogev et al., 2005). To further determine the impact of executive function and 
attention on balance and gait performances, static balance and gait measurements 
under dual task conditions were conducted as part of the research project reported in 
this thesis (refer to Chapter 5 and Chapter 6). 
There are certain limitations to this study. Firstly, the sample size was 
relatively small and the participants with PD were in the early stages of the disease. 
A second limitation of this study was constraints on the equipment which only 
allowed responses using the left hand were recorded. Nonetheless, the PD 
participants have demonstrated the significant impairments of the components of 
executive function including inhibition response and flexibility compared with 
healthy controls. 
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Chapter 5: Impact of dual tasking on standing 
postural stability 
5.1 INTRODUCTION 
Postural instability is one of the key features leading to falls in people with PD. 
The prevalence of falls has been prospectively reported to range from 46% over a 3 
month period (Pickering et al., 2007) to nearly 70% over a 12 month period (Wood et 
al., 2002). Falls can cause many recognisable consequences such as injuries (e.g. 
fracture) (Gray & Hildebrand, 2000), fear of falling (Adkin et al., 2003; Bloem et al., 
2001a), increase in nursing home or hospital admission, and increased risk of 
mortality and morbidity (Hely et al., 1999; Wenning et al., 1999). Identification of 
risk factors for potential falls in people with PD has long been a challenge. Clinical 
balance and gait tests have been used widely to assess functional capacity and fall 
risk in older adults (Tinetti, 1986) and people with PD (Kerr et al., 2010). However, 
their scoring criteria are qualitative, based on observation of performance and their 
diagnostic value for postural stability may be influenced by subjective factors 
(Marchese et al., 2003). As such, there is a need to develop objective and accurate 
quantitative measures of balance performance. 
Measurement of postural sway is one of the approaches currently used to 
objectively evaluate postural instability in people with PD. A study reported that 
various measures of postural sway were greater in people with PD compared to age-
matched healthy controls including sway range, sway area, and path length 
(Blaszczyk et al., 2007). Similar studies also showed that path length, sway area, and 
sway range in the medio-lateral (ML) direction were greater for people with PD and 
that they were positively correlated with the severity and duration of the disease. 
Specifically, the ML deflection could therefore act as a marker for impaired balance. 
However, measure of sway range in the anterior-posterior (AP) direction was not 
significantly different between people with PD and healthy controls (Mitchell et al., 
1995; Viitasalo et al., 2002). Conversely, other studies showed that postural sway 
was not different between PD individuals and controls (Chong et al., 1999; Frenklach 
et al., 2009) or that the postural sway area was less for PD individuals than controls 
(Dietz et al., 1988; Horak et al., 1992). 
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Furthermore, it is unclear as to which sway measures are best for identification 
of falls risk in people with PD. Some studies have suggested that greater sway area 
and the UPDRS scores (Matinolli et al., 2007) or greater postural sway in the ML 
direction during standing tasks completed with eyes closed (Blaszczyk et al., 2007) 
could be helpful for identifying PD individuals at an increased risk of falls. However, 
these studies used retrospective falls data which may not reflect the true incidence of 
falls. Subsequently, a prospective study has shown that AP postural sway was greater 
for PD fallers than PD non-fallers while standing on a firm surface with eyes open, 
and that this could be one of the predictors of falls (Kerr et al., 2010). However, 
postural sway was not reported as an independent predictor of falls, although postural 
sway was greater for fallers, in particular, standing on a foam surface either with 
eyes open or eyes closed. The study used a swaymeter to measure displacement of 
the body at waist level (Latt et al., 2009a). Given the variable findings of previous 
studies, it is evident that further work is needed to identify which postural sway 
measure is most useful for detecting the subtle alteration in standing postural stability 
for people with PD. 
Previous studies have indicated that deficits in sensory and motor factors alone 
could not explain postural instability in older people (Lord et al., 1991), suggesting 
that postural stability also relies on high-level cognitive functioning (Lajoie et al., 
1996; Teasdale et al., 1993). Research has indicated that attentional resources play a 
key role in balance control in healthy people (Maylor & Wing, 1996; Teasdale et al., 
1993; Woollacott & Shumway-Cook, 2002). Given that many falls occur in 
situations where an individual is performing multiple tasks (Tideiksaar, 1996), the 
dual task paradigm has been designed to explore the role of cognitive function on 
balance control. A concurrent cognitive task has been shown to produce challenges 
on balance control and poorer balance performance in elderly participants compared 
with younger adults (Maylor & Wing, 1996; Teasdale et al., 1993; Woollacott & 
Shumway-Cook, 2002). This suggested that older adults may require more 
attentional resources to maintain balance compared to younger adults. Previous 
research has shown that cognitive impairments are more evident for people with PD 
than for healthy controls (Muslimovic et al., 2009), but it remains unclear how these 
cognitive impairments affect balance control in this population. 
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The different type and complexity of cognitive tasks utilised in dual task 
paradigms has indicated the varied demands of attention for postural control 
(Woollacott & Shumway-Cook, 2002). Most dual task paradigms have been 
designed to evaluate the inference of different elements of executive function. 
Executive dysfunction in people with PD has been demonstrated in previous research 
(Aarsland et al., 2009; Muslimovic et al., 2005) and in the previous study in this 
research (refer to section 4.3.2). Admittedly, a variety of cognitive tasks have been 
applied in dual task research and some of these tasks include VF, arithmetic (e.g. 
serial subtraction of 7), talking, counting, memorisation, and responses to auditory 
and visual stimuli. Among these tasks, VF is considered to be a measure of executive 
function evaluating response generation (response inhibition and switching abilities) 
(Dirnberger & Jahanshahi, 2013). The serial SN task measures working memory and 
attention (Hittmair-Delazer et al., 1994). Although, the VF and SN tasks have been 
separately described in gait studies (Brauer & Morris, 2010; Plotnik et al., 2011), 
their evaluation and impact of the two cognitive tasks on static postural control has 
not been previously investigated within the same study for people with PD. 
Only a few studies have investigated how cognition influences postural sway in 
people with PD, but these studies have yielded conflicting results. Research has 
shown that while simultaneously performing a counting backwards task or a motor 
sequence task, sway area was greater for people with PD compared with controls, 
particularly in PD patients, who had already experienced falls (Ashburn et al., 2001; 
Marchese et al., 2003). However, another study which used a visuospatial cognitive 
task did not demonstrate an effect on standing balance in people with PD (Schmit et 
al., 2006), or a VF task caused a similar increase in the COP velocity for people with 
PD and older adults.(Yogev-Seligmann et al., 2013). Furthermore, a study showed 
that PD participants had a significantly smaller COP length, excursion in AP and ML 
direction along with increased complexity of cognitive task (Holmes et al., 2010). 
Therefore, the cognitive effect on postural stability has not been clarified. 
Importantly, previous studies have focused on investigation of the motor aspect 
of performance (balance), whereas the performance on the secondary cognitive task 
has less been studied in people with PD. The linking between motor and cognitive 
ability could be identified by assessing both profiles in balance and cognitive 
performance during dual tasking. For example, a recent study has reported that there 
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was no difference between people with PD and healthy controls while performing a 
VF task and a standing balance simultaneously (Yogev-Seligmann et al., 2013). 
Force platforms have been used extensively in previous research to provide 
quantitative measures of static balance that are based on the displacement pattern of 
the COP. The outcome measures that have been used to evaluate postural stability 
include sway path length (PL), C90, and range of sway in the ML and AP directions 
(Bortolami et al., 2006). Given that balance relies on the integration of 
somatosensory, visual and vestibular information, assessing changes in postural 
control under different testing conditions (e.g. different standing positions, different 
surface) could provide insight into the specific aspects of postural control that are 
affected in clinical populations (Morris et al., 2000). Generally, performing a 
standing balance test with eyes closed is used to simulate situations where an 
individual may be deprived of vision, whereas standing on a foam surface may be 
used to simulate reduced somatosensory information. However, standing on a foam 
surface poses a considerable challenge for people with PD and also represents a 
situation that would be rarely faced by patients in their living environment. This 
study has been designed to use a firm surface for data collection, as it represents a 
more stable setting that is more like their daily living conditions. 
This study used a force platform to measure standing balance both with and 
without the secondary cognitive loadings (VF and SN) in people with PD and healthy 
controls when eyes were open and eyes closed. Outcome measures for postural sway 
included PL, C90, postural sway range and variability in the ML and AP directions. 
In this present study, VF and SN performances were during the standing balance 
assessments. It was hypothesised that the dual task (cognitive task) paradigms would 
induce greater postural sway in people with PD. 
5.2 METHOD 
5.2.1 Participants 
The sample for this study comprised 15 participants with PD (age 68.5±7.5 
years) and 17 age and gender-matched healthy controls (age 70.1±1.8 years) derived 
from Section 4.2.1 (see page 64). Participants with PD were predominantly in the 
early-stages of the disease, with a mean UPDRS total score of 31.9±15.1 and a mean 
Hoehn &Yahr score of 1.6±0.7. The ACE and MMSE assessments were used to 
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screen participants for significant cognitive impairment. For participants with PD, 
the ACE total score was 91.1±7.4, compared with 95.6 ±2.3 for the controls (p=0.038) 
and the MMSE total score was 29.1±1.2 for participants with PD compared with 
29.5±0.5 for controls (p>0.05). 
All of the tests were undertaken at the Institute of Health and Biomedical 
Innovation at the Queensland University of Technology between October, 2011 and 
June, 2012. Participants with PD performed all assessments during their optimally-
medicated state. 
5.2.2 Procedures 
Baseline assessments 
The ABC scale was used to examine fear of falling in the two groups (Powell 
& Myers, 1995). For the Participants with PD, additional measures were evaluated 
using the FOG questionnaire (Giladi et al., 2000) and the PIGD score derived from 
the UPDRS scores (see Section 3.2.2). 
Cognitive task 
For the purposes of this study, participants performed two secondary cognitive 
tasks, which were VF and SN. The VF task required participants to generate as many 
words as possible beginning with a specific letter. For this task, proper names and 
duplicated words were not allowed. Understandably, different letters pose a different 
level of difficulty for individuals, hence letters are defined as being either a “hard” or 
an “easy” letter (Fu et al., 2002). The commonly used letters “F”, “A” and S” 
(Benton, 1968) are considered to fall within the relative easy category. Cerebral 
activation studies using fMRI have revealed extensive regional brain activation for 
“hard” letters compared to “easy” letters (Fu et al., 2002). Separate studies have 
observed the role of the letters “B” and “M” in the evolution of dementia in the 
different stages of PD (Lees & Smith, 1983; Mahieux et al., 1998). Therefore, to 
better evaluate the impact of VF on balance control, eight letters were chosen, “B, R, 
L, S, T, P, C, and M”, based on the available evidence. The order of the letters was 
randomly-generated using the tool available at http://www.randomizer.org. 
For the SN task, participants were required to consecutively subtract three from 
a predefined three digit number as quickly and accurately as possible. This paradigm 
has been previously described in an earlier gait study involving people with PD 
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(Plotnik et al., 2011). The predefined 3-digit number was randomly-generated prior 
to each testing session using a tool available at http://stattrek.com/tables/random.aspx. 
A total of 1,000 3-digit numbers were generated from 199 to 999. Subsequently, the 
“numbers” and “letters” for the testing were randomly-assigned to the dual task of 
cognitive loading (see Appendix F). 
Force plate measurement 
To assess postural stability under static conditions, postural sway was 
measured using a force platform (HUR Labs, OY, Finland) with and without a 
secondary cognitive task. Data were collected under six different testing conditions; 
these included two visual conditions (eyes open and eyes closed) for the three 
cognitive states (no additional cognitive loading, VF and SN). Four trials were 
completed for each condition, resulting in 24 trials that were performed in a random 
order for each participant. To minimise any order or learning effects, six testing 
orders for force plate measurement (code 1-6), were organised according to a Latin 
square design (refer to Appendix D). The testing orders were randomly-allocated 
across all the participants (e.g. Appendix F). 
During each trial, participants stood barefoot on the firm surface of the 
platform, placed their feet 10 cm apart and relaxed with their arms by their sides. 
Participants were instructed to look straight ahead at a cross approximately two 
metres in front of them at eye level marked on the facing wall. The participants were 
required to stand as still as possible during trials, and allowed to rest between trials 
as needed (Figure 5.1). The predefined three-digit number for the SN task and the 
specific letter for the VF task were provided by the examiner at the beginning of each 
test. The instruction to start and end the tasks coincided with the beginning and 
completion of the force platform testing. “When you are standing I am going to ask 
you to do some cognitive tasks. Please stand as stable as possible while you are 
doing the cognitive task”. The participants were not asked to divide their attention to 
prioritize one of the tasks. During the performance of these tasks, COP data were 
recorded for a total of 30 seconds per trial at a sampling rate of 100 Hz. To ensure 
safety, researchers were always in close proximity during the balance assessments. 
Data analysis 
Cognitive performance was measured by scoring the number of correctly 
subtracted numbers or the number of words generated in each 30-second trial. Proper 
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names, duplicated words and incorrect subtractions were excluded. The data acquired 
from the force plate was processed using HUR Labs Balance Software after the 
completion of test. The measurements derived from the COP displacements data 
consisted of PL, sway area (C90), and the range and standard deviation of postural 
sway in the ML and AP directions. Specifically, PL is the overall length of the COP 
path and sway area is defined as smallest ellipse covering about 90% of the COP 
points. PL and sway area were processed using HUR Labs Balance Software for each 
trial. The range and standard deviation of postural sway in the ML and AP directions 
were calculated from the actual COP data. ML postural sway is the measurement of 
the COP displacement in the ML direction (x-axis), while AP sway measures the 
COP displacement in the AP direction (y-axis). 
In addition, dual task interference (%) was calculated as the difference between 
single task (quiet standing) and dual task by single task performance (Rochester et al., 
2014). 
 
  
Figure 5.1 Force platform (left), depiction of balance measurement (right) 
 
5.2.3 Statistical analyses 
Analysis of the baseline assessments measures, including the demographic 
variables and clinical characteristics have been described in Section 4.2.3. For each 
continuous variable derived from the force plate measurements, descriptive statistics 
(mean, SD) were initially calculated. The normality of the data was determined by 
examining frequency statistics, histograms, and the values of skew and kurtosis. 
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Independent two-tailed t-tests were used to examine mean differences between the 
PD cases and the healthy controls with respect to performance on the cognition tasks. 
If the data were found not to be normally distributed, the Mann-Whitney test was 
used to examine the differences between the two groups. The Chi-square test was 
used to compare the PD and control groups for categorical variables. 
To assess the effects of cognitive factors on postural stability, the repeated 
measures ANOVA procedure was applied with one between-subject factor (group, 2 
levels) and two repeated within-subject factors (cognition states, 3 levels) and vision 
(2 levels, eyes open, eyes closed). Mauchley’s test was used to assess the assumption 
of sphericity for the repeated measure variables. If this assumption was violated, the 
Greenhouse-Geisser correction was used to adjust the degrees of freedom for the F-
ratio. The interaction term of group by cognitive task was used to ascertain whether 
the performance of the dual task affected the postural sway measures differently for 
the two groups. In the situation where a significant effect was reported, post-hoc 
comparisons were conducted using Fisher’s LSD test. Spearman’s correlation was 
performed to determine the correlations between postural sway measures and 
measures of general cognition and executive function even though they are normally 
distributed given relative small sample size.  
All statistical analyses were performed using the SPSS v19.0 for Windows. 
The level of significance was defined as p<0.05, with p values between 0.1 and 0.05 
considered to be marginally significant. The significant level was set p<0.01 for 
bivariate correlations as conservative purpose to accommodate multiple corrections. 
5.3 RESULTS 
The PD and control groups were of a similar age, gender, height and mass, and 
had received a similar number of years of education. The clinical characteristics and 
the results of baseline assessments are described in Chapter 4.3.1 (see page 69). 
5.3.1 Cognitive performance during standing balance measurement 
The numbers of generated words for the VF task and the performance on the 
SN task were not significantly different between the PD and control groups for the 
eyes open or eyes closed conditions (Table 5.1). 
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Table 5.1 Cognitive performance during standing balance assessment for the participants with PD 
and the controls 
 Control (n=17) PD (n=15) p value 
Generated words (EO) 11.82 (3.14) 9.60 (3.61) 0.072 
Generated words (EC) 11.59 (2.57) 10.27 (3.60) 0.237 
Subtracted numbers (EO) 14.03 (4.10) 13.73 (4.31) 0.844 
Subtracted numbers (EC) 14.59 (4.57) 13.83 (4.53) 0.643 
 
Notes: All values reported are mean (SD) and the p value relates to an independent samples t-test. 
EO=eyes open, EC=eyes closed. 
 
5.3.2 Postural sway 
Visual inspection of each trial revealed that some performance errors occurred 
because of unexpected movement, particularly during the first trial. The percentage 
of performance errors was 2.94% (12/408 trials) for controls, and 6.39% (23/360 
trials) for participants with PD. Therefore, these error trials were excluded from the 
analysis. To ensure the same number of trials for the two groups, three trials were 
therefore used in the analysis for each testing condition. 
Figure 5.2 illustrates the representative COP data for a control participant and a 
PD participant with eyes open during quiet standing and while performing the SN 
and VF tasks. This depicts an increase in postural sway for the participant with PD 
compared to the healthy control and an increase for both the VF and SN tasks 
relative to the quiet standing condition. 
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Figure 5.2 Depicts postural sway with eyes open for representative PD and control participants 
during the quiet standing (QS), subtraction of numbers (SN) and verbal fluency (VF) conditions 
Note: AP =anterior-posterior COP=centre of pressure. 
 
Path length 
Participants with PD had a greater PL than the controls [F (1, 94) =13.505, 
p<0.001]. The significant main effect of vision revealed a greater PL when eyes were 
closed compared to eyes open [F (1, 94) = 125.626, p<0.001]. Additionally, there 
was a significant main effect of cognition [F (1.2, 116) =25.262, p<0.001], with post-
hoc analyses showing that the two cognitive tasks resulted in poorer performance 
compared to the quiet standing condition (p<0.001). 
There were significant two-way interactions for cognition × group [F (1.2, 116) 
=5.111, p=0.019] and vision × cognition [F (2,187) =3.900, p=0.022], and a three-
way interaction for cognition × vision × group [F (2, 188) =4.418, p=0.013]. Figure 
5.3 illustrates the differences between the groups, tasks and visual conditions. Post-
hoc comparisons demonstrated that the participants with PD recorded a significant 
increase in PL when performing the cognitive tasks (SN, VF) compared to the quiet 
standing condition with eyes either open or closed (p<0.001), and a greater increase 
in PL during the SN task than during the VF task with eyes open (p=0.001). For the 
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control group, only the VF task resulted in a significant increase in PL compared to 
the quiet standing condition in either eyes open (p=0.005) or closed (p=0.003). 
Notably, the greater change in PL was observed for the participants with PD. 
Also, the SN task resulted in a 65% increase in PL and the VF task resulted in a 43% 
increase in PL during the eyes open condition for that group. For the control group, 
the VF task resulted in a 26% increase in PL and the SN task resulted in a 20% 
increase in PL under the eyes open condition. For the PD group during the eyes 
closed condition, the SN task resulted in a 36% increase in PL and the VF task 
resulted in a 35% increase in PL. For the control group during the eyes closed 
condition, the VF task resulted in a 24% increase in PL and the SN task resulted in a 
19% increase in PL. 
 
  
Figure 5.3 Mean (+1SD) Path length under eyes open and closed conditions for PD and Control 
groups during quiet standing (QS),subtraction (SN) and verbal fluency (VF) conditions 
Notes: * p<0.05 comparisons between the participants with PD and the controls. 
# p<0.05 comparisons between the different cognitive conditions. 
 
Postural sway area 
The PD group recorded a greater sway area than the control group (p<0.001). 
The significant main effect of vision demonstrated greater sway area when eyes were 
closed compared to when they were open [F (1, 94) =41.914, p<0.001]. Additionally, 
there was a significant main effect of cognition [F (2, 188) =4.539, p=0.012] and the 
post-hoc comparisons indicated that the VF task resulted in greater sway area than 
the quiet standing condition (p=0.008) and during the SN task (p=0.047) (Figure 5.4). 
No significant difference was observed between the SN task and the quiet standing 
condition (p=0.297). There were no significant two-way or three-way interactions. 
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Figure 5.4 Mean (+1SD) Sway area under eyes open and closed conditions for PD and Control 
groups during quiet standing (QS), subtraction (SN) and verbal fluency (VF) conditions 
Note: * p<0.05 comparisons between the participants with PD and the controls. 
 
Anterior-posterior postural sway and variability 
Increased AP postural sway [F (1, 94) =57.332, p<0.001] and AP postural 
sway SD [F (1, 94) =59.140, p<0.001] were observed for the PD group compared to 
the control group. The significant main effect of vision for both variables 
demonstrated that there was greater AP postural sway [F (1, 94) =105.565, p<0.001] 
and AP postural sway SD [F (1, 94) =58.623, p<0.001] when the eyes were closed 
compared to open (Figure 5.5 and Figure 5.6). However, there was no significant 
main effect of cognition for AP postural sway [F (2,188) =2.514, p=0.084] or AP 
postural sway SD [F (2,188) =2.142, p=0.120]. There were no significant two-way or 
three-way interactions for AP postural sway or AP postural sway SD. 
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Figure 5.5 Mean (+1SD) anterior-posterior sway for the eyes open and closed conditions for the 
PD and Control groups during the quiet standing (QS),subtraction (SN) and verbal fluency (VF) 
conditions 
Note: * p<0.05 comparisons between participants with PD and controls. 
 
  
Figure 5.6 Mean (+1SD) anterior-posterior sway SD with eyes open and closed conditions for PD 
and Control groups during the quiet standing (QS), subtraction (SN) and verbal fluency (VF) 
conditions 
Note: * p<0.05 comparisons between participants with PD and the controls. 
 
Medio-lateral postural sway and variability 
ML postural sway 
Increased ML postural sway [F (1, 94) =24.530, p<0.001] was observed for the 
PD group compared to the control group. The significant main effect of vision 
demonstrated that there was greater ML postural sway when the eyes were closed 
compared to open [F (1, 94) =20.325, p<0.001]. Furthermore, the significant main 
effect of cognition [F (1.8, 169) =7.991, p=0.001] and post-hoc analyses showed that 
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both cognitive tasks (VF and SN) resulted in greater ML sway than in the quiet 
standing condition (both p=0.001). 
There was also a significant two-way interaction of vision × cognition [F (2, 
188) =6.146, p=0.003] (Figure 5.7). Post-hoc analyses showed a greater postural 
sway in the ML direction when performing either the SN task (p<0.001) or the VF 
task (p=0.003) compared to the quiet standing condition when the eyes were open. 
When the eyes were closed, only the VF task resulted in greater postural sway in the 
ML direction compared with the quiet standing condition (p=0.003) and the SN task 
condition (p=0.032). There were no other two-way or three-way interactions. 
 
  
Figure 5.7 Mean (+1SD) medio-lateral sway with eyes either open and closed conditions for the 
PD and Control groups during the quiet standing (QS), subtraction (SN) and verbal fluency (VF) 
conditions 
Note: * p<0.05 comparisons between participants with PD and controls. 
 
ML postural sway variability 
Increased ML postural sway variability was observed for the PD group 
compared to the control group [F (1, 94) =28.896, p<0.001]. Additionally, the 
significant main effect of cognition [F (1.8, 172) =5.908, p=0.004] showed that the 
VF task (p=0.006) and the SN task (p=0.003) both resulted in greater ML postural 
sway variability compared to the quiet standing condition (Figure 5.8). There was no 
significant main effect for vision and no two-way or three-way interactions. 
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Figure 5.8 Mean (+1SD) medio-lateral sway SD for the eyes open and closed conditions for the PD 
and Control groups during the quiet standing (QS), subtraction (SN) and verbal fluency (VF) 
conditions 
Note: * p<0.05 comparisons between participants with PD and the controls. 
 
5.3.3 Effect of dual task on postural sway 
The dual task interferences for the two groups are shown in Figure 5.9 and 
Figure 5.10. Interference for PL was significantly greater for participants with PD 
compared to healthy controls while performing either cognitive task. However, while 
the dual task interferences of other sway measures were greater for controls these did 
not reach significance. 
 
 
 
Figure 5.9  Percentage of dual task interference of SN (subtraction of numbers) for postural sway 
measures for the PD and Control group 
Note: * p<0.05 interaction between group and cognition.  
* 
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Figure 5.10 Percentage of dual task interference of VF (verbal fluency) for postural sway measures 
for the PD and Control group 
Note: * p<0.05 interaction between group and cognition.   
 
5.3.4 Correlation between measures of postural sway and cognitive function 
As noted above, the significant interaction between cognition and groups 
indicated PL could be the best measure reflecting cognitive impact on static balance. 
Therefore, the focus was examined in respect to correlation between measures of 
executive function and PL for the different cognitive states. Overall, there was no 
significant correlation for the two groups (Table 5.2 &Table 5.3). However, a trend 
can be observed that declines in some measures of attention and executive function 
were associated with greater PL during quiet stance, specifically; the longer time on 
the TMT-A test, the greater reaction time variability both on the Go condition the 
NoGo condition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
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Table 5.2 Correlations between path length and cognitive and executive measures for the PD 
group 
  EO   EC  
 QS SN VF QS SN VF 
General cognition       
ACE -.473 (.075) -.428 (.111) -.367 (.178) -.559 (.030) -.545 (.035) -.580 (.024) 
MMSE -.473 (.075) -.248 (.372) -.206 (.461) -.421 (.118) -.309 (.262) -.368 (.177) 
Executive measures       
Trail Making Tests       
TMT-A (s) .591 (.026) .345 (.227) .371 (.191) .613 (.020) .266 (.358) .341 (.233) 
TMT-B (s) .314 (.274) .059 (.840) .116 (.692) .389 (.169) -.011 (.970) .029 (.923) 
TMT-B (error) .343 (.230) .185 (.527) .197 (.499) .309 (.282) .105 (.722) .163 (.578) 
TMT B-A (s) -.081 (.782) -.024 (.935) .015 (.958) .015 (.958) -.064 (.829) -.204 (.483) 
GoNoGo test       
 RT_Go .382 (.160) -.039 (.889) -.075 (.791) .268 (.334) .029 (.919) -.064 (.820) 
 RTsd-Go .554 (.032) .186 (.508) .196 (.483) .520 (.047) .179 (.524) .100 (.723) 
RT_NoGo .314 (.254) -.046 (.869) -.061 (.830) .229 (.412) .104 (.713) -.082 (.771) 
 RTsd_NoGo .543 (.037) .239 (.390) .214 (.443) .595 (.019) .318 (.248) .282 (.308) 
Stroop test       
 RT_Congruent .221 (.428) -.021 (.940) .007 (.980) .052 (.854) .018 (.950) -.179 (.524) 
 RTsd_ Congruent .439 (.101) .079 (.781) .161 (.567) .179 (.524) .125 (.657) -.039 (.889) 
 RT_Incongruent .489 (.064) .343 (.211) .404 (.136) .388 (.153) .314 (.254) .129 (.648) 
 RTsd_Incongruent .146 (.603) -.107 (.704) -.100 (.723) .011 (.970) .007 (.980) -.039 (.889) 
 
Notes: MMSE=Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination; TMT-
A=Trail making test A; TMT-B=Trail making test B; TMT B-A=TMT- A (time)-TMT-B (time)); 
QS=quiet standing; SN=subtraction of numbers; VF=verbal fluency; EO=eyes open; EC=eyes closed. 
RT=reaction time, RTsd=standard deviation of RT 
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Table 5.3 Correlations between path length and cognitive and executive measures for the control 
group 
  EO   EC  
 QS SN VF QS SN VF 
General cognition       
ACE .104 (.691) .256 (.321) .383 (.130) .249 (.335) .194 (.455) .414 (.099) 
MMSE -.241 (.352) .217 (.404) .096 (.713) -.217 (.404) .000 (1.00) .144 (.580) 
Executive measures       
Trail Making Tests       
TMT-A (s) .233 (.368) -.157 (.548) .248 (.338) .294 (.252) .125 (.633) -.027 (.918) 
TMT-B (s) .078 (.765) .049 (.852) .032 (.903) .078 (.765) .201 (.439) .152 (.560) 
TMT-B (error) -.153 (.557) -.357 (.159) -.255 (.323) -.204 (.432) -.306 (.232) -.357 (.159) 
TMT B-A (s) .005 (.985) .184 (.480) -.123 (.639) -.047 (.859) .115 (.660) .216 (.406) 
GoNoGo test       
 RT_Go -.061 (.815) .206 (.428) .169 (.516) .029 (.911) .154 (.554) .162 (.535) 
 RTsd_Go .007 (.978) .147 (.573) .186 (.474) -.029 (.911) .223 (.390) .218 (.400) 
RT _NoGo -.061 (.815) .142 (.586) .015 (.955) -.002 (.993) -.103 (.694) .039 (.881) 
RTsd _NoGo -.152 (.560) .093 (.722) .221 (.395) -.199 (.445) .206 (.428) .203 (.434) 
Stroop test       
 RT_Cogruent .007 (.978) .120 (646) .456 (.066) .029 (.911) .289 (.260) .056 (.830) 
 RTsd _Congruent .275 (.286) .461 (.063) .559 (.020) .250 (.333) .404 (.107) .375 (.138) 
 RT_Incongruent -.203 (.434) .100 (.701) .164 (.529) -.064 (.808) .015 (.955) .032 (.903) 
 RTsd _Incongruent -.240 (.353) .120 (.646) .091 (.729) -.314 (.220) -.034 (.896) -.157 (.548) 
 
Note: MMSE=Mini-Mental State Examination; ACE=Addenbrooke’s Cognitive Examination; TMT-
A=Trail making test A; TMT-B=Trail making test B; TMT B-A=TMT-A (time)-TMT-B (time). 
QS=quiet standing; SN=subtraction of numbers; VF=verbal fluency; EO=eyes open; EC=eyes closed. 
RT=reaction time, RTsd=standard deviation of RT 
 
5.4 DISCUSSION 
The present study has investigated the impact of a secondary cognitive task on 
standing balance in people with PD and healthy controls. The significant interaction 
of cognition, and vision demonstrated that increased demands on executive function 
have a greater effect on standing balance for participants with PD. In general, all of 
the postural sway measures were greater in people with PD compared to controls. 
Sway measures were increased when visual information was excluded (eyes closed) 
compared with when the eyes were open. The additional cognitive loads had a 
substantial impact on PL, sway area and postural sway in the ML direction for both 
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groups and, interestingly, the cognitive performances were not significantly different 
between the two groups. 
Interaction of cognition, group and vision 
Typically, PL measures the sum of distances covered between successive time 
points based on the moving COP, which reflects the amount of postural sway. The 
significant interaction of cognition, vision and group for PL demonstrated that a 
much greater portion was induced by cognitive tasks (SN, VF) in the participants 
with PD than in the controls during either the eyes open or eyes closed conditions. 
This finding indicates that the two cognitive tasks influence balance performance 
more in people with PD than controls. The SN task induced a greater increase for PL 
compared with the VF task. The finding reflects postural sway dependant on the 
nature of dual task. Furthermore, changes in postural stability with the performance 
of a secondary task may be due to changes in the connectivity between brain 
structures, which could influence the integration of vestibular, visual and 
proprioception information to stabilise posture (Coppin et al., 2006; Shumway-Cook 
et al., 1997). This result is unlike those of another dual task study that used a 
calculation task, indicating the similar effect of cognition on increased PL for people 
with PD than controls (Marchese et al., 2003). A recent study by Yogev-Seligmann 
et al. (2013) showed that COP velocity was increased in people with PD and older 
adults when performing a secondary VF task. However, the latter study employed a 
more challenging semi-tandem stance during balance measurement. In addition, it is 
possible that the decision to use a variety of letters that included “hard letters” (Fu et 
al., 2002) in the current study and the application of a separate subtraction task may 
have posed a greater cognitive challenge. 
 Given that participants with PD demonstrated a higher deficit in executive 
function compared to healthy controls (see Section 4.3.2), this may help to explain 
why participants with PD are likely to be more affected by the cognitive performance 
of the dual task. Therefore, PL could be a sensitive indicator for the detection of the 
static postural instability in people with PD. 
Postural sway between the two groups 
Under all testing conditions, the participants with PD recorded significantly 
greater values for each of the postural sway measures compared with the controls. 
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The results were supported by a non-dual task study which showed that various 
aspects of postural sway, including sway range, sway area, and path length, were 
greater in participants with PD compared to healthy controls (Blaszczyk et al., 2007). 
It should be noted that lateral deflection was previously observed in people with PD 
(Matinolli et al., 2007; Viitasalo et al., 2002). However, the measure of sway range 
in the AP direction was not significantly different between people with PD and 
healthy controls (Mitchell et al., 1995; Viitasalo et al., 2002). The findings here have 
demonstrated a greater range of postural sway both in the ML and in the AP 
directions for participants with PD compared with the controls. Postural sway in the 
AP direction is consistent with a prospective falls study for the identification of falls 
risk, which demonstrated greater AP postural sway while standing on a firm surface 
with eyes open in PD fallers compared to PD non-fallers (Kerr et al., 2010). 
The effect of vision for both groups 
For the vision deprived condition, most of the postural sway measures were 
increased compared with the eyes open condition for both groups. The significant 
effect of vision is understandable, since the visual cues are some of the most 
important aspects involving in postural control. Similar findings have been reported 
for another study, which demonstrated an increasing trend in postural sway for 
people with PD and controls during the eyes closed condition (Marchese et al., 2003). 
However, this is inconsistent with a non-dual task study, which reported a greater 
postural sway when eyes were closed for people with PD compared with controls 
(Blaszczyk et al., 2007). The current study did not find an interaction of vision and 
group in this study. It is possible that this occurred because participants with PD 
were predominantly in the early stage of the disease or the visual factors had similar 
impact on both groups.  
Understandably, standing with the eyes closed is a relatively challenge 
condition compared to standing with the eyes open, but cognitive tasks may help to 
further distinguish these two conditions. However, few studies have addressed the 
impact of increased cognitive load on different vision conditions. This study found a 
significant interaction between vision and cognition for postural sway in the ML 
direction. Both cognitive tasks induced a greater postural sway in the ML direction 
compared to the quiet standing condition when the eyes were open, whereas only the 
VF task resulted in a greater postural sway in the ML direction when the eyes were 
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closed. One of the advantages of this study is that two different cognitive tasks were 
employed, which made it possible to compare the two cognitive tasks and their 
impacts on standing balance. It is interesting to find that, for the eyes open condition, 
both cognitive tasks had similar effects on postural stability, but the VF task resulted 
in more postural sway than the SN task during the eyes closed condition. 
The main effect of cognition for both groups 
Previous studies have revealed that secondary cognitive loading could induce 
greater postural sway for healthy individuals (Maylor & Wing, 1996; Teasdale et al., 
1993; Woollacott & Shumway-Cook, 2002). Older adults have required more 
attentional resources in maintenance of postural control than young adults (Teasdale 
et al., 1993). Although cognitive impairment is a common non-motor symptom in 
people with PD, it remains unclear as to how cognitive factors contribute to impaired 
balance. 
The present study has shown an increased postural instability when adding a 
cognitive task for sway area, sway range and variability in the ML direction for both 
groups. It is important to note that the cognitive loadings resulted in an increase 
postural sway and variability in the ML direction, whereas there was less change for 
postural sway or variability in the AP direction during static balance measurement. 
Therefore, the postural sway in the ML direction may be sensitive enough to detect 
the subtle changes under the dual task. The result was in partial agreement with a 
previous research, which reported that sway area was greater for people with PD 
compared to controls when simultaneously performing a counting backward task or a 
motor sequence task, particularly for those patients who had experienced falls. 
However, sway range in the ML and AP direction was not significantly different 
between participants with PD and controls. Furthermore, the motor sequence task 
produced similar effects as the cognitive task (Marchese et al., 2003). A separate 
study using a visuospatial cognitive task did not demonstrate an effect on standing 
balance in people with PD (Schmit et al., 2006). It is possible that the current study 
used more challenging executive tasks. 
Furthermore, after controlling the baseline performance, dual task interference 
was observed to be greater for PL for the participants with PD. In contrast, another 
study (Holmes et al., 2010) observed that cognitive task resulted in less postural 
sway in PD participants compared to healthy controls, reflecting suppression of 
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postural adjustment for people with PD to focus on cognitive task for increasing 
cognitive loading. Therefore, the observation requires further study to determine. 
Cognitive performance during standing balance measurement 
However, people with PD had similar cognitive performances regarding the 
number of generated words or subtraction of numbers compared with the controls 
with either the eyes open or closed. The finding is consistent with a recent study, 
which also reported the similar cognitive performance (generated words) for people 
with PD and controls (Yogev-Seligmann et al., 2013). In terms of the two aspects of 
balance and cognition, postural stability relies on high-level cognitive functioning 
(Lajoie et al., 1996; Teasdale et al., 1993). Thus cognitive loading could influence 
standing balance. Considering this cohort has demonstrated executive impairment for 
individuals with PD, the similar cognitive performance may indicate that the they 
allocated more attention to the cognitive task than the healthy controls did, 
accordingly, they prioritised the cognitive task at the expense of standing balance. 
The inefficacy of the “posture first” strategy may lead to increased falls risk in this 
population. 
Correlation between postural sway and executive function 
To date, limit research has examined the correlation between baseline 
executive function and postural sway in PD. The current study did not find 
correlation between baseline cognitive performance and postural sway for either 
group. Consistent with this, a recent study reported that executive function was not 
associated with static balance parameters (Muir-Hunter et al., 2014). However, that 
study was restricted to older women and used a swaymetre for recording postural 
sway and TMT test performance for executive function.  
There were a number of limitations of this study that may influence the 
outcomes. Specifically, the sample size was relatively small and the participants with 
PD were predominately in the early stages of the disease. The cognitive tasks 
required a vocalisation activity, which inevitably may have introduced somewhat 
artefact into the biomechanical data. 
In summary, PD participants show greater postural sway than the healthy 
controls. Executive function influences the measures of postural sway; in particular, 
PL could be the best measure to detect this change for people with PD. 
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Chapter 6: Impact of dual tasking on gait 
characteristics 
6.1 INTRODUCTION 
Gait difficulties are a common symptom which pose a significant impact on the 
independence and QOL of people with PD. Compared to healthy people, PD 
individuals present a variety of alterations in gait characteristics including reduced 
gait speed, shorter stride length (Cole et al., 2010; Hausdorff et al., 1998), stooped 
posture, reduced arm swing (Morris et al., 1994; Morris et al., 1996b), increased 
stride time variability (Cole et al., 2010; Hausdorff et al., 1998), increased double 
support time (Cole et al., 2010) and poorer coordination (Plotnik et al., 2007; Plotnik 
& Hausdorff, 2008). Furthermore, FOG is a common and disabling symptom; this is 
an episodic arrest because of an inability to initiate normal steps during walking 
(Giladi & Nieuwboer, 2008). In particular, FOG is a contributor to falls in this 
population (Giladi et al., 2000; Kerr et al., 2010). 
While walking has been previously viewed as a simple automatic rhythmic 
movement (Fukuyama et al., 1997), recent studies have demonstrated that cognitive 
factors, particularly executive function, are involved in gait (Hausdorff et al., 2005; 
Lajoie et al., 1993), This has resulted in a number of studies that have examined the 
association between gait disturbances and cognitive impairment in both healthy 
people and people with PD. Theoretically, the walking activity requires greater 
cognitive resources than maintaining postural stability during quiet stance (Lajoie et 
al., 1996). 
The dual task methodology has been used to evaluate the impact of executive 
function on gait. This methodology requires the performance of a concomitant 
attention-demanding task while walking, and the resulting changes in gait 
performance can then be assessed (Bloem et al., 2001b). However, the specific 
nature of the dual tasks may contribute to the diverging results in both older adults 
and people with PD. Theoretically, dual tasks examining cognitive aspects involve 
elements of set shifting, divided attention and response inhibition (Yogev-Seligmann 
et al., 2008), but the type and complexity of cognitive tasks can be expected to 
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induce different effects on gait performance. More demanding cognitive tasks may 
have a greater effect on gait (Hausdorff et al., 2001; Herman et al., 2010). The VF 
task requires executive searching and retrieval abilities and is considered a measure 
of executive function. Specifically, VF can be affected by impaired switching ability 
because of frontal dysfunction (Green et al., 2002; Williams-Gray et al., 2007). 
Furthermore, VF poses a considerable challenge for the general population 
(Bootsma-van der Wiel et al., 2003), and poorer VF performance has been noted in 
people with PD (Levy et al., 2002; Mahieux et al., 1998). The serial subtraction 
numbers (SN) task measures working memory and attention (Hittmair-Delazer et al., 
1994). Therefore, the two cognitive tasks could provide important information to 
evaluate the executive function effect on gait performance within the same study. 
Very few studies have examined the impact of cognitive function on gait 
characteristics in people with PD (Yogev et al., 2005; Yogev et al., 2007). Walking 
stability deteriorated when performing a concomitant cognitive task in people with 
PD (Plotnik et al., 2011; Yogev et al., 2005), and was poorer than age-matched 
healthy controls (Yogev-Seligmann et al., 2013; Yogev et al., 2005). Under different 
dual task paradigms, the observed changes of gait parameters included decreased 
speed, shorter stride length (Plotnik et al., 2011; Yogev-Seligmann et al., 2013), 
increased stride time variability and increased swing time variability (Hausdorff et al., 
2003; Plotnik et al., 2011; Yogev et al., 2005). Dual task training for walking has 
been reported to improve gait performance (e.g. increased step length) in people with 
PD (Brauer & Morris, 2010). However, other researchers have argued that walking 
speed, or stride length are not significantly different using cognitive tasks between 
participants with PD and healthy controls (O'Shea et al., 2002; Yogev et al., 2005); 
and the cognitive task (digit subtraction) had a similar effect as a motor secondary 
task (coin transfer) on gait performance. The reduced cadence for participants with 
PD indicates a compensation under a dual task condition in order to reduce the risk 
of falling (O'Shea et al., 2002). Therefore, the association between executive function 
and gait characteristics in people with PD has yet to be determined. 
Importantly, the variability of temporal-spatial gait parameters could be 
considered an important marker due to its ability to reflect the adaptation to a 
changing walking environment. Frontal cortical function, for example, executive 
function is involved in these gait alterations, and profound cognitive changes while 
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dual tasking could provide useful or early information for gait difficulties and falls 
risk in older adults (Sheridan et al., 2003). Swing time variability was reported to 
predict future falls rather than gait velocity for older adults (Herman et al., 2010), 
particularly for older adults who had already experienced falls (Springer et al., 2006). 
Furthermore, a separate study reported that participants with PD had greater stride 
time variability and swing time variability than healthy controls (Yogev et al., 2005). 
These studies focused on temporal gait parameters using a force sensitive insole 
(Plotnik et al., 2011; Yogev et al., 2005). However, spatial gait parameters and 
variability were not included in these studies. Overall, which gait parameters are 
most sensitive to the changes under dual task situations have not been well-
researched in the past. 
Furthermore, some studies reported that FOG was associated with increased 
fall risk (Kerr et al., 2010; Latt et al., 2009a). A separate study has shown that FOG 
was associated with executive dysfunction in people with PD (Amboni et al., 2008). 
Since FOG occurs frequently in turning conditions, the use of a turning task in tight 
spaces has been shown to be effective for studying FOG. This method has been used 
to examine the effect of deep brain stimulation on gait in PD (Thevathasan et al., 
2012). However, few studies have investigated changes of gait characteristics while 
performing an executive task in a turning situation. 
The mechanism of dual tasking contributing to gait abnormalities in people 
with PD is uncertain. It has been suggested that the healthy elderly give priority to 
the stability of their gait when walking and performing a cognitive task. The 
unconscious and healthy “posture first” strategy might be one of the keys to avoiding 
hazards and preventing falls while walking. However, PD patients may inadvertently 
apply a “posture second” strategy and hence unnecessarily exacerbate their risk of 
falling in dual tasking situations (Bloem et al., 2006; Bloem et al., 2001b; Galletly & 
Brauer, 2005). Presumably, the decrement in cognitive performance may be less than 
changes in gait during dual task situation. However, previous studies have focused 
on gait performance, the secondary cognitive performance has less been studied. By 
assessing the decrement both in gait and cognitive performance during dual tasks, the 
linking of motor and cognitive ability could be identified. 
The objective of this study was to examine the impact of executive function on 
gait difficulties in people with PD. Gait characteristics were evaluated using the 
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GAITRite walkway. The GAITRite system has been shown to be a valid tool for the 
assessment of gait in older people (Menz et al., 2004) and people with PD (Bilney et 
al., 2003). It facilitates the automated measurement of both temporal and spatial 
parameters of gait. In addition, it has been shown to be useful for assessing turning 
tasks in a tight space in a study that evaluated the effect of FOG on gait 
characteristics (Thevathasan et al., 2012). To further explore the impact of executive 
function on gait during turning, two walking conditions (walking straight and turning) 
were examined under dual tasks in people with PD and healthy controls. Importantly, 
cognitive performances were assessed by correct responses of the generated words 
and calculations during the motor and cognitive tasks simultaneously. It was 
hypothesized that the dual task (cognitive task) paradigms would induce greater 
deteriorated gait characteristics for both straight walking and turning in people with 
PD compared to healthy controls. It was also hypothesized that gait parameters are 
selectively vulnerable under dual-tasking. 
6.2  METHODS 
6.2.1 Participants 
The same 15 participants with PD (age 68.5 ± 7.5 years) and 17 gender-
matched healthy controls (age 70.1 ±1.8 years) took part in this experiment (Section 
4.2.1, page 64). Participants with PD were predominantly in the early-stages of the 
disease, with a mean UPDRS total score of 31.9 ± 15.1, and a mean Hoehn & Yahr 
score of 1.6 ± 0.7. The ACE and MMSE assessments were used to screen 
participants. For the participants with PD, the mean ACE total score was 91.1±7.4 
compared with 95.6±2.3 for controls (p=0.038) and the MMSE score was 29.1±1.2 
for participants with PD and 29.5±0.5 for controls (p>0.05). 
All of the tests were undertaken at the Institute of Health and Biomedical 
Innovation at the Queensland University of Technology between October, 2011 and 
June, 2012. The participants with PD performed all assessments during their 
optimally-medicated state. 
6.2.2 Procedures 
Baseline assessments 
The extent of any gait difficulties was evaluated using the FOG questionnaire 
and sub-score which measures gait and falls (Giladi et al., 2000). The ABC scale was 
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used to examine fear of falling in the two groups (Powell & Myers, 1995) (refer to 
Section 4.2.2). 
Cognitive task 
The VF and SN (serials subtraction of 3) tasks were applied as secondary 
cognitive tasks during a walking assessment. The details were described in the 
assessment of static postural stability (refer to Section 5.2.2). 
GAITRite measurement 
Gait characteristics were assessed using the 8.3 m long GAITRite mat 
(Platinum, Rev 3.9, CIR Systems Inc. USA), which is an instrumented walkway 
facilitating the automated measurement of spatiotemporal gait parameters based on 
embedded pressure sensors. When a participant walks along the electronic walkway, 
these sensors are activated and record accurate information regarding the location of 
the footsteps with a spatial resolution of approximately 1.27cm. 
Participants performed in six conditions consisting of two walking conditions 
(walking straight and walking with a tight 180° turn) and three cognitive states (no 
cognitive task, VF, SN). Four trials were performed for each condition, resulting in 
24 trials that were performed in a random order for each participant. To minimise 
any order or learning effects, the testing order of the six combinations were randomly 
allocated using the Latin square method (refer to Appendix E). “When you are 
walking I am going to ask you to do some cognitive tasks. Please continue to walk at 
a comfortable pace when you are doing the cognitive task”. The participants were not 
asked to divide their attention to prioritize one of the tasks. During the gait 
measurement, one researcher monitored the performance and safety of the 
participants, and one researcher operated the GAITRite computer recording. 
Straight walking: Gait measurements were performed in a well-lit gait 
laboratory. Prior to gait measurement, participants were provided with the 
instructions and a demonstration of what they would be expected to do. Coloured 
adhesive tape was used to label both the starting point and the ending point. 
Participants were instructed to stand two metres away from the edge of the mat and 
begin walking along the walkway at the word “go”. The 2-metre lead-in to the 
walkway ensured that participants achieved a “steady-state” gait pattern before any 
data were collected by the mat. For straight line walking, participants were instructed 
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to walk barefoot across the mat at a self-selected pace. For the dual task, participants 
were provided with either a three-digit number or letter at the beginning of the test. 
Turning: For the turning task, a mark was placed in the middle the GAITRite 
mat two-thirds of the distance along the mat. Participants were asked to walk to the 
central marker, turn around the marker, and walk back to the starting point. 
Participants were asked to turn right or left in alternative trials. The details of the 
cognitive tasks were described above. 
 
  
Figure 6.1 GAITRite mat (left) and experimental set-up (right) 
 
Data analysis 
Cognitive performances were measured by scoring the number of correctly 
subtracted numbers or the number of words generated during the walking tasks. The 
footprint data derived from the GAITRite measurement were processed using the 
GAITRite software (v3.9) for the straight walking and turning conditions, 
respectively. 
Straight walking: The GAITRite software was used to process the collected 
data. After each trial, verification and analysis of footsteps were undertaken for each 
walk. Any footsteps at the beginning or end of the trial that did not completely fall 
within the active area of the walkway were manually deleted. Outcome variables 
were spatiotemporal gait parameters including gait velocity, cadence, stride time and 
stride time variability, swing time (% gait cycle) and swing time variability, stance 
time (% gait cycle) and stance time variability, double support time (% gait cycle), 
stride length and stride length variability and step width and step width variability. 
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These parameters were automatically computerised for left and right gait parameters 
and then were calculated to an average value for each gait parameter. 
Turning: For the turn condition, the outcome measures were cadence, steps 
taken and duration of turning. The detail of these measures has been described 
elsewhere (Thevathasan et al., 2012). Specifically, given the two opposing directions 
produced overlapping footsteps, the dynamic analysis (timing) was used in the 
process. The footsteps of the 180° arc were individually identified frame by frame 
manually (Figure 6.2), and the duration of turning and cadence were calculated for 
each trial. When footsteps did not fall in the activated region due to the complexity 
of the turning condition, these trials were excluded to ensure accurate results. To 
maintain the same numbers of trials for the two groups, the three trials were used for 
each participant during the turning conditions. 
 
Figure 6.2 Illustration of turn 
In addition, dual task interference (%) was expressed as the difference between 
single task (walking) and dual task by single task performance (Rochester et al., 
2014). The dual task interference of cognitive performance was expressed as the 
difference between quiet standing and walking conditions.  
6.2.3 Statistical analyses 
Analysis of the baseline assessments, including the demographic variables and 
clinical characteristics were described in Section 4.2.3. For each of the continuous 
variables derived from the GAITRite measurement, descriptive statistics (mean, SD) 
were initially calculated. The normality of the data was determined by examining 
frequency statistics, histograms, and the values of skew and kurtosis. Independent 
two-tailed t-tests were used to examine the mean difference between the PD cases 
and the healthy controls on the accuracy of the cognition performances. If the data 
were found to be not normally distributed, the Mann-Whitney test was used to 
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examine the difference between the two groups. The Chi-square test was used to 
compare the PD and control groups for categorical variables. 
To examine the effect of cognitive factors on gait characteristics, the repeated 
measures ANOVA procedure was applied with one between-subjects factor (group, 2 
levels) and one repeated within-subject factor (cognitive states, 3 levels). Mauchley’s 
test was used to assess the assumption of sphericity for the repeated measure 
variables. If the assumption was violated, the Greenhouse-Geisser correction was 
used to adjust the degrees of freedom for the F-ratio. The interactive term of group 
by cognitive task was used to ascertain whether the performance of the dual task 
affected the gait parameters differently for the two groups. In a situation where a 
significant main effect was reported, Fisher’s LSD post-hoc test was conducted. 
Following variables, stride time and stride length variability, swing time variability, 
stance time variability, and step width variability, became normally distributed after 
log transformations. Then the repeated measures ANOVA procedures were 
performed. Spearman’s correlation was performed to determine the correlations 
between measures of general cognition and executive function and gait parameters. 
For the turning condition, outcome variables included cadence, steps taken and 
turn duration. The repeated measures ANOVA procedure was performed with one 
between-subjects-factor (group, 2 levels) and one repeated within-subject factor 
(cognitive states, 3 levels). All statistical analyses were performed using the SPSS 
19.0 for Windows. The level of significance was defined as p<0.05, with p values 
between 0.1 and 0.05 considered to be marginally significant. The significant level 
was set p<0.01 for bivariate correlations as conservative purpose to accommodate 
multiple corrections. 
6.3 RESULTS 
The PD and control groups were of a similar age, gender, height and mass, and 
had received a similar number of years of education. The clinical characteristics and 
the results of baseline assessments were described in Section 4.3.1 (see page 69). 
6.3.1 The cognitive performance during walking 
The number of generated words and the performance on the subtraction of 
numbers task were not significantly different between the PD and control groups 
(Table 6.1). 
 Chapter 6: Impact of dual tasking on gait characteristics 109 
Table 6.1 The cognitive performance during walking for participants with PD and the controls 
 Control (n=17) PD (n=15) p value 
Generated words (SW) 5.87 (1.34) 5.77 (1.88) 0.861 
Generated words (turn) 7.68 (1.83) 6.95 (2.23) 0.320 
Subtracted numbers (SW) 5.00 (1.67) 5.30 (1.00) 0.537 
Subtracted numbers (turn) 7.01 (2.59) 6.93 (1.65) 0.918 
 
Notes: SW=straight walking. 
All values reported are mean (SD) and the p value relates to an independent samples t-test. 
 
6.3.2 Temporal gait parameters 
Velocity 
There was no significant difference between the two groups [F (1, 126) =0.245, 
p=0.621] with respect to walking velocity. However, there was a significant main 
effect for the different cognitive states [F (1.7, 214.4) =130.526, p<0.001] and the 
post-hoc analyses showed that all participants walked more slowly when performing 
the cognitive tasks (VF, SN) compared with normal walking. Furthermore, 
participants walked significantly slower during the VF task compared with the SN 
task (p<0.001). 
The significant interaction between cognition and group [F (1.7, 214.4) =8.889, 
p<0.001] revealed that, while both groups reduced velocity in response to the 
cognitive tasks (SN, VF), the change in walking speed was greater for the 
participants with PD (p<0.001). In particular, the VF task resulted in a greater 
reduction in walking velocity than the SN task either for the participants with PD 
(p<0.001) and for the controls (p=0.028) (see Figure 6.3). 
Cadence 
There was no significant difference between the two groups with respect to 
cadence [F (1,126) =0.227, p=0.634]. However, there was a significant main effect 
for cognition [F (1.9, 238.5) =67.535, p<0.001] and the results of the post-hoc 
analyses demonstrated that all participants reduced their cadence when performing 
the cognitive tasks (SN, VF) compared with normal walking (p<0.001). Additionally, 
cadence was significantly slower when performing the VF task compared with the 
SN task (p=0.001). 
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The significant interaction between cognition and group [F (1.9, 238.5) =5.441, 
p=0.006] demonstrated that, while both groups reduced cadence in response to 
cognitive tasks (SN, VF), the change was greater for the participants with PD. In 
particular, the VF task resulted in a greater reduction in cadence than the SN task for 
both the participants with PD (p=0.01) and for the controls (p=0.022) (see Figure 
6.3). 
 
  
Figure 6.3 Mean (+1SD) velocity and cadence for the PD and control groups during normal 
walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions   
 
Stride time and stride time variability 
Stride time: While there was no significant difference between the two groups, 
with respect to stride time [F (1,126) =0.637, p=0.426], there was a significant main 
effect for cognition [F (1.9, 235.2) =56.506, p<0.001]. Post-hoc analyses 
demonstrated that cognitive tasks (SN, VF) resulted in longer stride times compared 
with normal walking for both groups (both p<0.001) and that there was a greater 
change in stride time during the VF task than during the SN task (p=0.001). 
The significant interaction between cognition and groups [F (1.9, 235.2) 
=3.728, p=0.028] revealed that, while stride time increased in response to the 
cognitive tasks (SN, VF) compared to normal walking (p<0.001) for both groups, 
and there was a greater change for participants with PD. Furthermore, the VF task 
resulted in longer stride times compared to the SN task for the PD group (p=0.013) 
and for the controls (p=0.023). 
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Stride time variability: Participants with PD had significantly greater stride 
time variability compared to the controls [F (1,126) =13.686, p<0.001] and the 
significant main effect of cognition [F (2, 252) =31.483, p<0.001] demonstrated that 
all participants increased stride time variability when performing cognitive tasks (SN, 
VF) compared to normal walking. Post-hoc analyses showed that there was the 
greater variability during the VF task than during the SN task (p<0.001). There was 
no significant interaction between cognition and group [F (2, 252) =1.856, p=0.158] 
(see Figure 6.4). 
 
 
Figure 6.4 Mean (+1SD) stride time and variability for the PD and control groups during normal 
walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions, * p<0.05 comparison between 
the two groups   
 
Swing time and swing time variability 
Swing time: There was no significant difference between the two groups with 
respect to swing time [F (1,126) =0.062, p=0.804]. The significant main effect of 
cognition [F (2, 252) =16.076, p<0.001] demonstrated that, cognitive tasks (SN, VF) 
resulted in significantly shorter swing times compared to normal walking (p<0.001), 
but that the two cognitive tasks were not significantly different (p=0.587). 
The interaction of cognition and group was significant for swing time [F (2, 
252) =6.013, p=0.003]. For the PD group, both cognitive tasks (SN, VF) resulted in 
significantly shorter swing times compared to normal walking (p<0.001), whereas 
only the SN task resulted in shorter swing times for the controls (p=0.041). 
Swing time variability: With respect to the variability of swing time, there was 
no significant difference between the two groups [F (1,126) =2.519, p=0.115]. The 
* 
 
* 
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significant main effect of cognition [F (2, 252)=20.956, p<0.001] demonstrated that 
swing time variability significantly increased when performing the SN task (p=0.001) 
and the VF task (p<0.001) compared to normal walking for both groups, Furthermore, 
swing time variability was significantly greater when performing the VF task 
compared with the SN task (p=0.008). However, there was no significant interaction 
of cognition and group [F= (2, 252) =1.127, p=0.326] (see Figure 6.5). 
 
  
Figure 6.5 Mean (+1SD) swing time and swing time variability for the PD and control groups 
during normal walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions 
 
Stance time and stance time variability 
Stance time: There was no significant difference between the two groups [F 
(1,126) =0.075, p=0.863] for stance time. The significant main effect for cognition [F 
(2, 252) =11.705, p<0.001] demonstrated that the cognitive tasks (SN, VF) resulted 
in increased stance time compared to normal walking (p<0.001), but the two 
cognitive tasks were not significantly different (p=0.608). 
The significant interaction between cognitive tasks and groups [F (2, 252) 
=6.359, p=0.002] revealed that participants with PD had significantly increased 
stance times when performing the cognitive tasks (SN, VF) compared to normal 
walking (p<0.001), while stance times were not affected by the cognitive tasks for 
the controls (p>0.05) (see Figure 6.6). 
Stance time variability: Participants with PD demonstrated greater variability 
with respect to stance time than the controls [F (1,126) =6.969, p=0.009]. The 
significant main effect of cognition [F (2,252) =22.398, p<0.001] demonstrated that 
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the performance of the cognitive tasks (SN and VF) resulted in increased stance time 
variability compared to the normal walking condition (p<0.001) for both groups, and 
greater stance time variability when performing the VF task compared to the SN task 
(p=0.007). However, there was no significant interaction of cognition and group [F 
(2,252) =0.859, p=0.425] (see Figure 6.6). 
 
  
Figure 6.6 Mean (+1SD) stance time and stance time variability for the PD and control groups 
during normal walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions, * p<0.05 comparison between 
the two groups 
 
Double support time 
Double support time: There was no significant difference between the two 
groups for double support time [F (1,126) =0.008, p=0.931]. However, the 
significant main effect of cognition [F (2, 252) =15.722, p<0.001] revealed that 
participants spent more time in double support time when performing the cognitive 
tasks (SN and VF) compared to normal walking (p<0.001), but not different between 
the two cognitive tasks (p=0.581) (see Figure 6.7). 
The significant interaction between cognition and group [F (2, 252) =6.063, 
p=0.003] revealed that the participants with PD spent more time in double support 
when performing the cognitive tasks (SN, VF) (p<0.001), while the secondary tasks 
did not influence double support time for the controls (p>0.05). 
 
* 
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Figure 6.7 Mean (+1SD) double support time for the PD and control groups during normal walking, 
subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions 
 
6.3.3 Spatial gait parameters 
Stride length and stride length variability 
Stride length: There was no significant difference between the two groups with 
respect to stride length [F (1,126) =0.605, p=0.438]. However, the significant main 
effect of cognition [F (1.5, 187.4) =112.033, p<0.001] demonstrated that participants 
took shorter strides when performing the secondary cognitive tasks and that stride 
lengths were shorter during the VF task compared with the SN task (p<0.001). 
The significant interaction between cognition and group [F (1.5, 187.4) 
=12.377, p<0.001] demonstrated that both cognitive tasks (SN, VF) resulted in a 
shorter stride length than the normal walking task for the two groups, but that this 
change was greater for the participants with PD (p<0.001). Additionally, the 
participants with PD took significantly shorter stride in the VF task than in the SN 
task (p<0.001). 
Stride length variability: The participants with PD had greater stride length 
variability than the controls [F (1,126) =4.564, p=0.035]. The significant main effect 
of cognition [F (2, 252) =19.992, p<0.001] indicated that both groups demonstrated 
more stride length variability when performing the cognitive tasks (SN, VF) than 
when walking normally (p<0.001). Furthermore, there was greater stride length 
variability when performing the VF task compared with the SN task (p=0.044). 
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There was no significant interaction between cognition and groups [F (2, 252) 
=1.396, p=0.250] (see Figure 6.8). 
 
  
Figure 6.8 Mean (+1SD) stride length and stride length variability for the PD and control groups 
during normal walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions, * p<0.05 comparison between 
the two groups 
 
Step width and step width variability 
Step width: There was no significant difference between the two groups for 
step width [F (1, 126) =0.402, p=0.527], but the significant main effect of cognition 
[F (2,252) =9.396, p<0.001] demonstrated that both of the cognitive tasks (SN, VF) 
resulted in significantly greater step width than in normal walking (p<0.001). There 
was no difference between the two cognitive tasks (p=0.725). 
The significant interaction between cognition and group [F (2, 252) =3.076, 
p=0.048] revealed that the cognitive tasks (SN, VF) resulted in increased step width 
for the participants with PD (p<0.001), but not for the controls (p>0.05). 
Step width variability: There was no significant differences between the two 
groups with respect to step width variability [F (1,126) =0.043, p=0.837]. However, 
the significant main effect of cognition [F (1.9, 238.6) =6.592, p=0.002] 
demonstrated that all participants had greater step width variability when performing 
the SN (p=0.008) and the VF tasks (p<0.001) compared with the normal walking. 
There was no significant difference between the two cognitive tasks (p=0.499) and 
there was no significant interaction between cognition and group [F (1.9, 238.6) 
=0.278, p=0.745] (see Figure 6.9). 
 
* 
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Figure 6.9 Mean (+1SD) step width and step width variability for the PD and control groups during 
normal walking, subtraction (SN) and verbal fluency (VF) conditions 
Notes: # p<0.05 comparison between different cognitive conditions 
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Table 6.2 The gait parameters during different cognitive tasks for PD and control groups 
 
Notes: * significant main effect of group; Δ significant main effect of cognition; □ significant interaction of cognition and group; a the SN task significantly worse than 
in normal walking for controls; b the VF task significantly worse than in normal walking for controls; c the VF task significantly worse than the SN task for controls. d the SN 
task significantly worse than normal walking for participants with PD; e the VF task significantly worse than the walking for participants with PD ; f the VF task significantly 
worse than the SN task for participants with PD. 
Control PD Sig
Normal walking Walking & SN Walking & VF Normal Walking Walking &SN Walking & VF
Temporal- and spatial- parameters
Velocity (m/s) 1.296 (0.126) 1.201 (0.132) 1.169 (0.135) 1.324 (0.213) 1.191 (0.225) 1.106 (0.245) △□a,b,c,d,e,f
Cadence (steps/s) 115.504 (7.337) 112.660 (9.355) 111.103 (10.543) 116.720 (10.942) 111.013 (10.264) 109.138 (11.737) △□a,b,c,d,e,f
Stride time (s) 1.044 (0.068) 1.073 (0.086) 1.091 (0.103) 1.038 (0.097) 1.093 (0.109) 1.114 (0.123) △□a,b,c,d,e,f
Swing cycle (%) 41.198 (1.065) 40.912 (1.353) 41.004 (1.432) 41.543 (2.052) 40.793 (2.153) 40.573 (2.108) △□a,d,e
Double support time (%) 17.934 (2.858) 18.497 (2.900) 18.340 (2.830) 17.066 (4.054) 18.715 (4.320) 19.136 (4.062) △□d,e
Stance cycle (%) 58.888 (1.427) 59.097 (1.348) 58.995 (1.430) 58.473 (2.049) 59.215 (2.152) 59.438 (2.112) △□d,e
Stride length (cm) 134.963 (13.230) 128.219 (12.972) 126.832 (13.543) 135.778 (15.004) 128.066 (16.752) 120.383 (17.962) △□a,b,d,e,f
Step width (cm) 8.984 (2.515) 9.278 (2.306) 9.191 (2.846) 8.294 (3.213) 9.016 (3.428) 9.204 (3.296) △□d,e
Variability
Stride time variability 0.014 (0.008) 0.016 (0.007) 0.023 (0.013) 0.016 (0.007) 0.024 (0.016) 0.030 (0.029) * △
Swing time variability 0.013 (0.007) 0.016 (0.015) 0.018 (0.012) 0.013 (0.008) 0.019 (0.017) 0.021 (0.016) △
Stance time variability 0.016 (0.021) 0.017 (0.013) 0.021 (0.012) 0.016 (.008) 0.024 (0.025) 0.025 (0.019) * △
Stride length variability 2.536 (1.360) 2.858 (1.222) 3.326 (1.621) 2.658 (1.458) 3.504 (1.718) 3.581 (1.260) * △
Step width variability 1.632 (0.672) 1.963 (0.879) 1.947 (0.772) 1.697 (0.735) 2.137 (1.620) 2.063 (1.128) △
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6.3.4 Gait parameters during turning 
Duration of turning 
Participants with PD spent more time on the turn task than the controls [F (1, 
94) =5.688, p=0.019] (Table 6.3). The significant main effect of cognition [F (2, 188) 
=10.814, p<0.001] demonstrated that all participants took a longer time when 
performing the SN task (p=0.001) and the VF task (p<0.001) compared to normal 
turning and that the two cognitive tasks were not significantly different (p=0.292). 
There was no significant interaction between cognition and group [F (2, 188) =2.463, 
p=0.088] (see Figure 6.10). 
Steps 
There was no significant difference between the two groups with respect to the 
number of steps taken to complete the turn [F (1, 94) =2.838, p=0.095]. There was no 
significant main effect of cognition [F (2,188) =2.577, p=0.079] or significant 
interaction between cognition and group [F (2,188) =1.298, p=0.275]. 
Cadence 
There was no significant difference between the two groups with respect to 
cadence [F (1, 94) =1.701, p=0.195]. The significant main effect of cognition [F (2, 
188) =15.404, p<0.001] demonstrated that the cognitive tasks (SN, VF) resulted in a 
reduced cadence compared to normal turning (p<0.001), but there was no difference 
between the two tasks (p=0.935). No significant interaction was found between 
cognition and group [F (2, 188) =0.584, p=0.559]. 
 
   
Figure 6.10 Mean (+1SD) the duration of turning, steps taken and cadence for participants with PD 
and controls during normal turning, subtraction (SN) and verbal fluency (VF) conditions 
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Table 6.3 The gait parameters during dual task turning for Parkinson’s disease and control groups 
 
Note: * significant main effect of group; Δ significant main effect of cognition 
 
6.3.5 Effect of dual task on gait characteristics and cognitive performance 
The dual task interferences for straight walking are shown in Figure 6.11 and 
Figure 6.12. For most gait parameters, dual task interference was greater for 
participants with PD. Swing time and stance time were relatively constant for healthy 
controls compared with participants with PD. Furthermore, the dual task interference 
for variability of gait parameters and cognitive performance were the same for the 
two groups. 
 
 
 
Figure 6.11  Percentage of dual task interference for subtraction of numbers (SN) during straight 
walking for gait parameters and cognitive performance for the PD and Control group 
Note: * p<0.05 interaction between group and cognition.   
 
Sig
turning only turning & SN turning & VF turning only turning &SN turning & VF
Duration of turn (s) 2.154 (0.363) 2.294 (0.431) 2.277 (0.470) 2.262 (0.553) 2.475 (0.702) 2.616 (0.592) * ,△
Steps (n) 3.941 (0.614) 3.980 (0.707) 4.000 (0.917) 4.044 (0.878) 4.178 (0.960) 4.378 (0.806)
Cadence (steps/min) 110.278 (8.055) 104.891 (10.815) 105.847 (12.130) 108.577 (11.628) 103.179 (11.172) 102.021 (12.348) △
Control PD
* 
* 
* 
* 
* 
* 
* 
* 
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Figure 6.12 Percentage of dual task interference for verbal fluency (VF) during straight walking for 
gait parameters and cognitive performance for the PD and Control group 
Note: * p<0.05 interaction between group and cognition.   
 
Figure 6.13 and Figure 6.14 showed that greater dual task interference for 
longer duration and decreased cadence and cognitive performance for both groups, 
particularly while performing a VF task during turn condition. 
 
 
 
Figure 6.13  Percentage of dual task interference during turning for gait parameters and cognitive 
performance for the PD and Control group 
 
* 
* 
* 
* 
* 
* 
* 
* 
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Figure 6.14 Percentage of dual task interference during turning for gait parameters and cognitive 
performance for the PD and Control group 
 
6.3.6 Correlation between gait parameters and cognitive function 
There was no correlation between general cognition and any gait parameters 
for both groups. 
For the participants with PD, longer reaction time on the Go and NoGo tasks 
were associated with walking slower when performing a SN task. However, a trend 
was observed for performing a VF task (r=-0.621, p=0.013; r=-.636, p=0.011) (Table 
6.4). Similarly, longer reaction time on the Go and NoGo tasks were associated with 
the reduced cadence during performing either secondary cognitive task for the 
participants with PD. (Table 6.5). However, no significant correlation was observed 
for the controls between executive function and velocity or cadence. 
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Table 6.4 Correlations between cognition and velocity during different cognitive states for the PD 
and control groups 
  PD   Control  
 Normal 
walking 
Walking & 
SN 
Walking & 
VF 
Normal 
walking 
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE .356 (.192) .113 (.687) .169 (.547) .336 (.187) .196 (.451) .236 (.363) 
MMSE .326 (.235) .544 (.036) .420 (.119) .337 (.186) .253 (.328) .229 (.337) 
Executive measures       
Trail making tests       
TMT-A (s) .015 (.958) -.068 (.817) -.262 (.366) .131 (.615) -.239 (.355) -.056 (.830) 
TMT-B (s) -.213 (.464) -.160 (.584) .169 (.563) -.090 (.732) -.235 (.363) -.130 (.619) 
TMT-B (error) -.368 (.196) -.204 (.483) -.032 (.914) -.102 (.696) .000 (1.00) .153 (.557) 
TMT B-A (s) -.046 (.876) .029 (.923) 437 (.118) -.133 (.612) -.059 (.822) -.145 (.579) 
GoNoGo test       
RT_Go -.493 (.062) -.661 (.007) -.621 (.013) .119 (.649) -.109 (.677) .010 (.970) 
RTsd _Go -.621 (.013) -.525 (.044) -.532 (.041) -.411 (.101) -.361 (.155) -.476 (.053) 
RT_NoGo -.525 (.044) -.704 (.003) -.636 (.011) .102 (.697) -.078 (.765) -.069 (.793) 
RTsd_NoGo -.493 (.062) -.550 (.034) -.593 (.020) -.249 (.335) -.130 (.619) -.137 (.599) 
Stroop test       
RT_Congruent -.336 (.221) -.564 (.028) -.504 (.056) .227 (.381) .270 (.295) .139 (.596) 
RTsd_Congruent -.432 (.108) -.382 (.160) -.518 (.048) -.285 (.268) -.040 (.877) -.383 (.129) 
RT _Incongruent -.046 (.869) .114 (.685) -.025 (.930) -.124 (.636) -.075 (.775) -.204 (.433) 
RTsd _Incongruent .079 (.781) -.061 (.830) -.121 (.666) -.133 (.612) .287 (.264) -.117 (.656) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
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Table 6.5 Correlations between cognition and cadence during different cognitive states for the PD 
and control groups 
  PD   Control  
 Normal 
walking 
Walking & 
SN 
Walking & 
VF 
Normal 
walking 
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE .044 (.876) .121 (.669) .056 (.843) .094 (.719) .183 (.481) .064 (.806) 
MMSE .124 (.659) .380 (.163) .330 (.229) .409 (.103) .325 (.203) .313 (.222) 
Executive measures       
Trail making tests       
TMT-A (s) -.216 (.459) -.156 (.594) -.292 (.311) -.544 (.024) -.557 (.020) -.554 (.021) 
TMT-B (s) -.015 (.958) -.051 (.864) .165 (.573) -.152 (.560) -.282 (.273) -.203 (.434) 
TMT-B (error) -.084 (.775) -.054 (.856) .168 (.566) -.051 (.846) .026 (.923) .051 (.846) 
TMT B-A (s) .068 (.817) .121 (.681) .371 (.191) .275 (.286) .145 (.580) .216 (.406) 
GoNoGo test       
RT_Go -.463 (.082) -.793 (<.001) -.689 (.004) .025 (.926) -.029 (.911) .061 (.815) 
RTsd_Go -.456 (.088) -.457 (.087) -.389 (.152) -.078 (.765) -.197 (.448) -.167 (.523) 
RT_NoGo -.416 (.123) -.700 (.004) -.643 (.010) -.113 (.667) -.185 (.477) -.257 (.319) 
RTsd_NoGo -.438 (.103) -.514 (.050) -.521 (.046) .042 (.874) -.088 (.736) .044 (.866) 
Stroop test       
RT_Congruent -.357 (.191) -.550 (.034) -.596 (.019) -.167 (.523) .033 (.900) -.071 (.786) 
RTsd_Congruent -.129 (.648) -.175 (.533) -.332 (.226) -.069 (.794) .109 (.677) .020 (.940) 
RT_Incongruent -.155 (.580) -.150 (.594) -.218 (.435) .316 (.216) -.047 (.859) -.225 (.384) 
RTsd_Incongruent .427 (.112) .079 (.781) -.025 (.930) -.103 (.694) .237 (.360) -.042 (.874) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
 
For the PD participants, longer reaction time on the Go task was associated 
with increased stride time during performance of either concurrent cognitive task.  
Similarly, greater reaction time on the NoGo task was associated with longer stride 
time when performing a SN task, and revealed a trend for performing a VF task 
(r=0.631, p=0.012). For the controls, there was only marginal significance between 
longer time on the TMT-A and increased stride time with performing a SN task 
(r=0.593, p=0.012) (Table 6.6).  
The PD participants did not show any significant correlations between 
executive measures and swing time, stance time and double support time. For the 
controls, longer time taken on the TMT-A was associated with reduced swing time, 
increased stance time and increased double support time during normal walking. 
Greater reaction time variability on the Go was correlated with decreased swing time 
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and increased stance time during performing a VF task (Table 6.7, Table 6.8 and 
Table 6.9). 
 
Table 6.6 Correlations between cognition and stride time during different cognitive states for the 
PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE -.086 (.759) -.121 (.669) -.052 (.853) -.124 (.636) -.165 (.528) -.064 (.806) 
MMSE -.149 (.596) -.311 (.259) -.331 (.229) -.433 (.083) -.337 (.186) -.313 (.222) 
Executive measures       
Trail making tests       
TMT-A (s) .222 (.446) .112 (.703) .312 (.277) .534 (.027) .593 (.012) .554 (.021) 
TMT-B (s) .033 (.911) .086 (.771) -.163 (.578) .147 (.573) .294 (.252) .203 (.434) 
TMT-B (error) .124 (.672) .054 (.858) -.155 (.597) .051 (.846) .000 (1.00) -.051 (.846) 
TMT B-A (s) -.086 (.771) -.051 (.864) -.376 (.185) -.272 (.291) -.145 (.580) -.216 (.406) 
GoNoGo test       
RT_Go .475 (.074) .743 (.002) .672 (.006) -.049 (.852) .034 (.896) .061 (.815) 
RTsd_Go .464 (.081) .479 (.071) .399 (.141) .071 (.786) .213 (.411) .167 (.523) 
RT_NoGo .404 (.136) .686 (.005) .631 (.012) .078 (.765) .189 (.468) .257 (.319) 
 RTsd_NoGo .439 (.101) .536 (.040) .533 (.041) -.054 (.837) .113 (.667) -.044 (.866) 
Stroop test       
RT_Congruent .332 (.226) .543 (.037) .595 (.019) .150 (.567) .002 (.993) .071 (.786) 
RTsd_Congruent .107 (.704) .154 (.585) .354 (.196) .076 (.772) -.081 (.758) -.020 (.940) 
RT_Incongruent .132 (.639) .143 (.612) .216 (.439) .287 (.264) .042 (.874) .225 (.384) 
RTsd_Incongruent -.414 (.125) -.164 (.558) .020 (.945) .123 (.639) -.240 (.353) .042 (.874) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
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Table 6.7 Correlations between cognition and swing time during different cognitive states for the 
PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE .148 (.600) .130 (.645) .059 (.833) .019 (.942) .021 (.936) .217 (.402) 
MMSE .082 (.771) .107 (.705) .178 (.527) .109 (.678) -.072 (.783) .096 (.713) 
Executive measures       
Trail making tests       
TMT-A (s) .253 (.383) .385 (.175) .073 (.805) -.718 (.001) -.388 (.124) -.412 (.100) 
TMT-B (s) -.182 (.533) -.160 (.584) .152 (.605) -.188 (.470) -.334 (.190) -.364 (.151) 
TMT-B (error) -.177 (.691) -.122 (.679) .114 (.697) .077 (.770) .128 (.625) -.026 (.923) 
TMT B-A (s) -.033 (.911) -.143 (.626) .345 (.227) .359 (.157) -.029 (.911) -.088 (.736) 
GoNoGo test       
RT_Go -.214 (.443) -.386 (.156) -.268 (.334) -.447 (.072) -.324 (.205) -.311 (.224) 
RTsd_Go -.225 (.420) -.325 (.237) -.275 (.321) -.044 (.866) -.252 (.330) -.618 (.008) 
RT_NoGo -.232 (.405) -.411 (.128) -.321 (.243) -.472 (.056) .049 (.852) -.060 (.819) 
RTsd_NoGo -.161 (.567) -.200 (.475) -.364 (.182) .061 (.815) -.211 (.416) -.505 (.039) 
Stroop test       
RT_Congruent -.139 (.621) -.314 (.254) -.186 (.508) -.283 (.272) .013 (.959) -.284 (.268) 
RTsd_Congruent -.143 (.612) -.204 (.467) -.221 (.428) .199 (.444) .199 (.444) -.156 (.551) 
RT_Incongruent .336 (.221) .193 (.491) .343 (.211) -.518 (.033) .023 (.929) -.167 (.522) 
RTsd_Incongruent -.089 (.752) -.146 (.603) -.050 (.860) .251 (.332) .372 (.142) .119 (.649) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
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Table 6.8 Correlations between cognition and stance time during different cognitive states for the 
PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE -.148 (.600) -.115 (.682) -.059 (.833) .007 (.979) -.079 (.764) -.231 (.372) 
MMSE -.082 (.771) -.114 (.687) -.178 (.527) -.073 (.782) .084 (.748) -.072 (.783) 
Executive measures       
Trail making tests       
TMT-A (s) -.253 (.383) -.372 (.190) -.073 (.805) .702 (.002) .406 (.106) .424 (.090) 
TMT-B (s) .182 (.533) .139 (.637) -.152 (.605) .106 (.686) .341 (.181) .362 (.154) 
TMT-B (error) .117 (.691) .106 (.718) -.114 (.697) -.026 (.922) -.153 (.557) .026 (.923) 
TMT B-A (s) .033 (.911) .117 (.691) -.345 (.227) -.435 (.081) .018 (.944) .074 (.779) 
GoNoGo test       
RT_Go .214 (.443) .402 (.137) .268 (.334) .397 (.115) .332 (.193) .324 (.205) 
RTsd_Go .225 (.420) .327 (.234) .275 (.321) .026 (.921) .248 (.338) .620 (.008) 
RT_NoGo .232 (.405) .427 (.112) .321 (.243) .398 (.114) -.058 (.826) .055 (.833) 
RTsd_NoGo .161 (.567) .213 (.447) .364 (.182) -.085 (.746) .217 (.403) .508 (.037) 
Stroop test       
RT_Congruent .139 (.621) .336 (.221) .186 (.508) .227 (.381) -.016 (.952) .265 (.304) 
RTsd_Conguent .143 (.612) .213 (.447) .221 (.428) -.229 (.376) -.239 (.355) .121 (.643) 
RT_Incongruent -.336 (.221) -.195 (.487) -.343 (.211) .450 (.070) -.070 (.790) .145 (.580) 
RTsd_Incongruent .089 (.752) .152 (.589) .050 (.860) -.262 (.309) -.353 (.164) -.131 (.616) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
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Table 6.9 Correlations between cognition and double support time during different cognitive 
states for the PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE -.148 (.600) -.101 (.721) -.074 (.794) -.083 (.751) .010 (.970) -.308 (.230) 
MMSE -.082 (.771) -.120 (.669) -.225 (.420) -.060 (.818) .108 (.679) .024 (.927) 
Executive measures       
Trail making tests       
TMT-A (s) -.253 (.383) -.358 (.208) -.099 (.737) .653 (.004) .423 (.091) .267 (.299) 
TMT-B (s) .182 (.533) .116 (.692) -.116 (.692) -.032 (.903) .375 (.138) .221 (.394) 
TMT-B (error) .117 (.691) .090 (.759) -.007 (.980) -.026 (.922) -.102 (.697) -.051 (.846) 
TMT B-A (s) .033 (.911) .090 (.759) -.284 (.326) -.566 (.018) .047 (.859) .006 (.981) 
GoNoGo test       
RT _Go .214 (.443) .418 (.121) .268 (.334) .426 (.088) .372 (.142) .240 (.352) 
RTsd_Go .225 (.420) .329 (.232) .261 (.348) .011 (.966) .233 (.368) .451 (.051) 
RT_NoGo .232 (.405) .443 (.098) .361 (.187) .363 (.152) .064 (.808) .063 (.811) 
RTsd_NoGo .161 (.567) .225 (.420) .407 (.132) -.069 (.793) .179 (.492) .309 (.227) 
Stroop test       
RT_Congruent .139 (.621) .357 (.191) .164 (.558) .113 (.666) -.022 (.933) .216 (.405) 
RTsd_Congruent .143 (.612) .221 (.428) .246 (.376) -.225 (.386) -.313 (.222) .000 (1.00) 
RT_Incongruent -.336 (.221) -.196 (.483) -.396 (.143) .309 (.227) -.011 (.966) .297 (.247) 
RTsd_Incongruent .089 (.752) .157 (.576) .068 (.810) -.292 (.255) -.348 (.171) .043 (.870) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
 
For the PD participants, greater reaction time variability on the congruent 
condition of the Stroop test was associated with a shorter stride length during 
performance of a VF task. Greater reaction time variability on the Go task tended to 
be associated with a shorter stride length during normal walking (r=-0.625, p=0.013). 
For the participants with PD, more errors on the TMT-B tended to have a wider step 
width across while performing a VF task (r=0.638, p=0.014). In contrast, no 
significant correlations were observed for the controls between executive measures 
and stride length or step width (Table 6.10 and Table 6.11). 
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Table 6.10 Correlations between cognition and stride length during different cognitive states for the 
PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE .398 (.142) .220 (.432) .126 (.655) .271 (.292) .116 (.656) .166 (.524) 
MMSE .374 (.169) .571 (.026) .479 (.071) .096 (.713) .000 (1.00) .072 (.783) 
Executive measures       
Trail making tests       
TMT-A (s) .200 (.493) 064 (.829) -.081 (.782) .223 (.390) .142 (.586) .179 (.492) 
TMT-B (s) -.327 (.253) -.240 (.409) -.147 (.615) -.064 (.808) -.135 (.606) -.027 (.918) 
TMT-B (error) -.494 (.073) -.192 (.510) -.192 (.510) -.102 (.697) .000 (1.00) -.051 (.846) 
TMT B-A (s) -.143 (.626) -.007 (.982) .130 (.659) -.216 (.406) -.252 (.328) -.181 (.486) 
GoNoGo test       
RT_Go -.329 (.232) -.468 (.079) -.443 (.098) -.069 (.794) -.184 (.480) -.039 (.881) 
RTsd_Go -.625 (.013) -.557 (.031) -.475 (.074) -.402 (.110) -.311 (.224) -.326 (.202) 
RT_NoGo -.389 (.152) -.554 (.032) -.471 (.076) .113 (.667) .015 (.955) .145 (.580) 
RTsd_NoGo -.357 (.191) -.375 (.168) -.307 (.265) -.297 (.248) -.191 (.462) -.142 (.586) 
Stroop test       
RT_Congruent -.125 (.657) -.361 (187) -.479 (.071) .216 (.406) .191 (.462) .147 (.573) 
RTsd_Congruent -.418 (.121) -.450 (.092) -.707 (.003) -.179 (.492) -.113 (.667) -.201 (.439) 
RT_Incongruent .146 (.603) .186 (.508) -.021 (.940) -.056 (.830) -.037 (.889) -.105 (.687) 
RTsd_Incongruent -.089 (.752) -.371 (.173) -.486 (.066) .083 (.751) .184 (.480) .020 (.940) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
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Table 6.11 Correlations between cognition and step width during different cognitive states for the 
PD and control groups 
  PD   Control  
 Normal 
walking  
Walking & 
SN 
Walking & 
VF 
Normal 
walking  
Walking & 
SN 
Walking & 
VF 
General cognition       
ACE -.252 (.365) -.311 (.258) -.409 (.130) -.015 (.955) .066 (.802) -.020 (.940) 
MMSE .082 (.771) -.032 (.909) -.027 (.925) .072 (.783) .096 (.713) -.144 (.580) 
Executive measures       
Trail making tests       
TMT-A (s) .020 (.946) -.029 (.923) -.037 (.899) -.292 (.256) -.316 (.216) -.123 (.639) 
TMT-B (s) .380 (.180) .420 (.135) .349 (.221) -.088 (.736) .132 (.613) -.022 (.933) 
TMT-B (error) .577 (.031) .599 (.024) .638 (.014) -.357 (.159) -.357 (.159) -.357 (.159) 
TMT B-A (s) .222 (.446) .358 (.208) .275 (.342) .250 (.333) .387 (.125) .118 (.653) 
GoNoGo test       
RT_Go -.086 (.761) .046 (.869) -.029 (.919) -.154 (.554) -.010 (.970) -.100 (.701) 
RTsd_Go .321 (.243) .246 (.376) .243 (.383) .002 (.993) -.126 (.626) -.047 (.859) 
RT_NoGo -.082 (.771) .107 (.704) .039 (.889) -.110 (.673) -.191 (.462) -.118 (.653) 
RTsd _NoGo .221 (.428) .275 (.321) .229 (.413) -.176 (.498) -.098 (.708) -.169 (.516) 
Stroop test       
RT_Congruent -.179 (.524) .057 (.840) -.021 (.940) -.157 (.548) -.093 (.722) .132 (.613) 
RTsd_Congruent .179 (.524) .311 (.260) .429 (.111) .341 (.181) .091 (.729) .483 (.050) 
RT_Incongruent -.150 (.594) -.039 (.889) .004 (.990) -.007 (.978) -.081 (.758) .196 (.451) 
RTsd_Incongruent .036 (.899) .221 (.428) .250 (.369) -.120 (.646) -.184 (.480) .056 (.830) 
 
Notes: RT=reaction time, RTsd=standard deviation of RT 
 
6.4 DISCUSSION 
This study has examined the impact of executive function on gait difficulties 
using a dual task paradigm in people with PD and healthy controls. The participants 
with PD had greater stride length variability, stride time variability and stance time 
variability than the controls. All the gait parameters were influenced by the 
performance of the secondary cognitive tasks. The significant interactions between 
cognition and group indicated that the participants with PD had a poorer gait 
performance compared to the controls when performing the cognitive tasks, 
including greater reduction in velocity and cadence, shorter stride lengths and swing 
time (% gait cycle), increased stride time, increased double support time (% gait 
cycle) and stance time (% gait cycle), and increased step width. Furthermore, the VF 
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task, as an executive measure, had a greater impact on these gaits parameters than the 
SN task. These findings demonstrate that the decreased executive functions affect 
gait performance particularly for participants with PD. 
Velocity and Cadence 
This study has found that participants with PD tend to walk significantly 
slower and with reduced cadence during performance of cognitive tasks compared 
with the healthy controls, particularly when performing the VF task. This finding is 
consistent with a previous study that used a visuospatial sequencing task as a 
secondary task, and reported dual task interference accounted for 12% variance of 
velocity for people with PD (Rochester et al., 2008). However, there was no 
significant difference between the two groups for velocity and cadence. It should be 
noted that participants with PD had similar velocity and cadence compared with 
controls during normal walking. This result was in line with that cadence was 
relatively preserved in baseline condition (Latt et al., 2009b; O'Sullivan et al., 1998). 
The decreased speed in response to the performance of a secondary cognitive task 
was consistent with a recent study (Yogev-Seligmann et al., 2013), but in contrast 
with other studies, which reported decreased speeds in both people with PD and 
older adults (O'Shea et al., 2002; Yogev et al., 2005). Consistently, the present study 
demonstrated that cadence was similar for both groups during normal walking and 
that cadence decreased during the dual task condition, particularly for people with 
PD. This finding is in accordance with a study implying that gait change is a 
compensation strategy under dual task in order to reduce the risk of falling in PD 
individuals, since cadence decreased for people with PD, but not for healthy controls 
(O'Shea et al., 2002). The mechanism of alteration in gait speed may be associated 
with cholinergic degeneration in PD (Bohnen et al., 2013; Rochester et al., 2012). 
Other temporal gait parameters  
The present study showed a markedly increased stride time, decreased swing 
time (% gait cycle), increased stance time (% gait cycle) and double support time (% 
gait cycle) during performance of an executive task for participants with PD. The 
findings suggested that concurrent cognitive load had a greater effect on people with 
PD compared to healthy controls. As impairment is in the basal ganglia function, PD 
individuals are required to use executive control cortically for routine tasks that 
healthy people perform automatically (Dirnberger & Jahanshahi, 2013). In contrast, a 
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separate study that observed the secondary cognitive tasks had similar effects for 
stride time and swing time between people with PD and older adults (Yogev et al., 
2005). During unconstrained walking, PD fallers spent more time in double support 
compared to controls in single task (walking) (Cole et al., 2010). However, little is 
known about the stance time (% gait cycle) and variability and double support time 
under dual tasking in people with PD. The present study provided evidence of the 
changes for these gait characteristics.  
Temporal gait parameters variability 
This investigation demonstrated that there was significant difference for stride 
time variability and stance time variability between participants with PD and controls. 
Importantly, gait variability may be considered an important marker for gait in older 
adults due to its ability to reflect the adaptation for a changing walking environment. 
Gait alterations are controlled through frontal cortical function, and profound 
cognitive change under dual task provided useful or early information for gait 
disturbance and falls risk for older adults (Sheridan et al., 2003). Furthermore, gait 
variability was reported to predict future falls rather than gait velocity (Herman et al., 
2010) in older adults. Similarly, gait characteristics of PD have shown abnormalities 
not only in general mobility but also in rhythmicity represented by variability. There 
was a greater increased stride time variability and swing time variability in people 
with PD compared to controls, and this variability was associated with executive 
function for individuals with PD (Yogev et al., 2005). However, the present study did 
not find a difference of swing time variability between participants with PD and 
controls reported by other studies (Hausdorff et al., 2003; Plotnik et al., 2011; Yogev 
et al., 2005). It may be due to the different PD cohort in this study, which was not 
divided into subgroups (e.g. faller and non-faller) because of sample constraints. It 
was reported the swing time variability increased in fallers but not in non-fallers for 
older adults under dual tasking (Springer et al., 2006). Stance time variability has 
less been studied in people with PD. The present study is similar to a study 
conducted in older adults, which identified impairment of the central nervous system 
using cognitive function assessments. This study found greater stance time variability 
was related to increased impairment of central nervous system (Brach et al., 2008). 
Therefore, impairment of the central nervous system may affect motor control and 
accordingly influence stance time variability. 
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Spatial gait parameters and variability 
The results showed that there was a significant main effect of cognition and 
interaction between cognition and group. This suggested that the cognitive task gave 
rise to reduced stride length, particularly for people with PD. A study has reported 
people with PD are known to take shorter steps than healthy controls under normal 
walking condition (O'Shea et al., 2002). Furthermore, in this study, there was greater 
stride length variability for participants with PD compared with controls. However, 
the interaction between cognitive factors and group was not significant for stride 
length variability, which suggested that cognitive factors induced a similar effect on 
stride length variability for both participants with PD and controls. It is important to 
note that previous studies emphasised timing of gait parameters (stride time 
variability and swing time variability), whereas only few studies have investigated 
the variability of spatial gait parameters, for example, stride length variability. 
Additionally, step width and step width variability have been less examined in 
PD studies. The interaction between cognitive factor and group was significant for 
step width in the present study, suggesting cognitive task caused wider step width for 
people with PD, but not for the controls. However, a study has found change in step 
width was one of the indicators for risk of falls in older adults (Nordin et al., 2010). 
Step width variability was positively associated with speed (Brach et al., 2001).  
Gait characteristics during turning 
During the turning condition, participants with PD took longer time than 
controls. The lower mobility confidence in participants with PD (refer to Chapter 4) 
may contribute to the change of gait characteristics, since turning performance was 
previously reported to be associated with self-assessed disability in people with PD 
(Stack & Ashburn, 2008). Similarly, a recent study reported participants with PD, 
who had with severe FOG and had had deep brain stimulation, took longer time and 
had reduced cadence under the turn condition compared with participants with PD 
without severe FOG and healthy controls (Thevathasan et al., 2012). However, to 
date, little is known regarding the impact of additional cognitive load on the turning 
condition. This study showed when performing the secondary cognitive task, both 
groups tended to reduce velocity and cadence compared to normal turning. However, 
in the present study, the participants with PD were mainly in the early stages of the 
disease and were not divided into subgroups. Nevertheless, the finding suggests that 
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cognitive loading may induce longer turning times for participants with PD but 
equivalently reduce cadence compared with controls. 
Cognitive impact and performance during dual task 
Dual task interference could be conceptualized as competition between 
cognitive and motor aspects. To date, the contribution of dual task has been poorly 
understood. The current study has shown that dual task interference was greater for 
most gait parameters for participants with PD. However, changes observed under the 
dual task conditions were similar for variability measures of gait parameters for the 
two groups. The finding is contrast to a recent study (Rochester et al., 2014), which 
reported a similar dual task effect for all gait measures except step width between the 
participants with PD and healthy controls. The healthy controls adopted wider steps 
and step width variability under dual tasking condition, while PD participants did not, 
suggesting PD participants could not to adjust step width as healthy controls. This is 
likely due to the different cognitive paradigms utilised in the present study. 
The mechanism of cognitive impact on gait characteristics is not yet fully 
understood. Bloem et al. (2001b) suggested that the healthy elderly give priority to 
the stability of their gait when walking and performing a cognitive task. The 
unconscious and healthy “posture first” strategy might be one of the keys to avoiding 
hazards and preventing falls while walking. Some researchers proposed that people 
with PD may inadvertently apply a “posture second” strategy and hence 
unnecessarily exacerbate their risk of falling in dual tasking situations (Bloem et al., 
2006; Bloem et al., 2001b), thereby leading to an increased falls risk (Galletly & 
Brauer, 2005; O'Shea et al., 2002). Therefore, the dual task cost could be considered 
an indicator for risk of falls in individuals with PD (Yogev et al., 2005). To date, 
most dual task researches have examined the effect of performing a secondary motor 
task rather than evaluating the effect of a secondary cognitive task. This study 
documented both motor and the cognitive performance by generated words or 
calculation while performing cognitive and motor tasks concurrently. The results 
showed that there was no difference in number of generated words or the accuracy of 
the calculations between PD and control groups. The finding is consistent with a 
recent study which also did not observe any differences between people with PD and 
controls for the number of generated words (Yogev-Seligmann et al., 2013). In 
contrast, poorer performance on a subtraction task during dual tasking was reported 
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in a previous study for people with PD (Yogev et al., 2005). A recent study reported 
a reduction in both the performance of the cognitive task and the motor performance 
(speed) while performing two tasks concurrently in people with PD (Fuller et al., 
2013). However, gait parameters were not extensively explored and did not have 
healthy controls (Fuller et al., 2013). Therefore, the pronounced changes in gait 
parameters and less changed cognitive performance during the dual task may support 
the “posture second” strategy in the PD group, which may provide insight into the 
increased falls risk faced by these people. 
Previous dual task studies used an arithmetic task as cognitive loading and 
recently VF has emerged in assessing effect of executive function in people with PD 
(Fuller et al., 2013; Yogev-Seligmann et al., 2013). This study combined the two 
dual task paradigms. This study observed that the gait parameters progressively 
deteriorated from baseline testing to dual tasking, particularly during performance of 
a VF task. The finding is partially in agreement with a study (Al-Yahya et al., 2011), 
which summarised that VF task have been shown to have the greatest effect on gait 
speed and stride time; while working memory tasks have the greatest effect on gait 
cadence and stride length and mental tracking has a greater impact on stride time 
variability.  It was observed that VF had a significant effect on gait measures (stride 
time and stride time variability, velocity) in participants with PD, and induced slower 
walking speed and greater stride variability compared to healthy controls (Camicioli 
et al., 1998; Yogev-Seligmann et al., 2013). There was no difference between SN 
and VF for the measures of stride length variability, step width or step width 
variability. Overall, the present study demonstrated that VF had a pronounced effect 
on gait characteristics. This is likely the VF task is regarded as measure of executive 
function and was reported to be associated with the frontal cortex dysfunction in 
people with PD (Green et al., 2002). However, neural connect for the SN task is 
uncertain. Hence, further investigation of the cerebral hemodynamic changes that 
underlie the VF task was conducted in the following fNIRS study (see Chapter 7).  
Correlation between gait characteristics and executive function 
The study has revealed that deficits in baseline performance on executive 
function were correlated with worse performance on gait characteristics, but there 
was a different pattern for the two groups. There was no correlation between general 
cognition and gait parameters for the PD participants. The finding was supported by 
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the outcomes of the Phase I study, which indicated that executive function plays an 
important role in the regulation of gait. 
With respect to executive function, longer reaction time on the Go and NoGo 
tasks and the congruent condition of the Stroop tests were correlated with walk 
slower, reduced cadence and longer stride time for the PD participant during dual 
tasking. The observation was partially consistent with a previous study which 
reported that reaction times were correlated with increased stride time variability and 
swing time variability (derived from stride time and wing time). However, the 
correlation analyses of the study did not separate participants with PD from older 
adults (Yogev et al., 2005). 
Interestingly, poorer executive performance was associated with shorter swing 
time, increased stance time and double support time for the control group but not for 
the PD group. Specifically, greater reaction time variability on the GoNoGo test was 
associated with shorter swing time and increased stance time under the VF condition 
for the controls. Similarly, longer time on the TMT-A test was correlated with 
shorter swing time and increased stance time and increased double support time 
during normal walking. It is speculated that processing factors may be compromised. 
A study reported that decreased executive function, expressed by TMTB-A, 
contributed to the alteration of gait (velocity, swing time) during dual tasking 
(Plotnik et al., 2011).  
Poorer performance on executive function was also correlated with shorter 
stride length and wider step width for PD participants but not for healthy controls. 
Specifically, greater reaction time variability on the Stroop test (congruent) was 
associated with shorter stride length while performing a VF task. Furthermore, more 
errors on TMT-B were correlated with wider step width when performing a VF task. 
The outcome is in partial agreement with evidence in community-based older adults 
(van Iersel et al., 2008). The TMT ratio (TMTB-A /TMTA) was associated with 
stride length variability and trunk movement during a VF task (van Iersel et al., 2008) 
and TMTB-A contributed to stride length for PD participants (Plotnik et al., 2011). 
Nevertheless, the present study has demonstrated that poorer performances on some 
of baseline executive measures were associated with changes in gait characteristics. 
Briefly, decreases in velocity, temporal and spatial parameters of gait for people with 
PD, while decreases in some temporal gait measures for the controls. The distinct 
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difference between the two groups may reflect different strategies applied during 
cognitive loading and therefore this needs to be determined in further research. 
There are several limitations that should be taken into account in this study. 
The effect size was relatively small for interaction between cognitive factors and 
groups. In addition, the participants with PD were predominately mild severity of 
disease. 
In conclusion, the profound changes of gait parameters under dual tasking 
reflect impact of executive function on postural stability and gait characteristics for 
people with PD. Poorer performance on executive functions is associated with 
greater changes in gait characteristics for PD individuals.  
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Chapter 7: Cerebral activation associated with 
executive function measured using 
functional near-infrared spectroscopy 
7.1 INTRODUCTION 
Executive function has been considered to be associated with the frontal cortex, 
particularly, the PFC of the brain. In the past, neuroanatomical studies have assessed 
executive function in brain-damaged people (e.g. frontal damaged) and demonstrated 
impairment of executive function is related to frontal lobe lesions (Demakis, 2004; 
Golden, 1976a). The pattern of executive function impairment in PD, such as deficits 
in cognitive flexibility and working memory, is similar to symptoms in people with 
frontal lobe lesions (Foltynie et al., 2004; Kehagia et al., 2010). This frontal cortex 
dysfunction is associated with impaired switching ability reflected by a deficit in 
phonemic fluency performance in people with PD (Green et al., 2002). 
With the advance of neuroimaging, a number of investigations have examined 
the relationship between cerebral hemodynamic changes and executive function 
using fMRI in healthy individuals. These studies have revealed brain activation 
primarily in the PFC and anterior cingulated cortex during the performance of the 
incongruent condition of the Stroop test (Leung et al., 2000; MacDonald III et al., 
2000; Mitchell, 2010), the virtual stylus TMT (Zakzanis et al., 2005) or the VF task 
(Fu et al., 2002). Hence, these assessments of executive function have suggested the 
PFC region plays an important role in executive function for healthy population. 
Recently, the fNIRS approach has been applied to brain research by measuring 
the relative concentration of changes in oxygenated haemoglobin (O2Hb) and 
deoxygenated haemoglobin (HHb) in specific brain regions of the superficial cortex 
(Irani et al., 2007). In healthy populations, several fNIRS studies have observed that 
the PFC is the primary activation region underlying executive function tasks. Higher 
levels of O2Hb in PFC have been associated with shorter reaction times in a conflict 
Stroop test (Leon-Carrion et al., 2008; Turner & Spreng, 2012). Bilateral increases in 
O2Hb have also been reported in PFC when performing the TMT-B task indicating 
an association with the set shifting ability of executive function (Shibuya-Tayoshi et 
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al., 2007). Increases in O2Hb in the frontal cortex regions have also been 
demonstrated during VF tasks (Chaudhary et al., 2011; Kameyama et al., 2004). 
Furthermore, a number of studies have cross-validated the hemodynamic 
response represented by optical measures in fNIRS in accordance with BOLD-based 
fMRI (Huppert et al., 2006; Strangman et al., 2002; Toronov et al., 2001). fMRI and 
fNIRS methodologies were performed simultaneously using event-related motor task 
(finger tapping) in healthy subjects. Hemodynamic changes were found in primary 
and sensory regions in BOLD-based fMRI, which temporally corresponded with the 
findings of the fNIRS approach. In addition, a strong correlation was reported 
between measures of HHb in the fNIRS and the BOLD signal in fMRI (Huppert et 
al., 2006). Interestingly, another study found all the optical measures (O2Hb, HHb 
and tHb) were correlated with the BOLD-based fMRI, but the highest correlation 
was observed for the O2Hb measure (Strangman et al., 2002). 
However, fMRI is restricted by testing environment and its enclosed 
environment makes it difficult to perform executive function tasks concurrently. In 
addition, fMRI is highly influenced by movement artefacts (Chance et al., 1993). By 
contrast, the advantages of the fNIRS technique are that it has a flexible experimental 
time setting for measurement of brain activation when performing an executive task 
simultaneously. Importantly, fNIRS technique has less movement artefacts (Irani et 
al., 2007), and is appropriate for people with PD who have difficulty remaining 
motionless. In this regard, the fNIRS technique could be a promising quantitative 
approach to explore the correlation between neural activation and cognitive function. 
In general, alterations of cerebral blood flow (CBF) correspond to changes in 
brain activation. A small numbers of studies have previously investigated brain 
perfusion using SPECT or PET in people with PD. On the whole, these 
neuroimaging studies yield discrepant perfusion patterns (Owen et al., 1998; Van 
Laere et al., 2004). The results have indicated that executive-related decreased 
perfusion patterns are mainly in the frontal cortex (Firbank et al., 2003; Van Laere et 
al., 2004) in people with PD, particularly in the early stage of the disease (Paschali et 
al., 2010). Decreased perfusion patterns also extend to the posterior cingulate and the 
parietal regions (Nobili et al., 2011; Van Laere et al., 2004). However, since an 
influx CBF may exceed the demand of cerebral oxygenation (Fox & Raichle, 1986), 
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brain perfusion studies may not accurately reflect the brain activation in people with 
PD. 
To date, little is known about the relationship between cerebral activation and 
executive function in people with PD. A distinct metabolic pattern has been reported 
in people with PD compared with neurodegenerative disease (Griffith et al., 2008; 
Hosokai et al., 2009). A PET study reported that regional cerebral glucose 
metabolism was decreased in extensive regions of the brain in people with PD 
compared to healthy controls (Hosokai et al., 2009). A separate study using a proton 
magnetic resonance spectroscope has shown reduced N-acetyl aspartate/creatine and 
glutamate/creatine in people with PD compared to healthy controls (Griffith et al., 
2008). However, these studies may be limited by inevitable radioactive restriction 
and the cognitive task was not undertaken simultaneously (Pavese & Brooks, 2009). 
Theoretically, performances of cognitive tasks result in neuronal activation 
characterised by increased O2Hb and a decreased HHb, and increased rCBF in the 
related area of the cerebral cortex (Obrig & Villringer, 2003). Investigation of 
cerebral oxygenation could provide insight into the functional correlation between 
cerebral activation and executive function in people with PD. Given the high 
prevalence of executive impairment in people with PD, it is imperative to explore the 
neural correlations of executive function in this population. However, there has been 
no investigation using fNIRS to map the neurophysiological alteration underlying 
executive tasks in people with PD. 
Furthermore, the PFC region is important for initiating, selecting and planning 
movement (Rizzolatti & Luppino, 2001). Smaller gray matter volume in crucial 
regions (prefrontal and parietal cortex, putamen and cerebellum) have been 
associated with poorer gait speed and balance in older adults (Rosano et al., 2007). 
Interestingly, these regions are also associated with executive function (Royall et al., 
2001), implicating the similar brain region involvement in completion of executive 
function and gait. A investigation has shown greater brain activation (increased 
O2Hb level) in the PFC during a concurrent cognitive task (dual task condition) 
compared with just the normal walking condition (Holtzer et al., 2011) in healthy 
individuals, and increased activation in the PFC in preparation for walking (Suzuki et 
al., 2008). More recently, fNIRS study has demonstrated the activation in PFC prior 
to a walking task, suggesting PFC region is involved in initiating and planning gait 
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(Koenraadt et al., 2014). Moreover, this activation in the PFC was not different 
between usual standing and walking condition, the increased oxygenation showed 
correlation with dual task in healthy young adults (Mirelman et al., 2014) 
Consistently, the preceding chapters of this thesis have also shown executive 
dysfunction was demonstrated in people with PD compared with healthy controls, 
and that a concurrent VF task induced a greater impact on static balance and gait 
parameters. Given the higher rate of executive impairment and its potential 
contribution to postural instability and gait difficulties in people with PD, a better 
understanding of the relationship between cortical activation and executive function 
would have significant implications. 
This study sought to explore brain activation in the PFC for participants with 
PD and controls using the fNIRS approach while performing a VF task. The WD task 
was used as a control task to compare the difference of the cerebral activation 
between the two groups. In the present study, the change of O2Hb was used as a 
primary outcome for assessing brain activation. It was hypothesised that 
hemodynamic change in PFC region measured by O2Hb correlates with executive 
function in people with PD. 
7.2 METHOD 
7.2.1 Participants 
The cohort was the same as that described in Section 4.2.1 (see page 64). One 
participant with PD was excluded because of an error that occurred during the fNIRS 
measurement, which resulted in 14 participants with PD being included in this study. 
The participants with PD performed all assessments during their optimally-medicated 
state. 
7.2.2 Procedures 
Baseline assessments 
Baseline assessments were described in Section 4.2.2 (see page 66). 
Activation tasks 
Verbal fluency task 
The VF task required participants to generate as many words as possible in 30 s 
beginning with a specific letter. Prior to the trial, instructions were given to the 
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participants and proper names (nouns) and duplicated words were not allowed. A set 
of letters composed of “F, A, S, P, C” were randomly allocated to each participant. A 
letter was presented on a computer screen at the commencement of the fNIRS 
measurement. The number of generated words for each participant was recorded by 
the researcher. 
Recitation of weekdays 
Participants were required to recite the days of the week from “Monday” to 
“Sunday”. The WD task is less cognitively demanding and was used as a control task 
to exclude movement associated with speech (Heinzel et al., 2013). 
fNIRS measurement 
Cerebral cortical oxygenation was measured using a two channel NIRO 200 
NIRS device (Hamamatsu Photonics, Hamamatsu City, Shizuoka, Japan). The 
transmitter optode of the device emits a light source at 775 nm, 810 nm and 850 nm 
wavelength respectively, which are received by two detectors. The distance of 
transmitter to detector was set at 40 mm with a separation distance between 
transmitters of 6 mm. The transmitter and receivers were arranged with the optically 
dense black rubber holder, and were placed symmetrically on the forehead with 
adhesive tapes that correspond to the PFC region (Fp1 (right) and Fp2 (left)) 
according to the 10-20 International Electroencephalography (10-20 IEEG) system 
(Homan et al., 1987) (see Figure 7.1). In order to eliminate the penetration of 
environmental light, the optodes were covered with a black elastic shield. O2Hb, 
HHb and tHb were monitored and recorded for both channels. 
fNIRS measurement was undertaken in a dimly illuminated and quiet 
environment. Participants were seated throughout the experiment. The fNIRS 
measurement utilised event-related blocked design and time frame defined as 30 s. 
Prior to commencement of each block, there was a consistent 5 s rest while the 
screen was blank in order to ensure that the oxygenation measures were aligned with 
the stimuli. Briefly, for the first 3 s of this period a blank black computer screen was 
presented to participants. The remaining 2 s were used for instructions specific to 
performance of the task in the subsequent test block. The 5 s recorded data were used 
to establish a baseline for fNIRS variables. Following this, either the VF task or the 
WD task was performed for 30 s. The researcher pressed a keyboard button to start 
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recording oxygenation measures immediately the activation test started. After 
completion of a 30 s block, there was a 30 s baseline for rest. Throughout the 
experimental process, there were five blocks for the VF tasks and 5 five blocks for 
the WD task. The first and last rest periods were 60 s, and there were 0.5 ~ 1 s 
instructions before every trial. Therefore, total measurement time was 12 min. 
 
 
  
Figure 7.1 a) Illustration of the 10-20 international electroencephalography system; 
b) Depiction of the placement of transmitter and receivers 
Source from: http://immrama.org/eeg/electrode.html 
Physiological measures 
Physiological measures including blood pressure (BP) and heart rate (HR) were 
also collected accompanying the fNIRS measurement. 
Blood pressure was measured using finger cuff photoplethysmography and the 
left upper arm was wrapped in an arm cuff as a reference (Finapres Medical Systems, 
The Netherlands). The finger cuff was placed on the middle phalange of the middle 
finger of the left hand. The light detectors were located on the medial and lateral part 
of the finger with the finger cuff. The control box attached to the finger cuff was 
securely placed on the dorsal side of the left hand. The vertical displacement from 
the finger and arm cuff was determined with a calibration tube which was located 
between the finger and arm cuffs. The role of the tube was to calibrate the finger cuff 
as the zero reference point. Systolic BP (SBP) and Diastolic BP (DBP) were 
monitored and recorded throughout the fNIRS measurement. 
HR was monitored using a 3-lead electrocardiogram (ECG) (Finapres Medical 
Systems, The Netherlands). Pre-gelled silver/silver chloride electrodes (3M, Ontario, 
a) b) 
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Canada) were placed on the right clavicle as a reference electrode and on the fourth 
intercostal space on the mid-clavicular line of both sides as recording electrodes. 
Data analyses 
The recorded fNIRS and physiological variables were processed with Labchart 
software designed for this purpose (V6.1.1, ADInstruments, Dunedin, New Zealand). 
These measures were converted from an analogue to digital signal (ADInstruments, 
Dunedin, New Zealand) and sampled continuously at 200 Hz. 
Oxygenation variables comprised concentration change of O2Hb and HHb 
relative to baseline for the two channels. Raw data was filtered at 0.1Hz by low pass 
filter to eliminate possible signals of respiration and heart rate (Huppert et al., 2009). 
Baseline correction was performed by averaging the 5 s immediately pre-test then 
subtracting this value from all data points in the 35 s data set. The relative changes in 
O2Hb and HHb concentration over the 30 s trials and subsequent 5 s rest were 
calculated, respectively. The mean was calculated for all measures for the five VF 
trials. The same process was applied to the five WD trials. 
The concentration level of O2Hb was used as a primary outcome for assessing 
brain activation in the present study. The average and peak levels in O2Hb were 
calculated for both baseline and activation conditions while performing a cognitive 
task. The comparisons between symmetrical left and right region were conducted for 
both groups 
Mean BP (MBP), SBP, DBP and HR were used as physiological variables. For 
the BP measures, three controls and two participants with PD were excluded from 
the analysis due to error of signal input or equipment malfunction during the 
measurement. 
7.2.3 Statistical analyses 
For each continuous variable derived from the fNIRS measurement, descriptive 
statistics (mean, SD) were initially calculated. The normality of the data was 
determined by examining frequency statistics, histograms and the values of skew and 
kurtosis. Independent two-tailed t-tests were used to examine mean difference 
between the participants with PD and healthy controls on general oxygenation 
measures and cognitive performance, and between the two cognitive tasks on 
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oxygenation for each group. If the data were found not to be normally distributed, the 
Mann-Whitney U test was used. 
To examine cerebral oxygenation (PFC) in response to different cognitive tasks, 
repeated measure ANOVA was performed for concentration changes of O2Hb and 
HHb and physiological measures (BP and HR) during the VF or WD tasks and left or 
right hemisphere, separately. There were one between-subject factor (group, 2 levels) 
and one within-subject factor (time lapse, 6 levels). Mauchley’s test was used to 
assess the assumption of sphericity for the repeated measure variables. If this 
assumption was violated, the Greenhouse-Geisser correction was used to adjust the 
degrees of freedom for the F ratio. In situations where a significant main effects or 
interaction was identified, post-hoc comparisons using Fisher’s LSD test were 
conducted. All statistical analyses were performed using SPSS v19.0 for Windows. 
The level of significance was defined as p<0.05, with p values between 0.1 and 0.05 
considered to be marginally significant. 
7.3 RESULTS 
7.3.1 Baseline assessments 
The PD and control groups were of a similar age, gender, height and mass, and 
had received a similar number of years of education. The clinical characteristics and 
the results of baseline assessments were described in Section 4.3.1 (see page 69). 
7.3.2 Cognitive performance 
The average number of words generated was similar for participants with PD 
(10.59 ±3.21) and for controls (12.36 ±2.40) (p=0.088). 
7.3.3 fNIRS measurement 
Oxygenation measures during the whole fNIRS measurement 
The change in the right PFC in the concentrations of O2HB and HHb compared 
to baseline for a control participant during the performance of the VF task is shown 
in Figure 7.2. The data are referenced to baseline measures obtained during a 5 s 
period immediately prior to the start of the task. The O2Hb increased after a short 
latency to a peak approximately 25 s after the start of the task. Conversely, HHb 
decreased during the same period. The total change in O2Hb and HHb over the 30 s 
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provides a measure of change in cerebral blood flow as an inference for altered 
cerebral activation. 
 
 
Figure 7.2 Change in O2HB and HHb in the right hemisphere for a control participant during 
performance of a verbal fluency task 
 
Figure 7.3 depicts the total average change in O2Hb for each participant in the 
PD and control groups during the VF task and the WD task and illustrates the inter-
subject variability in performance. For the WD task in the left hemisphere 85.7% (12) 
of participants with PD and 76.5% (13) of control participants had decreased O2Hb. 
In contrast, 57.1% (8) of participants with PD and 58.8% (10) of control participants 
had an increase in O2Hb for the VF task. Similarly for the WD task in the right 
hemisphere, 92.9% (13) of participants with PD and 88.2% (15) of control 
participants had a decrease in O2Hb. In contrast, 50.0% (7) of participants with PD 
and 58.8% (10) of control participants had an increase in O2Hb for the VF task. 
Group comparisons revealed that the average change of O2Hb during the VF task for 
the PD group was less than that of the control group (p=0.048) for the right PFC. 
There were no differences between the PD and control groups for either PFC during 
the VF task or the WD task for both left and right PFC. 
Figure 7.3 also shows that there was an increase in O2Hb from WD to VF tasks 
for PD (left hemisphere 78.6% (11); right hemisphere 64.3 % (9)) and control 
participants (left hemisphere 70.6% (12); right hemisphere 82.4 % (14)). This 
increase was significant for both the left PFC (p=0.0004) and right PFC (p=0.0027) 
for the control group, and for the left PFC (p=0.040) for the PD group. 
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Figure 7.4 depicts the total average change in HHb for each participant of the 
two groups during the VF task and the WD task and illustrates inter-subject 
variability in performance. For the WD task in the left hemisphere, 78.6 % (11) of 
participants with PD and 70.6 % (12) of control participants had a decrease in HHb. 
Also, 78.6 % (11) of participants with PD and 82.4 % (14) of control participants had 
a decrease in HHb for the VF task. For the WD task in the right hemisphere, 57.1% 
(8) of participants with PD and 58.8 %( 10) of control participants had a decrease in 
HHb. Also, 64.3% (9) of participants with PD and 64.7% (11) of control participants 
had a decrease in HHb for the VF task. There were no differences between groups in 
HHb for the VF or the WD task in either hemisphere (p>0.05). 
The figure also shows that there was a decrease in HHb from WD to VF tasks 
for participants with PD (left hemisphere 78.6 % (11); right hemisphere 50.0% (7)) 
and controls (left hemisphere 58.8% (10); right hemisphere 64.7% (11)). However, 
these changes were not significant (p>0.05) for either left or right PFC for both the 
PD and control groups. 
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Figure 7.3 O2Hb changes between the verbal fluency (VF) task and the weekday (WD) task for the two groups 
a) b) 
c) d) 
Left Right 
PD 
Control 
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Figure 7.4 HHb changes between the verbal fluency (VF) task and the weekday (WD) task for the two groups 
Left Right 
PD 
Control 
a) b) 
c) 
d) 
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Oxygenation measures during different time periods 
The average changes in O2Hb and HHb at 5 s intervals during the WD and VF 
tasks are shown in Figure 7.5 and Figure 7.6 for both the PD and control groups. 
These changes are described separately below for the left and right PFC. 
Oxygenation measures in left prefrontal cortex region 
O2Hb changes 
For the VF task, the control group showed a slight but non-significant greater 
increase compared to the PD group (Figure 7.5). There was not a significant main 
effect for group [F (1, 29) =1.441, p=0.240] or time [F (2.1, 60.8) =0.975, p=0.387] 
and no significant group by time interaction [F (2.1, 60.8) =0.365, p=0.706]. 
For the WD task, there was no significant main effect for group [F (1, 29) 
=0.356, p=0.555]. However, there was a significant main effect for time [F (2.3, 67.7) 
=12.263, p<0.001], which demonstrated a continued decrease in O2Hb for both 
groups as time progressed. Post-hoc analyses showed that the HHb level at 5 s was 
higher than at all following time points, and the level at 10 s was higher than that of 
15 s, 25 s and 30 s. In addition, the HHb level at both 20 s and 25 s was higher than 
that at 30 s. There was no significant group by time interaction [F (2.3, 67.7) =0.379, 
p=0.718]. 
HHb changes 
For the VF task, there was no significant main effect for group [F (1, 29) 
=0.482, p=0.493]. However, there was a significant main effect for time [F (2.1, 61.3) 
=7.710, p=0.001]. Figure 7.5 shows that HHb decreased to its lowest level between 
10 s and 15 s for both groups before increasing towards baseline levels. Post-hoc 
analyses showed that the HHb level at 10 s was lower than that between 20 s and 30 
s in addition to 5 s, and similarly, the level at 15 s was lower than that between 20 s 
and 30 s. The level at 20 s was also lower than that at 25 s and 3 0s. There was no 
significant group by time interaction [F (2.1, 61.3) =0.486, p=0.628]. 
As shown in Figure 7.6, HHb remained at a consistent level throughout the 
entire WD task duration. There were no significant main effects for group [F (1, 29) 
=0.898, p=0.351] or time [F (1.9, 55.2) =1.781, p=0.179] nor was there any 
significant group by time interaction [F (1.9, 55.20=0.358, p=0.690). 
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Oxygenation measures in right prefrontal cortex region 
O2Hb changes 
Figure 7.5 shows that there was a large increase in O2Hb for the control group 
(0.35±0.54) during the VF task. In contrast, for the PD group, the levels of O2Hb 
remained relatively constant. There was a significant group main effect [F (1, 29) 
=4.250, p=0.048]. There was no significant main effect of time [F (2.0, 58.2) =1.143, 
p=0.326] and no significant group by time interaction [F (2.0, 58.2) =1.466, p=0.239]. 
For the WD task, there was no significant main effect for group [F (1, 29) 
=0.006, p=0.937]. However, there was a significant main effect for time [F (2.6, 74.9) 
=6.168, p=0.001], which demonstrated a continued decrease in O2Hb for both groups 
as time progressed. Post-hoc analyses showed that the HHb level at 5 s was higher 
than at all the following time points. Also, the level at both 10 s and 20 s were higher 
than that at 30 s. There was no significant interaction between time and group [F (2.6, 
74.9) =0.145, p=0.910]. 
HHb changes 
For the VF task, there was no significant main effect for group [F (1, 29) 
=0.056, p=0.814]. However, there was a significant main effect for time [F (2.0, 57.2) 
=7.640, p=0.001]. Figure 7.5 shows that HHb decreased to its lowest level between 
10 s and 15 s for both groups before increasing towards baseline levels. Post-hoc 
analyses showed that the HHb level at 10 s and 15 s were lower than that between 20 
s and 30 s in addition to 5s. The level at 20 s was lower than that at 25 s and 30 s. 
There was no significant group by time interaction [F (2.0, 57.2) =0.353, p=0.701]. 
As depicted in Figure 7.6, HHb remained at a consistent level throughout the 
entire WD task. There were no significant main effects for group [F (1, 29) =0.014, 
p=0.908] or time [F (1.9, 54.6) =2.937, p=0.064] and there was no significant group 
by time interaction [F (1.9, 54.6) =0.787, p=0.454]. 
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Figure 7.5 O2Hb/HHb changes under VF task for PD and control groups 
Note: red line: O2Hb, blue line: HHb, solid line=participants with PD, dashed line=controls 
  
Figure 7.6 O2Hb /HHb changes during WD task for PD and control groups
VF 
WD 
a) b) 
c) d) 
Left Right 
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Physiological measures 
Blood pressure 
For the VF task, there were no significant differences between the two groups 
for MBP [F (1, 24) =0.021, p=0.887], SBP [F (1, 24) =2.773, p=0.109], and DBP [F 
(1, 24) =0.564, p=0.460]. The significant main effect of time for MBP [F (3.0, 70.9) 
=6.916, p<0.001], SBP [F (2.1, 51.0) =6.625, p=0.002], and DBP [F (2.9, 70.6) 
=4.359, p=0.007] showed a fluctuating trend as shown in Figure 7.7. Post hoc 
analysis revealed that the MBP at the starting point was significantly lower than that 
at 5-30 s. The SBP at the starting point was significantly lower than that at 5-30 s and 
the SBP at 5 s was significantly lower than that at 10-25 s. The DBP at starting point 
was significantly lower than that at 5-25 s, and the DBP at 10 s was significantly 
greater than that at 30 s. However, there were no significant interactions of group by 
time and for MBP [F (3.0, 70.9) =1.296, p=0.283], SBP [F (2.1, 51.0) =1.435, 
p=0.248], and DBP [F (2.9, 70.6) =0.335, p=0.796]. 
For the WD task, there were no significant differences between the two groups 
for MBP [F (1, 24) =0.246, p=0.624], SBP [F (1, 24) =2.454, p=0.130], and DBP [F 
(1, 24) =0.001, p=0.980]. There was a significant main effect of time for MBP [F 
(2.8, 66.6) =11.139, p<0.001], SBP [F (1.9, 44.6) =6.820, p=0.003], and DBP [F (2.1, 
50.6) =5.768, p=0.005] which showed a fluctuating trend (Figure 7.7). Post hoc 
analyses demonstrated the MBP at the starting point was lower than that at15-30 s. 
The MBP at 5 s or 10 s were lower than that at 20-30 s and at 15 s lower than that at 
20 s -25 s. The SBP at the starting point was lower than that at 5 s and between 20 s 
and 30 s, and at 5 s and 10 s was lower than that between 20 s and 30 s. The SBP at 
15s was lower than that between 20 s and 25 s. The DBP at the starting point and at 
10 s was significantly lower than that between 20 s and 30 s. The DBP at 5 s was 
lower than that between 15 s and 30 s and at 15 s was lower than that at 20 s. 
However, there were no significant interactions of group by time for MBP [F (2.8, 
66.6) =0.326, p=0.791], SBP [F (1.9, 44.6) =0.484, p=0.606], and DBP [F (2.1, 50.6) 
=0.684, p=0.516]. 
Heart rate 
For the VF task, there was no significant difference between the two groups [F 
(1, 29) =0.167, p=0.686]. The significant main effect for time [F (1.9, 56.3) =9.573, 
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p<0.001] with post hoc analysis demonstrated that the HR at the starting point was 
lower than at the following time points. The HR at 15 s was the highest. The HR at 
10 s was greater than that at 5 s and 20 s, and the HR at 20 s was greater than that at 
5 s. However, there was no significant interaction of group by time [F (1.9, 56.3) 
=2.772, p=0.073]. 
For the WD task, there was no significant difference between the two groups [F 
(1, 29) =0.340, p=0.564]. The significant effect for time [F (1.9, 53.9) =14.759, 
p<0.001] with post hoc analysis demonstrated the HR between starting point and 10 s 
was lower than that between 15 s and 30 s. However, there was no significant 
interaction of group by time [F (1.9, 53.9) =0.412, p=0.650]. 
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Figure 7.7 Blood pressure and heart rate changes during the VF task and WD tasks for PD and control groups 
Notes: solid line=participants with PD, dashed line=controls; maroon=systolic BP, green=mean BP, blue=diastolic BP, orange=heart rate 
a) b) 
c) d) 
VF 
WD 
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7.4 DISCUSSION 
The present study has investigated cerebral oxygenation changes in the PFC 
region during an executive function task in people with PD and healthy controls. The 
result showed a distinct pattern for the control group of increased O2Hb and 
decreased HHb during performance of a VF task. Participants with PD exhibited no 
change in cerebral O2Hb, but similar decreases as controls in HHb. 
Generally, brain activation can be evaluated through subsequent oxygenation 
response. The concentration of O2Hb elevation has been considered to be a sensitive 
and reliable indicator of cerebral activation (Obrig & Villringer, 2003) and alteration 
in rCBF (Heinzel et al., 2013). The current study has demonstrated a distinct 
oxygenation response underlying different tasks (VF, WD). The VF tasks induce an 
activation pattern in PFC through increased O2Hb. In contrast, the WD task did not 
result in brain activation but had a similar decrease in O2Hb for both groups. The 
comparison of concentration of O2Hb from the WD to VF tasks, an increase was 
significant for both the left PFC (p=0.0004) and right PFC (p=0.0027) for the control 
group, and for the left PFC (p=0.040) for the PD group. In healthy individuals, 
fNIRS studies have revealed an increased O2Hb in the frontal region during 
performance of a VF task (Chaudhary et al., 2011; Kameyama et al., 2004). Likewise, 
a greater bilaterally increased O2Hb in PFC was seen in the TMT-B task, reflecting 
the region is associated with set shifting ability of executive function (Shibuya-
Tayoshi et al., 2007). Previous studies using SPECT have reported decreased 
perfusion patterns in the frontal cortex relative to executive function (Firbank et al., 
2003; Van Laere et al., 2004) in adults with PD, particularly in the early stage of the 
disease (Paschali et al., 2010). PFC region associated with executive function is 
affected by dopaminergic input and pathways connecting with basal ganglia 
(Nieoullon, 2002). Consistently, the current study provides functional correlation 
between cerebral activation in the PFC region and executive function. 
Furthermore, the current study has revealed that participants with PD remained 
stable O2Hb, particularly the right PFC, compared to the controls during performance 
of the VF task. Interestingly, the comparison between older and younger adults has 
previously demonstrated the level of hemodynamic response in PFC increased less in 
older adults than in younger adults during performance of an executive task 
(Schroeter et al., 2003). An fMRI study reported executive function significantly 
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correlated with under-activation in frontal-parietal networks for people with PD 
(Williams-Gray et al., 2008). There is relatively greater recruitment in the right PFC 
compared with in the left PFC using the fNIRS approach in healthy people (Turner & 
Spreng, 2012). Similarly, a recent study concerned PD participants with FOG using 
fMRI demonstrated decreased activation in the right PFC and other regions 
(Vercruysse et al., 2013). The high prevalence of executive impairment in people 
with PD compared with healthy controls for this cohort should be noted (refer 
Chapter 4 see page 63). 
This study has found progressively decreasing HHb. In general, brain 
activation is accompanied with hemodynamic response through increased O2Hb and 
simultaneously decreased HHb (Herrmann et al., 2005; Huppert et al., 2006; 
Strangman et al., 2003) in fNIRS measurements. Participants with PD and controls 
showed a similar change for HHb in both VF and WD tasks. Notably, for the 
comparison of concentrations of HHb between the WD and VF tasks, the greater 
decrease was observed for the VF task for both groups, suggesting more oxygen 
consumption during performance of an executive task.  
Furthermore, this study has revealed that the significant effect of time indicated, 
that for both groups, the HHb changes during the VF task and O2Hb changes during 
the WD task were bilaterally time related. The results revealed that the significant 
effect of timing bilaterally on changes of HHb, which was in accordance with 
consuming more oxygen during brain activation. Theoretically, increased 
consumption of oxygen in an activated area during stimuli leads to increased HHb 
concentration initially, and subsequently, the decreased oxygen and glucose result in 
vasodilatation of the brain arteries. As a result, CBV and rCBF increase because 
more oxygen and glucose are supplied to the activated region via CBF. The increased 
CBF leads to increased O2Hb and decreased HHb. This mechanism is referred to as 
neurovascular coupling (Gratton et al., 2001). However, the O2Hb level decreased as 
the time progressed while performing the WD task. It may be possible that it is a 
non-challenge task. 
The simultaneous physiological measures (BP, HR) were also analysed to 
eliminate their effect on rCBF and eventually on oxygenation changes, although the 
fNIRS data has already been filtered to eliminate signals of respiration and heart rate 
(Huppert et al., 2009). A minor fluctuating trend for BP changes was found during 
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fNIRS measurement. Briefly, the BP at the starting point was lower than that of the 
following time points. However, the similar trends for both VF and WD tasks may 
support autonomic dysfunction due to cardiac sympathetic denervation (Goldstein et 
al., 2007) resulting in a less responsive SBP (Reuter et al., 1999). Similarly, the HR 
at the starting point was lower for both the VF and WD tasks. It is important to note 
the highest HR was in the middle of the time lapse for the controls during the VF 
task, while the participants with PD remained relatively stable. This inadequate 
increase in HR has been previously reported during submaximal exercise in people 
with PD (Speelman et al., 2012). Additionally, dopaminergic therapy may be one of 
the factors impairing BP and HR changes (Bouhaddi et al., 2004). 
The present study showed that the average number of generated words for 
participants with PD was similar to controls. This was inconsistent with frontal 
dysfunction or in subcortical dementia in people with PD, in which impaired 
switching ability is reflected by phonemic fluency performance (Green et al., 2002). 
The possible explanation may due to the majority of participants with PD in this 
cohort who are in the early stage of the disease; the impairment of executive function 
did to reach a significant level. 
Structural imaging studies have indicated that aging of the PFC and subcortical 
areas may affect gait speed in older adults (Rosano et al., 2007), and these regions 
are also associated with executive function (Royall et al., 2001). The PFC 
involvement with balance control (Mihara et al., 2008) and attention has been found 
in regulation of balance control (Woollacott & Shumway-Cook, 2002). In 
accordance with these, the present studies have already indicated that executive 
function and attention are associated with balance and gait performance. The VF task 
induced the greater impact on static balance and gait parameters (Chapter 5 and 
Chapter 6). Moreover, a distinct active brain pattern (increased O2Hb) in the PFC has 
been observed during the VF task for the same cohort, and participants with PD 
manifested less cerebral activation in the right PFC region compared to the controls. 
In healthy population, a recent study has shown that O2Hb level increased 
significantly in younger adults than in older adults, suggesting older adults may be 
unable to effectively use PFC during performing walking while talking task (Holtzer 
et al., 2011) and increased activation in PFC in preparation for walking (Suzuki et al., 
2008). Given the higher rate of executive impairment and its potential contribution to 
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postural instability and gait difficulties in people with PD, a future study could 
examine cortical activation while quiet standing or walking and performing an 
executive task simultaneously. 
There are a few of limitations that should be taken into account as follows. 
Firstly, fNIRS has poor depth penetration-depth of light penetration and difficulty in 
measuring absolute concentration because the real path length of light photons is 
unknown. Secondly, measurements are focused on the PFC region. It is unable to 
measure the anterior cingulated cortex which is observed in the switch task. However, 
executive function has been considered to be relative to the frontal cortex, 
particularly, the PFC based on previous evidence. Finally, fNIRS measurement is 
inevitably influenced by the interference of skull and meninges and scalp blood flow. 
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8.1 SUMMARY AND DISCUSSION 
As outlined above, participants with PD performed poorer both on the 
measures of cognitive function, balance and gait compared with healthy controls. In 
this study, the utilisation of comprehensive executive and attention measures 
included a series of CRT tasks, the TMT, the Stroop and the GoNoGo tests. The 
outcomes of the Phase I and Phase II studies have indicated the deficits in 
components of executive function including inhibition response, set shifting, 
attention and processing speed for people with PD. The findings are in accordance 
with other studies (Monchi et al., 2004; Muslimovic et al., 2005), but partially with a 
previous study which reported that TMT B-A times were not significantly different 
to normative data (Plotnik et al., 2011). In particular, when inhibition response was 
incorporated in the executive tests, the PD participants showed significantly longer 
reaction time, supporting inhibition response was impaired in people with PD (Obeso 
et al., 2011). 
Importantly, the results have shown that executive measures, rather than 
measures of general cognitive function, were correlated with the poorer performance 
on balance and gait measures for people with PD. Firstly, using a combination of 
commonly used clinical balance and gait tests and a series of CRT tests and TMT 
tests. The impaired components of executive function, particularly those involving 
set shifting (TMT-B), inhibition response and distracters (CRT-C, CRT-L and CRT-
D tests), were associated with poorer balance and gait performance. Also, decreased 
executive function was associated with lower UPDRS (Part III) motor and PIGD 
scores for PD subtype of akinetic-rigidity, but not for tremor dominance. Similarly, a 
previous study reported that axial motor symptoms in people with PD was correlated 
with declines both in general cognition and executive function (Gago et al., 2009). 
Notably, the present study used a different classification and executive function 
measures and revealed that the executive function was more closely related to PIGD. 
Secondly, the performances on baseline executive function were not associated with 
greater postural sway during quiet standing for both groups. Thirdly, for participants 
with PD, poorer performance on executive function was associated with decreased 
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velocity and cadence, temporal gait parameter (longer stride time) and spatial 
parameters (shorter stride length) particularly under dual tasking, while, for the 
controls, poorer performance on executive function was correlated with some 
measures on timing of gait cycle (shorter swing time, increased stance time and 
double support time). The distinct differences suggest that the participants with PD 
may adopt different strategies from healthy people undertaking dual tasking. These 
observations are partially consistent with a previous study that reported that reaction 
times were correlated with increased stride time variability and swing time variability 
(derived from stride time and wing time). However, the correlation analyses of the 
study did not separate participants with PD from older adults (Yogev et al., 2005). In 
contrast, a previous study revealed that measures of TMT B-A and TMT B 
accounted for changes of gait parameters (velocity and stride length) (Plotnik et al., 
2011), while poorer performance on TMT A was associated with some deteriorating 
changes of gait in the present study. Nonetheless, the present study has indicated that 
impaired response inhibition for participants with PD may impact their capacity to 
walk effectively, particularly in environments with many distracters. 
Furthermore, VF and SN tasks were selected to study the impact of executive 
function on static balance and gait characteristics. Firstly, for static balance tests, all 
measures of postural sway were greater for people with PD compared with the 
controls, and when eyes were closed compared to eyes open. The significant 
interaction of cognition, vision and group for PL demonstrated that a much greater 
portion was induced by cognitive tasks (SN and VF) in the participants with PD than 
in the controls during either the eyes open or eyes closed conditions. These findings 
are somewhat different from another study, which indicated that cognitive loading 
was similar to that between older adults and participants with PD (Yogev-Seligmann 
et al., 2013). However, there was no significant interaction between group and 
cognition for other measures of postural sway. It is important to note that the 
cognitive tasks induced a greater sway area and sway range in the ML direction for 
the PD and control groups, whereas the sway range in the AP direction was not 
significantly influenced by the secondary cognitive tasks. Secondly, for walking in a 
straight line, all of the gait parameters were influenced by a concomitant cognitive 
task. The significant interactions of cognition and group indicated that the PD 
participants had worse gait performance compared to the controls during the 
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performance of a cognitive task. These resulted in greater reduced velocity and 
cadence, shorter stride length and swing time (% gait cycle), increased stride time, 
increased double support time (% gait cycle), stance time (% gait cycle) and 
increased step width. These observations are in line with cognitive impacting on 
velocity and stride length for people with PD (Plotnik et al., 2011), but partially 
consistent with another study that reported significant interaction between group and 
cognitive task for swing time, but not for velocity and stride time (Yogev et al., 
2005). Thirdly, for turning, participants with PD took a longer time than controls to 
complete this task. The cognitive tasks induced significantly longer times and 
reduced cadence when performing either cognitive task compared to normal turning 
for both groups. Therefore, cognitive loading may aggravate gait performance for 
participants with PD. Changes in PL could be a valuable indicator for the detection 
of executive impact on static postural instability for people with PD. 
Additionally, participants with PD have greater variability in stride length, 
stride time and stance time compared with healthy controls. To some extent, gait 
variability may be considered to be an important marker due to its ability to reflect 
the adaptation for change in a walking environment. In addition to temporal gait 
parameters described in previous studies (stride time variability) (Hausdorff et al., 
2003; Plotnik et al., 2011; Yogev et al., 2005), the current study found significant 
differences for stride length variability and stance time variability between 
participants with PD and controls. However, there were no significant differences 
between the two groups for other parameters of gait. A possible explanation could be 
that the majority of individuals with PD were in the early stage of the disease and 
they utilised compensatory strategies. Also, the influence of cognitive deficits may 
not have caused enough pronounced alteration of gait measures to be recorded. 
Cognition performances were not significantly different between the PD and 
control groups in quiet standing, walking in a straight line or turning. These 
observations are in accordance with a recent study using a VF task in walking and 
quiet standing conditions (Yogev-Seligmann et al., 2013). In contrast, a previous 
study observed poorer performance on a subtraction task during dual tasking, 
suggesting that executive function decreased during dual tasking for people with PD 
(Yogev et al., 2005). Given that the individuals with PD in this cohort were shown to 
have executive function impairments, the similar cognitive performance may indicate 
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that the participants with PD allocated more attention to the cognitive task than the 
healthy controls. As such, these individuals may have prioritised the performance of 
the cognitive task at the expense of standing balance or gait performance. The 
possible mechanism of interaction between executive function, balance and gait 
would be a competition of the two different aspects. Prefrontal cortex may be 
involved in executive function and supervisory, as well as involvement of planning 
motor task from neural substrate (Koenraadt et al., 2014). The enlarged effects may 
be influenced by the nature of dual task paradigm, baseline condition of cognitive 
and motor aspects. Overall, executive functions pose greater changes in gait 
characteristics for individuals with PD compared to controls, particularly the VF task. 
Hence, it provides a rationale to further investigate the cerebral activation underlying 
the VF task. 
Importantly, using the fNIRS method in this study has indicated the distinct 
activation pattern in the PFC for people with PD compared with the control group. 
The participants with PD remained stable with respect to changes of O2Hb in the 
PFC cortex, particularly in the right PFC region, but showed similar decreases in 
HHb, compared with the controls, while performing the VF task. The significant 
effect of bilateral timing on changes to HHb was in line with consuming more 
oxygen during brain activation. Neuroanatomical substrate (frontostriatal circuits) 
may contribute to the underlying mechanism of correlation between executive 
function and balance and gait, since these networks are known to regulate both motor 
and cognitive function (Alexander et al., 1986). These substantial networks are 
dispersed through the prefrontal regions associated with executive function. The high 
prevalence of executive impairment in people with PD compared to the healthy 
controls for this cohort should be noted, although the cognitive performance (VF) 
was not significantly different between the two groups. A recent investigation 
showed greater brain activation in PFC under a dual task conditions than normal 
walking conditions for older adults (Holtzer et al., 2011) There was also increased 
activation in PFC in preparation for walking (Suzuki et al., 2008). Given the higher 
rate of executive impairment and its potential to contribute to increased postural 
instability and gait difficulties in people with PD, future studies need to investigate 
brain activation while performing a VF task using developments in fNIRS 
technology to elucidate the relationship between cortical activation and executive 
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function. The results would have significant implications for people with PD as the 
daily living environment inevitable compromised multiple tasking. 
8.2 STRENGTHS AND LIMITATIONS 
This study has investigated the relationship between executive function and 
PIGD using clinical psychology, biomedical and neurophysiological approaches. 
Firstly, a combination of the commonly used clinical balance and gait tests was used, 
while previous studies have typically only employed one of these tests. Secondly, a 
major strength of the present study is that the same dual paradigm was implemented 
both in static balance and gait measurement, and in normal walking and turning 180° 
conditions. Thirdly, cognitive performance was measured through the participants’ 
generation of words and making calculations while undertaking motor tasks 
simultaneously for both static balance and gait measurements. Lastly, the functional 
correlation between cerebral activation in the prefrontal region and executive 
function was investigated using the fNIRS measurement for the two groups. 
It is acknowledged that there are a number of limitations associated with this 
study. Firstly, the relatively small sample size and the predominately mild severity of 
disease in the PD group may have affected the capacity to detect some of the 
relationships between cognitive function and balance and gait. Secondly, although 
the clinical balance and gait evaluations are all widely used in clinical settings and 
have excellent validity and reliability, the evaluation scales involve somewhat 
subjective factors. However, by using more objective measures of balance and gait, 
the executive impact on balance and gait has been further demonstrated in people 
with PD. Thirdly, the cognitive tasks required a vocalisation activity, which 
inevitably may have introduced somewhat influence into the biomechanical data. 
However, comparison with age- and gender-matched controls may, to some extent, 
eliminate the influence. Lastly, inherent constraints of fNIRS measurement (e.g. poor 
penetration-depth) may influence the results. 
8.3 CONCLUSION 
Overall, this preliminary study indicates deficits in executive function, 
particularly inhibition response and flexible ability, are associated with poorer 
performance of balance and gait for people with PD. The importance of this study is 
the utilisation of the cognitive loadings to detect the subtle change of postural sway 
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and gait characteristics in people with PD. Changes in PL could be a valuable 
indicator for the detection of executive impact on static postural instability for people 
with PD. The profound changes of gait parameters reflect the impact of executive 
function on postural stability and gait characteristics for people with PD. 
Furthermore, decreased brain activation in the prefrontal cortex is associated with 
decreased executive function in people with PD. 
8.4 RECOMMENDATIONS FOR PRACTICE AND FUTURE RESEARCH 
The findings provide a promising direction for future intervention research in 
PD. Early implementation of effective strategies of improving cognitive function 
could actually reduce the risk of falls and consequently enhance QOL in people with 
PD. Importantly, the fNIRS can be potentially implemented to actual gait 
examination. A future study could examine cortical activation while quietly standing 
or walking and performing an executive task simultaneously. More recently, a 
preliminary study of the structural and functional correlation in a PD study has 
received attention (Sharman et al., 2013) Given the higher rate of executive 
impairment and the potential for this to contribute to increased PIGD in people with 
PD, future studies are required to combine structural and functional approaches to 
elucidate the association between executive function and balance and gait difficulties 
in this population. 
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Appendix A 
Title: Trail making test A 
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Appendix B 
Title: Trail making test B 
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Appendix C 
Title: Sample size consideration 
 
Test name  Control  PD-N PD-MCI  Combined PD-N&PD-MCI 
Average 
variance 
Sample 
size 
Stroop interference 0.52 (0.50) 0.38 (0.70) -0.94 (1.30) -0.28 (1.00) 0.75 14 
Trail making test A 0.35 (0.70) 0.05 (0.70) -0.93 (0.90) -0.44 (0.80) 0.75 15 
Trail making test B 0.69 (0.50) 0.17(0.80) -1.07 (1.10) -0.45 (0.95) 0.73 7 
 
Note: Data derived from Table 2 of  a published article relevant to cognitive deficits in people with PD 
(Dalrymple-Alford et al., 2011). Values reported are mean (SD). PD-N: PD participants with normal cognition, 
PD-MCI: PD with mild cognitive impairment. 
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Appendix D 
Title: Testing orders for force plate measurement 
1 2 3 4 5 6 
Firm EO_1  Firm EC_1  Firm EO_1 _VF  Firm EC_1 _VF  Firm EO_1 _SN  Firm EC_1 _SN  
Firm EO_2  Firm EC_2  Firm EO_2 _VF  Firm EC_2 _VF  Firm EO_2 _SN  Firm EC_2 _SN  
Firm EO_3  Firm EC_3  Firm EO_3 _VF  Firm EC_3 _VF  Firm EO_3 _SN  Firm EC_3 _SN  
Firm EO_4  Firm EC_4  Firm EO_4_VF  Firm EC_4_VF  Firm EO_4_SN  Firm EC_4_SN  
Firm EC_1  Firm EO_1 _VF  Firm EC_1 _VF  Firm EO_1 _SN  Firm EC_1 _SN  Firm EO_1  
Firm EC_2  Firm EO_2 _VF  Firm EC_2 _VF  Firm EO_2 _SN  Firm EC_2 _SN  Firm EO_2  
Firm EC_3  Firm EO_3 _VF  Firm EC_3 _VF  Firm EO_3 _SN  Firm EC_3 _SN  Firm EO_3  
Firm EC_4  Firm EO_4_VF  Firm EC_4_VF  Firm EO_4_SN  Firm EC_4_SN  Firm EO_4  
Firm EC_1 _SN  Firm EO_1  Firm EC_1  Firm EO_1 _VF  Firm EC_1 _VF  Firm EO_1 _SN  
Firm EC_2 _SN  Firm EO_2  Firm EC_2  Firm EO_2 _VF  Firm EC_2 _VF  Firm EO_2 _SN  
Firm EC_3 _SN  Firm EO_3  Firm EC_3  Firm EO_3 _VF  Firm EC_3 _VF  Firm EO_3 _SN  
Firm EC_4_SN  Firm EO_4  Firm EC_4  Firm EO_4_VF  Firm EC_4_VF  Firm EO_4_SN  
Firm EO_1 _VF  Firm EC_1 _VF  Firm EO_1 _SN  Firm EC_1 _SN  Firm EO_1  Firm EC_1  
Firm EO_2 _VF  Firm EC_2 _VF  Firm EO_2 _SN  Firm EC_2 _SN  Firm EO_2  Firm EC_2  
Firm EO_3 _VF  Firm EC_3 _VF  Firm EO_3 _SN  Firm EC_3 _SN  Firm EO_3  Firm EC_3  
Firm EO_4_VF  Firm EC_4_VF  Firm EO_4_SN  Firm EC_4_SN  Firm EO_4  Firm EC_4  
Firm EO_1 _SN  Firm EC_1 _SN  Firm EO_1  Firm EC_1  Firm EO_1 _VF  Firm EC_1 _VF  
Firm EO_2 _SN  Firm EC_2 _SN  Firm EO_2  Firm EC_2  Firm EO_2 _VF  Firm EC_2 _VF  
Firm EO_3 _SN  Firm EC_3 _SN  Firm EO_3  Firm EC_3  Firm EO_3 _VF  Firm EC_3 _VF  
Firm EO_4_SN  Firm EC_4_SN  Firm EO_4  Firm EC_4  Firm EO_4_VF  Firm EC_4_VF  
Firm EC_1 _VF  Firm EO_1 _SN  Firm EC_1 _SN  Firm EO_1  Firm EC_1  Firm EO_1 _VF  
Firm EC_2 _VF  Firm EO_2 _SN  Firm EC_2 _SN  Firm EO_2  Firm EC_2  Firm EO_2 _VF  
Firm EC_3 _VF  Firm EO_3 _SN  Firm EC_3 _SN  Firm EO_3  Firm EC_3  Firm EO_3 _VF  
Firm EC_4_VF  Firm EO_4_SN  Firm EC_4_SN  Firm EO_4  Firm EC_4  Firm EO_4_VF  
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Appendix E 
Title: Testing protocol for gait measurement 
A B C D E F 
Walk_SL_1 Walk_Turn_1 Walk_SL_VF_1 Walk_Turn_VF_1 Walk_SL_SN_1 Walk_Turn_SN_1 
Walk_SL_2 Walk_Turn_2 Walk_SL_VF_2 Walk_Turn_VF_2 Walk_SL_SN_2 Walk_Turn_SN_2 
Walk_SL_3 Walk_Turn_3 Walk_SL_VF_3 Walk_Turn_VF_3 Walk_SL_SN_3 Walk_Turn_SN_3 
Walk_SL_4 Walk_Turn_4 Walk_SL_VF_4 Walk_Turn_VF_4 Walk_SL_SN_4 Walk_Turn_SN_4 
Walk_Turn_1 Walk_SL_VF_1 Walk_Turn_VF_1 Walk_SL_SN_1 Walk_Turn_SN_1 Walk_SL_1 
Walk_Turn_2 Walk_SL_VF_2 Walk_Turn_VF_2 Walk_SL_SN_2 Walk_Turn_SN_2 Walk_SL_2 
Walk_Turn_3 Walk_SL_VF_3 Walk_Turn_VF_3 Walk_SL_SN_3 Walk_Turn_SN_3 Walk_SL_3 
Walk_Turn_4 Walk_SL_VF_4 Walk_Turn_VF_4 Walk_SL_SN_4 Walk_Turn_SN_4 Walk_SL_4 
Walk_Turn_SN_1 Walk_SL_1 Walk_Turn_1 Walk_SL_VF_1 Walk_Turn_VF_1 Walk_SL_SN_1 
Walk_Turn_SN_2 Walk_SL_2 Walk_Turn_2 Walk_SL_VF_2 Walk_Turn_VF_2 Walk_SL_SN_2 
Walk_Turn_SN_3 Walk_SL_3 Walk_Turn_3 Walk_SL_VF_3 Walk_Turn_VF_3 Walk_SL_SN_3 
Walk_Turn_SN_4 Walk_SL_4 Walk_Turn_4 Walk_SL_VF_4 Walk_Turn_VF_4 Walk_SL_SN_4 
Walk_SL_VF_1 Walk_Turn_VF_1 Walk_SL_SN_1 Walk_Turn_SN_1 Walk_SL_1 Walk_Turn_1 
Walk_SL_VF_2 Walk_Turn_VF_2 Walk_SL_SN_2 Walk_Turn_SN_2 Walk_SL_2 Walk_Turn_2 
Walk_SL_VF_3 Walk_Turn_VF_3 Walk_SL_SN_3 Walk_Turn_SN_3 Walk_SL_3 Walk_Turn_3 
Walk_SL_VF_4 Walk_Turn_VF_4 Walk_SL_SN_4 Walk_Turn_SN_4 Walk_SL_4 Walk_Turn_4 
Walk_SL_SN_1 Walk_Turn_SN_1 Walk_SL_1 Walk_Turn_1 Walk_SL_VF_1 Walk_Turn_VF_1 
Walk_SL_SN_2 Walk_Turn_SN_2 Walk_SL_2 Walk_Turn_2 Walk_SL_VF_2 Walk_Turn_VF_2 
Walk_SL_SN_3 Walk_Turn_SN_3 Walk_SL_3 Walk_Turn_3 Walk_SL_VF_3 Walk_Turn_VF_3 
Walk_SL_SN_4 Walk_Turn_SN_4 Walk_SL_4 Walk_Turn_4 Walk_SL_VF_4 Walk_Turn_VF_4 
Walk_Turn_VF_1 Walk_SL_SN_1 Walk_Turn_SN_1 Walk_SL_1 Walk_Turn_1 Walk_SL_VF_1 
Walk_Turn_VF_2 Walk_SL_SN_2 Walk_Turn_SN_2 Walk_SL_2 Walk_Turn_2 Walk_SL_VF_2 
Walk_Turn_VF_3 Walk_SL_SN_3 Walk_Turn_SN_3 Walk_SL_3 Walk_Turn_3 Walk_SL_VF_3 
Walk_Turn_VF_4 Walk_SL_SN_4 Walk_Turn_SN_4 Walk_SL_4 Walk_Turn_4 Walk_SL_VF_4 
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Appendix F 
Title: Individual testing protocol 
 
Time 
  
ID 
 
     Trials Balance Task Gait Task 
1 Firm EC_1 _SN  329 Walk_Turn_SN _1 788 
2 Firm EC_2 _SN  269 Walk_Turn _SN_2 708 
3 Firm EC_3 _SN  449 Walk_Turn _SN_3 786 
4 Firm EC_4_SN  711 Walk_Turn_SN _4 815 
5 Firm EO_1  
 
Walk_SL_1 
 6 Firm EO_2  
 
Walk_SL_2 
 7 Firm EO_3  
 
Walk_SL_3 
 8 Firm EO_4  
 
Walk_SL_4 
 9 Firm EO_1 _SN  939 Walk_SL_SN_1 515 
10 Firm EO_2 _SN  468 Walk_SL_SN_2 825 
11 Firm EO_3 _SN  278 Walk_SL_SN_3 909 
12 Firm EO_4_SN  423 Walk_SL_SN_4 233 
13 Firm EC_1  
 
Walk_Turn _1 
 14 Firm EC_2  
 
Walk_Turn _2 
 15 Firm EC_3  
 
Walk_Turn _3 
 16 Firm EC_4  
 
Walk_Turn _4 
 17 Firm EC_1 _VF  C Walk_Turn _VF_1 B 
18 Firm EC_2 _VF  M Walk_Turn _VF_2 L 
19 Firm EC_3 _VF  P Walk_Turn _VF_3 T 
20 Firm EC_4_VF  L Walk_Turn _VF_4 R 
21 Firm EO_1 _VF  T Walk_SL_VF_1 P 
22 Firm EO_2 _VF  R Walk_SL_VF_2 M 
23 Firm EO_3 _VF  S Walk_SL_VF_3 C 
24 Firm EO_4_VF  B Walk_SL_VF_4 S 
 
